Substance list · United Kingdom
GB mandatory classification and labelling list (GB MCL list, GB CLP Article 38A), file of 19 May 2026 (page 6)
Labelling: mandatory hazard classification, labelling, specific concentration limits, M factors and ATEs.
- When it applies
- Every substance on the list and every mixture containing it, placed on the GB market
- Entries
- 4429
- Version date
- 2026-05-19
- Guide
- United Kingdom
Entries 2501 to 3000 of 4429
500 rows
| Substance | English name | CAS | EC | Type | Category | Threshold | Conditions |
|---|---|---|---|---|---|---|---|
| 2,2-dibromo-2-nitroethanol | 2,2-dibromo-2-nitroethanol | 69094-18-4 | 412-380-9 | substance | Expl. 1.1; Carc. 2; Acute Tox. 4 *; STOT RE 2 *; Skin Corr. 1A; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | * | STOT SE 3; | H335: C ≥ 1 % | Hazard statement codes: H201; H351; H302; H373 **; H314; H317; H400; H410. Labelling pictogram and signal word: GHS01; GHS08; GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H201; H351; H302; H373 **; H314; H317; H410. Notes: T |
| 3-chloro-2,4-difluoronitrobenzene | 3-chloro-2,4-difluoronitrobenzene | 3847-58-3 | 411-980-8 | substance | Acute Tox. 4 *; Skin Corr. 1B; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H302; H314; H317; H400; H410. Labelling pictogram and signal word: GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H302; H314; H317; H410 | |
| 2-nitro-2-phenyl-1,3-propanediol | 2-nitro-2-phenyl-1,3-propanediol | 5428-02-4 | 410-360-4 | substance | STOT RE 1; Acute Tox. 4 *; Acute Tox. 4 *; Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H372 **; H312; H302; H317; H411. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Dgr. Labelling hazard statements: H372 **; H312; H302; H317; H411. Supplementary hazard statements: EUH070 | |
| 2-chloro-6-(ethylamino)-4-nitrophenol | 2-chloro-6-(ethylamino)-4-nitrophenol | 131657-78-8 | 411-440-1 | substance | Acute Tox. 4 *; Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H302; H317; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H317; H411 | |
| 4-[(3-hydroxypropyl)amino]-3-nitrophenol | 4-[(3-hydroxypropyl)amino]-3-nitrophenol | 92952-81-3 | 406-305-9 | substance | Skin Irrit. 2; Aquatic Chronic 2 | Hazard statement codes: H315; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H315; H411 | |
| (E,Z)-4-chlorophenyl(cyclopropyl)ketone O- (4-nitrophenylmethyl)oxime | (E,Z)-4-chlorophenyl(cyclopropyl)ketone O- (4-nitrophenylmethyl)oxime | 94097-88-8 | 406-100-4 | substance | Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H317; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H317; H410 | |
| 2-bromo-2-nitropropanol | 2-bromo-2-nitropropanol | 24403-04-1 | 407-030-7 | substance | Acute Tox. 3 *; Acute Tox. 4 *; STOT RE 2 *; Skin Corr. 1B; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H311; H302; H373 **; H314; H317; H400; H410. Labelling pictogram and signal word: GHS06; GHS08; GHS05; GHS09; Dgr. Labelling hazard statements: H311; H302; H373 **; H314; H317; H410 | |
| 2-[(4-chloro-2-nitrophenyl)amino]ethanol | 2-[(4-chloro-2-nitrophenyl)amino]ethanol | 59320-13-7 | 413-280-8 | substance | Acute Tox. 4 *; Aquatic Chronic 2 | Hazard statement codes: H302; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H411 | |
| mesotrione (ISO); 2-[4-(methylsulfonyl)- 2-nitrobenzoyl]-1,3- cyclohexanedione | mesotrione (ISO); 2-[4-(methylsulfonyl)- 2-nitrobenzoyl]-1,3- cyclohexanedione | 104206- 82-8 | substance | Repr. 2; STOT RE 2; Aquatic Acute 1; Aquatic Chronic 1 | M = 10 | M = 10 | Hazard statement codes: H361d; H373 (eyes, nervous system); H400; H410. Labelling pictogram and signal word: GHS08; GHS09; Wng. Labelling hazard statements: H361d; H373 (eyes, nervous system); H410 | |
| 2-nitrotoluene | 2-nitrotoluene | 88-72-2 | 201-853-3 | substance | Carc. 1B; Muta. 1B; Repr. 2; Acute Tox. 4 *; Aquatic Chronic 2 | Hazard statement codes: H350; H340; H361f ***; H302; H411. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Dgr. Labelling hazard statements: H350; H340; H361f ***; H302; H411 | |
| sodium and potassium 4-(3-aminopropylamino)- 2,6-bis[3-(4-methoxy-2-sulfophenylazo)- 4-hydroxy-2-sulfo-7-naphthylamino]- 1,3,5-triazine | sodium and potassium 4-(3-aminopropylamino)- 2,6-bis[3-(4-methoxy-2-sulfophenylazo)- 4-hydroxy-2-sulfo-7-naphthylamino]- 1,3,5-triazine | 156769-97-0 | 416-280-6 | substance | Skin Sens. 1 | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317 | |
| musk xylene; 5-tert-butyl-2,4,6-trinitro-m-xylene | musk xylene; 5-tert-butyl-2,4,6-trinitro-m-xylene | 81-15-2 | 201-329-4 | substance | Expl. 1.1; Carc. 2; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H201; H351; H400; H410. Labelling pictogram and signal word: GHS01; GHS08; GHS09; Wng. Labelling hazard statements: H201; H351; H410. Notes: T | |
| musk ketone; 3,5-dinitro-2,6-dimethyl-4-tert-butylacetophenone; 4’-tert-butyl-2’, 6’-dimethyl-3’, 5’-dinitroacetophenone | musk ketone; 3,5-dinitro-2,6-dimethyl-4-tert-butylacetophenone; 4’-tert-butyl-2’, 6’-dimethyl-3’, 5’-dinitroacetophenone | 81-14-1 | 201-328-9 | substance | Carc. 2; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H351; H400; H410. Labelling pictogram and signal word: GHS08; GHS09; Wng. Labelling hazard statements: H351; H410 | |
| 1,4-dichloro-2-(1,1,2,3,3,3-hexafluoropropoxy)- 5-nitrobenzene | 1,4-dichloro-2-(1,1,2,3,3,3-hexafluoropropoxy)- 5-nitrobenzene | 130841-23-5 | 415-580-4 | substance | Acute Tox. 4 *; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H302; H317; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H317; H410 | |
| reaction mass of: 2-methylsulfanyl-4,6-bis- (2-hydroxy-4-methoxy-phenyl)-1,3,5-triazine; 2-(4,6-bis-methylsulfanyl-1,3,5-triazin-2-yl)- 5-methoxy-phenol | reaction mass of: 2-methylsulfanyl-4,6-bis- (2-hydroxy-4-methoxy-phenyl)-1,3,5-triazine; 2-(4,6-bis-methylsulfanyl-1,3,5-triazin-2-yl)- 5-methoxy-phenol | 156137-33-6 | 423-520-3 | substance | Skin Sens. 1 | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317 | |
| 4-mesyl-2-nitrotoluene | 4-mesyl-2-nitrotoluene | 1671-49-4 | 430-550-0 | substance | Repr. 2; Acute Tox. 4 *; Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H361f***; H302; H317; H412. Labelling pictogram and signal word: GHS08; GHS07; Wng. Labelling hazard statements: H361f***; H302; H317; H412 | |
| lithium potassium sodium N,N’’-bis{]6-[}7-[4-(4-chloro-1,3,5-triazin-2-yl)amino-4-(2-ureidophenylazo){]naphthalene-1,3,6-trisulfonato[}-N’-(2-aminoethyl) piperazine | lithium potassium sodium N,N’’-bis{]6-[}7-[4-(4-chloro-1,3,5-triazin-2-yl)amino-4-(2-ureidophenylazo){]naphthalene-1,3,6-trisulfonato[}-N’-(2-aminoethyl) piperazine | 427-850-9 | substance | Skin Sens. 1 | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317 | ||
| 1,4-dichloro-2-nitrobenzene | 1,4-dichloro-2-nitrobenzene | 89-61-2 | 201-923-3 | substance | Carc. 1B | Hazard statement codes: H350. Labelling pictogram and signal word: GHS08; Dgr. Labelling hazard statements: H350. Date of Secretary of State decision: 2025-09-12. Date of entry into legal effect: 2025-09-23. Final compliance date: 2027-03-23 | |
| trichloronitromethane; chloropicrin | trichloronitromethane; chloropicrin | 76-06-2 | 200-930-9 | substance | Acute Tox. 2 *; Acute Tox. 4 *; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2 | Hazard statement codes: H330; H302; H319; H335; H315. Labelling pictogram and signal word: GHS06; Dgr. Labelling hazard statements: H330; H302; H319; H335; H315 | |
| 1,1-dichloro-1-nitroethane | 1,1-dichloro-1-nitroethane | 594-72-9 | 209-854-0 | substance | Acute Tox. 3 *; Acute Tox. 3 *; Acute Tox. 3 * | Hazard statement codes: H331; H311; H301. Labelling pictogram and signal word: GHS06; Dgr. Labelling hazard statements: H331; H311; H301 | |
| chlorodinitrobenzene | chlorodinitrobenzene | substance | Acute Tox. 3 *; Acute Tox. 3 *; Acute Tox. 3 *; STOT RE 2 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H331; H311; H301; H373 **; H400; H410. Labelling pictogram and signal word: GHS06; GHS08; GHS09; Dgr. Labelling hazard statements: H331; H311; H301; H373 **; H410. Notes: C | |||
| 2-chloro-1,3,5-trinitrobenzene | 2-chloro-1,3,5-trinitrobenzene | 88-88-0 | 201-864-3 | substance | Expl. 1.1; Acute Tox. 2 *; Acute Tox. 1; Acute Tox. 2 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H201; H330; H310; H300; H400; H410. Labelling pictogram and signal word: GHS01; GHS06; GHS09; Dgr. Labelling hazard statements: H201; H330; H310; H300; H410 | |
| 1-chloro-4-nitrobenzene | 1-chloro-4-nitrobenzene | 100-00-5 | 202-809-6 | substance | Carc. 2; Muta. 2; Acute Tox. 3 *; Acute Tox. 3 *; Acute Tox. 3 *; STOT RE 2 *; Aquatic Chronic 2 | Hazard statement codes: H351; H341; H331; H311; H301; H373 **; H411. Labelling pictogram and signal word: GHS06; GHS08; GHS09; Dgr. Labelling hazard statements: H351; H341; H331; H311; H301; H373 **; H411 | |
| chloronitroanilines with the exception of those specified elsewhere in this Annex | chloronitroanilines with the exception of those specified elsewhere in this Annex | substance | Acute Tox. 2 *; Acute Tox. 1; Acute Tox. 2 *; STOT RE 2 *; Aquatic Chronic 2 | Hazard statement codes: H330; H310; H300; H373 **; H411. Labelling pictogram and signal word: GHS06; GHS08; GHS09; Dgr. Labelling hazard statements: H330; H310; H300; H373 **; H411. Notes: A C | |||
| 1-chloro-1-nitropropane | 1-chloro-1-nitropropane | 600-25-9 | 209-990-0 | substance | Acute Tox. 4 *; Acute Tox. 4 * | * | Hazard statement codes: H332; H302. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H332; H302 |
| 2,6-dichloro-4-nitroanisole | 2,6-dichloro-4-nitroanisole | 17742-69-7 | 403-350-6 | substance | Acute Tox. 3 *; Aquatic Chronic 2 | Hazard statement codes: H301; H411. Labelling pictogram and signal word: GHS06; GHS09; Dgr. Labelling hazard statements: H301; H411 | |
| 2-chloro-4-nitroaniline | 2-chloro-4-nitroaniline | 121-87-9 | 204-502-2 | substance | Acute Tox. 4 *; Aquatic Chronic 2 | Hazard statement codes: H302; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H411 | |
| 2-bromo-1-(2-furyl)-2-nitroethylene | 2-bromo-1-(2-furyl)-2-nitroethylene | 35950-52-8 | 406-110-9 | substance | Acute Tox. 4 *; STOT RE 2 *; Skin Corr. 1B; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H302; H373 **; H314; H317; H400; H410. Labelling pictogram and signal word: GHS08; GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H302; H373 **; H314; H317; H410 | |
| azobenzene | azobenzene | 103-33-3 | 203-102-5 | substance | Carc. 1B; Muta. 2; Acute Tox. 4 *; Acute Tox. 4 *; STOT RE 2 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H350; H341; H332; H302; H373 **; H400; H410. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Dgr. Labelling hazard statements: H350; H341; H332; H302; H373 **; H410 | |
| azoxybenzene | azoxybenzene | 495-48-7 | 207-802-1 | substance | Acute Tox. 4 *; Acute Tox. 4 * | Hazard statement codes: H332; H302. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H332; H302 | |
| fenaminosulf (ISO); sodium 4-dimethylaminobenzenediazosulphonate | fenaminosulf (ISO); sodium 4-dimethylaminobenzenediazosulphonate | 140-56-7 | 205-419-4 | substance | Acute Tox. 3 *; Acute Tox. 4 *; Aquatic Chronic 3 | Hazard statement codes: H301; H312; H412. Labelling pictogram and signal word: GHS06; Dgr. Labelling hazard statements: H301; H312; H412 | |
| methyl-ONN-azoxymethyl acetate; methyl azoxy methyl acetate | methyl-ONN-azoxymethyl acetate; methyl azoxy methyl acetate | 592-62-1 | 209-765-7 | substance | Carc. 1B; Repr. 1B | Hazard statement codes: H350; H360D ***. Labelling pictogram and signal word: GHS08; Dgr. Labelling hazard statements: H350; H360D *** | |
| disodium {5-[(4'-((2,6-hydroxy-3-((2- hydroxy-5-sulphophenyl)azo)phenyl)azo) (1,1'-biphenyl)-4-yl)azo]salicylato(4-)}cuprate( 2-); CI Direct Brown 95 | disodium {5-[(4'-((2,6-hydroxy-3-((2- hydroxy-5-sulphophenyl)azo)phenyl)azo) (1,1'-biphenyl)-4-yl)azo]salicylato(4-)}cuprate( 2-); CI Direct Brown 95 | 16071-86-6 | 240-221-1 | substance | Carc. 1B | Hazard statement codes: H350. Labelling pictogram and signal word: GHS08; Dgr. Labelling hazard statements: H350 | |
| 4-o-tolylazo-o-toluidine; 4-amino-2',3-dimethylazobenzene; fast garnet GBC base; AAT; o-aminoazotoluene | 4-o-tolylazo-o-toluidine; 4-amino-2',3-dimethylazobenzene; fast garnet GBC base; AAT; o-aminoazotoluene | 97-56-3 | 202-591-2 | substance | Carc. 1B; Skin Sens. 1 | Hazard statement codes: H350; H317. Labelling pictogram and signal word: GHS08; Dgr. Labelling hazard statements: H350; H317 | |
| tricyclazole (ISO); 5-methyl-1,2,4-triazolo(3,4-b)benzo-1,3- thiazole; | tricyclazole (ISO); 5-methyl-1,2,4-triazolo(3,4-b)benzo-1,3- thiazole; | 41814-78-2 | 255-559-5 | substance | Acute Tox. 4 * | Hazard statement codes: H302. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302 | |
| 4-aminoazobenzene; 4-phenylazoaniline | 4-aminoazobenzene; 4-phenylazoaniline | 60-09-3 | 200-453-6 | substance | Carc. 1B; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H350; H400; H410. Labelling pictogram and signal word: GHS08; GHS09; Dgr. Labelling hazard statements: H350; H410 | |
| sodium (1-(5-(4-(4-anilino-3-sulphophenylazo)- 2-methyl-5-methylsulphonamidophenylazo)- 4-hydroxy-2-oxido-3-(phenylazo) phenylazo)-5-nitro-4-sulphonato-2- naphtholato)iron(II) | sodium (1-(5-(4-(4-anilino-3-sulphophenylazo)- 2-methyl-5-methylsulphonamidophenylazo)- 4-hydroxy-2-oxido-3-(phenylazo) phenylazo)-5-nitro-4-sulphonato-2- naphtholato)iron(II) | 401-220-3 | substance | Acute Tox. 4 *; Aquatic Chronic 3 | Hazard statement codes: H332; H412. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H332; H412 | ||
| 2'-(2-cyano-4,6-dinitrophenylazo)-5'-(N,N-dipropylamino)propionanilide | 2'-(2-cyano-4,6-dinitrophenylazo)-5'-(N,N-dipropylamino)propionanilide | 106359-94-8 | 403-010-7 | substance | Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H317; H412. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317; H412 | |
| N,N,N',N'-tetramethyl-3,3'-(propylenebis (iminocarbonyl-4,1-phenylenazo(1,6-dihydro-2-hydroxy-4-methyl-6-oxopyridine-3,1-diyl)))di(propylammonium) dilactate | N,N,N',N'-tetramethyl-3,3'-(propylenebis (iminocarbonyl-4,1-phenylenazo(1,6-dihydro-2-hydroxy-4-methyl-6-oxopyridine-3,1-diyl)))di(propylammonium) dilactate | 403-340-1 | substance | Eye Dam. 1; Aquatic Chronic 2 | Hazard statement codes: H318; H411. Labelling pictogram and signal word: GHS05; GHS09; Dg. Labelling hazard statements: H318; H411 | ||
| reaction mass of 2,2-iminodiethanol 6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazole-7-sulfonate and 2-methylaminoethanol 6-methyl-2-(4-(2,4,6-riaminopyrimidin-5-ylazo)phenyl)benzothiazole-7-sulfonate and N,N-diethylpropane-1,3-diamine 6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazole-7-sulfonate | reaction mass of 2,2-iminodiethanol 6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazole-7-sulfonate and 2-methylaminoethanol 6-methyl-2-(4-(2,4,6-riaminopyrimidin-5-ylazo)phenyl)benzothiazole-7-sulfonate and N,N-diethylpropane-1,3-diamine 6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazole-7-sulfonate | 114565-65-0 | 403-410-1 | substance | Skin Sens. 1 | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317 | |
| trilithium-1-hydroxy-7-(3-sulfonatoanilino)-2-(3-methyl-4-(2-methoxy-4-(3-sulfonatophenylazo)phenylazo)phenylazo)naphthalene- 3-sulfonate | trilithium-1-hydroxy-7-(3-sulfonatoanilino)-2-(3-methyl-4-(2-methoxy-4-(3-sulfonatophenylazo)phenylazo)phenylazo)naphthalene- 3-sulfonate | 117409-78-6 | 403-650-7 | substance | Expl. 1.3 ****; Aquatic Chronic 2 | Hazard statement codes: H203; H411. Labelling pictogram and signal word: GHS01; GHS09; Dgr. Labelling hazard statements: H203; H411 | |
| (tetrasodium 1-(4-(3-acetamido-4-(4'-nitro-2,2'-disulfonatostilben-4-ylazo)anilino)-6-(2,5-disulfonatoanilino)-1,3,5-triazin-2-yl)-3-carboxypyridinium) hydroxide | (tetrasodium 1-(4-(3-acetamido-4-(4'-nitro-2,2'-disulfonatostilben-4-ylazo)anilino)-6-(2,5-disulfonatoanilino)-1,3,5-triazin-2-yl)-3-carboxypyridinium) hydroxide | 115099-55-3 | 404-250-5 | substance | Skin Sens. 1 | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317 | |
| tetrasodium 4-amino-5-hydroxy-6-(4-(2-(2-(sulfonatooxy)ethylsulfonyl)ethylcarbamoyl)phenylazo)-3-(4-(2-(sulfonatooxy)ethylsulfonyl) phenylazo)naphthalene-2,7-disulfonate | tetrasodium 4-amino-5-hydroxy-6-(4-(2-(2-(sulfonatooxy)ethylsulfonyl)ethylcarbamoyl)phenylazo)-3-(4-(2-(sulfonatooxy)ethylsulfonyl) phenylazo)naphthalene-2,7-disulfonate | 116889-78-2 | 404-320-5 | substance | Skin Sens. 1 | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317 | |
| reaction mass of 1,1'-((dihydroxyphenylene)bis(azo-3,1-phenylenazo(1-(3-dimethylaminopropyl)-1,2-dihydro-6-hydroxy-4-methyl-2-oxopyridine-5,3-diyl)))dipyridiniumdichloride dihydrochloride, mixed isomers and 1-(1-(3-dimethylaminopropyl)-5-(3-((4-(1-(3-dimethylaminopropyl)-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-5-pyridinio-3-pyridylazo)phenylazo)-2,4(or2,6 or3,5)-dihydroxyphenylazo) phenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-3-pyridyl)pyridiniumdichloride | reaction mass of 1,1'-((dihydroxyphenylene)bis(azo-3,1-phenylenazo(1-(3-dimethylaminopropyl)-1,2-dihydro-6-hydroxy-4-methyl-2-oxopyridine-5,3-diyl)))dipyridiniumdichloride dihydrochloride, mixed isomers and 1-(1-(3-dimethylaminopropyl)-5-(3-((4-(1-(3-dimethylaminopropyl)-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-5-pyridinio-3-pyridylazo)phenylazo)-2,4(or2,6 or3,5)-dihydroxyphenylazo) phenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-3-pyridyl)pyridiniumdichloride | 404-540-1 | substance | Skin Sens. 1 | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317 | ||
| 2-(4-(diethylaminopropylcarbamoyl)phenylazo)-3-oxo-N-(2,3-dihydro-2-oxobenzimidazol-5-yl)butyramide | 2-(4-(diethylaminopropylcarbamoyl)phenylazo)-3-oxo-N-(2,3-dihydro-2-oxobenzimidazol-5-yl)butyramide | 404-910-2 | substance | Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H317; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H317; H411 | ||
| tetraammonium 5-(4-(7-amino-1-hydroxy-3-sulfonato-2-naphthylazo)-6-sulfonato-1-naphthylazo)isophthalate | tetraammonium 5-(4-(7-amino-1-hydroxy-3-sulfonato-2-naphthylazo)-6-sulfonato-1-naphthylazo)isophthalate | 405-130-5 | substance | Skin Sens. 1 | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317 | ||
| tetralithium 6-amino-4-hydroxy-3-(7-sulfonato-4-(4-sulfonatophenylazo)-1-naphthylazo)naphthalene-2,7-disulfonate | tetralithium 6-amino-4-hydroxy-3-(7-sulfonato-4-(4-sulfonatophenylazo)-1-naphthylazo)naphthalene-2,7-disulfonate | 106028-58-4 | 405-150-4 | substance | Skin Sens. 1 | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317 | |
| tetrakis(tetramethylammonium) 6-amino-4-hydroxy-3-(7-sulfonato-4-(4-sulfonatophenylazo)-1-naphthylazo)naphthalene-2,7-disulfonate | tetrakis(tetramethylammonium) 6-amino-4-hydroxy-3-(7-sulfonato-4-(4-sulfonatophenylazo)-1-naphthylazo)naphthalene-2,7-disulfonate | 116340-05-7 | 405-170-3 | substance | Acute Tox. 3 *; Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H301; H317; H412. Labelling pictogram and signal word: GHS06; Dgr. Labelling hazard statements: H301; H317; H412 | |
| 2-(4-(4-cyano-3-methylisothiazol-5-ylazo)-N-ethyl-3-methylanilino)ethyl acetate | 2-(4-(4-cyano-3-methylisothiazol-5-ylazo)-N-ethyl-3-methylanilino)ethyl acetate | 405-480-9 | substance | Acute Tox. 4 *; STOT RE 2 *; Skin Irrit. 2; Aquatic Chronic 4 | Hazard statement codes: H302; H373 **; H315; H413. Labelling pictogram and signal word: GHS08; GHS07; Wng. Labelling hazard statements: H302; H373 **; H315; H413 | ||
| 4-dimethylaminobenzenediazonium 3-carboxy-4-hydroxybenzenesulfonate | 4-dimethylaminobenzenediazonium 3-carboxy-4-hydroxybenzenesulfonate | 404-980-4 | substance | Self-react. C; Acute Tox. 3 *; Acute Tox. 3 *; Acute Tox. 4 *; STOT RE 2 *; Eye Dam. 1; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H242; H331; H301; H312; H373 **; H318; H317; H400; H410. Labelling pictogram and signal word: GHS02; GHS06; GHS08; GHS05; GHS09; Dgr. Labelling hazard statements: H242; H331; H301; H312; H373 **; H318; H317; H410. Notes: T | ||
| disodium 7-(4,6-dichloro-1,3,5-triazin-2-ylamino)-4-hydroxy-3-(4-(2-(sulfonatooxy) ethylsulfonyl)phenylazo) naphthalene-2-sulfonate | disodium 7-(4,6-dichloro-1,3,5-triazin-2-ylamino)-4-hydroxy-3-(4-(2-(sulfonatooxy) ethylsulfonyl)phenylazo) naphthalene-2-sulfonate | 404-600-7 | substance | Skin Sens. 1 | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317 | ||
| Benzidine based azo dyes; 4,4'-diarylazobiphenyl dyes, with the exception of those specified elsewhere in this Annex | Benzidine based azo dyes; 4,4'-diarylazobiphenyl dyes, with the exception of those specified elsewhere in this Annex | substance | Carc. 1B | Hazard statement codes: H350. Labelling pictogram and signal word: GHS08; Dgr. Labelling hazard statements: H350. Notes: A | |||
| disodium 4-amino-3-[[4'-[(2,4-diaminophenyl)azo][1,1'-biphenyl]-4-yl]azo]-5-hydroxy-6-(phenylazo)naphtalene-2,7-disulphonate; C.I. Direct Black 38 | disodium 4-amino-3-[[4'-[(2,4-diaminophenyl)azo][1,1'-biphenyl]-4-yl]azo]-5-hydroxy-6-(phenylazo)naphtalene-2,7-disulphonate; C.I. Direct Black 38 | 1937-37-7 | 217-710-3 | substance | Carc. 1B; Repr. 2 | Hazard statement codes: H350; H361d ***. Labelling pictogram and signal word: GHS08; Dgr. Labelling hazard statements: H350; H361d *** | |
| tetrasodium 3,3'-[[1,1'-biphenyl]-4,4'-diylbis(azo)]bis[5-amino-4-hydroxynaphthalene-2,7-disulphonate]; C.I. Direct Blue 6 | tetrasodium 3,3'-[[1,1'-biphenyl]-4,4'-diylbis(azo)]bis[5-amino-4-hydroxynaphthalene-2,7-disulphonate]; C.I. Direct Blue 6 | 2602-46-2 | 220-012-1 | substance | Carc. 1B; Repr. 2 | Hazard statement codes: H350; H361d ***. Labelling pictogram and signal word: GHS08; Dgr. Labelling hazard statements: H350; H361d *** | |
| disodium 3,3'-[[1,1'-biphenyl]-4,4'-diylbis(azo)]bis(4-aminonaphthalene-1-sulphonate); C.I. Direct Red 28 | disodium 3,3'-[[1,1'-biphenyl]-4,4'-diylbis(azo)]bis(4-aminonaphthalene-1-sulphonate); C.I. Direct Red 28 | 573-58-0 | 209-358-4 | substance | Carc. 1B; Repr. 2 | Hazard statement codes: H350; H361d ***. Labelling pictogram and signal word: GHS08; Dgr. Labelling hazard statements: H350; H361d *** | |
| C,C'-azodi(formamide) | C,C'-azodi(formamide) | 123-77-3 | 204-650-8 | substance | Resp. Sens. 1 | Hazard statement codes: H334. Labelling pictogram and signal word: GHS08; Dgr. Labelling hazard statements: H334. Notes: G | |
| o-dianisidine based azo dyes; 4,4'-diarylazo-3,3'-dimethoxybiphenyl dyes, with the exception of those mentioned elsewhere in this Annex | o-dianisidine based azo dyes; 4,4'-diarylazo-3,3'-dimethoxybiphenyl dyes, with the exception of those mentioned elsewhere in this Annex | substance | Carc. 1B | Hazard statement codes: H350. Labelling pictogram and signal word: GHS08; Dgr. Labelling hazard statements: H350. Notes: A | |||
| o-tolidine based dyes; 4,4'-diarylazo-3,3'-dimethylbiphenyl dyes, with the exception of those mentioned elsewhere in this Annex | o-tolidine based dyes; 4,4'-diarylazo-3,3'-dimethylbiphenyl dyes, with the exception of those mentioned elsewhere in this Annex | substance | Carc. 1B | Hazard statement codes: H350. Labelling pictogram and signal word: GHS08; Dgr. Labelling hazard statements: H350. Notes: A | |||
| 4,4'-(4-iminocyclohexa-2,5-dienylidenemethylene)dianiline hydrochloride; C.I. Basic Red 9 | 4,4'-(4-iminocyclohexa-2,5-dienylidenemethylene)dianiline hydrochloride; C.I. Basic Red 9 | 569-61-9 | 209-321-2 | substance | Carc. 1B | Hazard statement codes: H350. Labelling pictogram and signal word: GHS08; Dgr. Labelling hazard statements: H350 | |
| 1,4,5,8-tetraaminoanthraquinone; C.I. Disperse Blue 1 | 1,4,5,8-tetraaminoanthraquinone; C.I. Disperse Blue 1 | 2475-45-8 | 219-603-7 | substance | Carc. 1B; Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1 | Hazard statement codes: H350; H315; H318; H317. Labelling pictogram and signal word: GHS08; GHS05; GHS07; Dgr. Labelling hazard statements: H350; H315; H318; H317 | |
| hexasodium [4,4''-azoxybis(2,2'-disulfonatostilbene-4,4'-diylazo)]-bis[5'-sulfonatobenzene-2,2'- diolato-O(2),O(2),N(1)]-copper(II) | hexasodium [4,4''-azoxybis(2,2'-disulfonatostilbene-4,4'-diylazo)]-bis[5'-sulfonatobenzene-2,2'- diolato-O(2),O(2),N(1)]-copper(II) | 82027-60-9 | 400-020-3 | substance | Aquatic Chronic 2 | Hazard statement codes: H411. Labelling pictogram and signal word: GHS09. Labelling hazard statements: H411 | |
| N-(5-(bis(2-methoxyethyl)amino)-2-((5-nitro-2,1-benzisothiazol-3-yl)azo)phenylacetamide | N-(5-(bis(2-methoxyethyl)amino)-2-((5-nitro-2,1-benzisothiazol-3-yl)azo)phenylacetamide | 105076-77-5 | 402-430-8 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | |
| tetralithium 6-amino-4-hydroxy-3-[7-sulfonato-4-(5-sulfonato-2-naphthylazo)-1-naphthylazo]naphthalene-2,7-disulfonate | tetralithium 6-amino-4-hydroxy-3-[7-sulfonato-4-(5-sulfonato-2-naphthylazo)-1-naphthylazo]naphthalene-2,7-disulfonate | 107246-80-0 | 403-660-1 | substance | Aquatic Chronic 2 | Hazard statement codes: H411. Labelling pictogram and signal word: GHS09. Labelling hazard statements: H411 | |
| 2-(4-(5,6(or 6,7)-dichloro-1,3-benzothiazol-2-ylazo)-N-methyl-m-toluidino)ethyl acetate | 2-(4-(5,6(or 6,7)-dichloro-1,3-benzothiazol-2-ylazo)-N-methyl-m-toluidino)ethyl acetate | 405-440-0 | substance | Skin Sens. 1 | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317 | ||
| 3(or 5)-(4-(N-benzyl-N-ethylamino)-2-methylphenylazo)-1,4-dimethyl-1,2,4-triazolium methylsulphate | 3(or 5)-(4-(N-benzyl-N-ethylamino)-2-methylphenylazo)-1,4-dimethyl-1,2,4-triazolium methylsulphate | 124584-00-5 | 406-055-0 | substance | Acute Tox. 4 *; Eye Dam. 1; Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H302; H318; H317; H411. Labelling pictogram and signal word: GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H302; H318; H317; H411 | |
| trisodium 1-hydroxynaphthalene-2-azo-4'(5',5''-dimethylbiphenyl)-4''-azo(4''-phenylsulfonyloxybenzene)-2',2'',4-trisulfonate | trisodium 1-hydroxynaphthalene-2-azo-4'(5',5''-dimethylbiphenyl)-4''-azo(4''-phenylsulfonyloxybenzene)-2',2'',4-trisulfonate | 406-820-9 | substance | Eye Irrit. 2 | Hazard statement codes: H319. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H319 | ||
| 7-[((4,6-dichloro-1,3,5-triazin-2-yl)amino)-4-hydroxy-3-(4-((2-sulfoxy)ethyl)sulfonyl)phenylazo]naphthalene-2-sulfonic acid | 7-[((4,6-dichloro-1,3,5-triazin-2-yl)amino)-4-hydroxy-3-(4-((2-sulfoxy)ethyl)sulfonyl)phenylazo]naphthalene-2-sulfonic acid | 117715-57-8 | 407-050-6 | substance | Skin Sens. 1 | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317 | |
| 3-(5-acetylamino-4-(4-[4,6-bis(3-diethylaminopropylamino)-1,3,5-triazin-2-ylamino]phenylazo)-2-(2-methoxyethoxy)phenylazo)-6-amino-4-hydroxy-2-naphthalenesulfonic acid | 3-(5-acetylamino-4-(4-[4,6-bis(3-diethylaminopropylamino)-1,3,5-triazin-2-ylamino]phenylazo)-2-(2-methoxyethoxy)phenylazo)-6-amino-4-hydroxy-2-naphthalenesulfonic acid | 115099-58-6 | 407-670-7 | substance | Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H400; H410. Labelling pictogram and signal word: GHS09; Wng. Labelling hazard statements: H410 | |
| 2-[[4[[4,6-bis[[3-(diethylamino)propyl]amino]-1,3,5-triazine-2-yl]amino]phenyl]azo]-N-(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)-3-oxobutanamide | 2-[[4[[4,6-bis[[3-(diethylamino)propyl]amino]-1,3,5-triazine-2-yl]amino]phenyl]azo]-N-(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)-3-oxobutanamide | 98809-11-1 | 407-680-1 | substance | Eye Dam. 1; Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H318; H317; H411. Labelling pictogram and signal word: GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H318; H317; H411 | |
| trisodium 5-amino-3-[5-(2-bromoacryloylamino)-2-sulfonatophenylazo]-4-hydroxy-6-(4-vinylsulfonylphenylazo)naphthalene-2,7- disulfonate | trisodium 5-amino-3-[5-(2-bromoacryloylamino)-2-sulfonatophenylazo]-4-hydroxy-6-(4-vinylsulfonylphenylazo)naphthalene-2,7- disulfonate | 136213-71-3 | 411-770-6 | substance | Aquatic Chronic 3 | Hazard statement codes: H412. Labelling pictogram and signal word: —. Labelling hazard statements: H412 | |
| reaction mass of: trisodium N(1')-N(2):N(1''')-N(2'')-η-6-[2-amino-4-(or 6)-hydroxy-(or 4-amino-2-hydroxy)phenylazo]-6''-(1-carbaniloyl-2-hydroxyprop-1-enylazo)-5',5'''-disulfamoyl-3,3''-disulfonatobis(naphthalene-2,1'-azobenzene-1,2'-diolato-O(1),O(2'))-chromate; trisodium N(1')-N(2):N(1''')-N(2'')-η-6,6''-bis(1-carbaniloyl-2-hydroxyprop-1-enylazo)-5',5'''-disulfamoyl-3,3''-disulfonatobis (naphthalene-2,1'azobenzene-1,2'-diolato-O(1),O(2'))-chromate; trisodium N(1')-N(2):N(1''')-N(2'')-η-6,6''-bis[2-amino-4-(or 6)-hydroxy-(or 4-amino-2-hydroxy)phenylazo]5',5'''-disulfamoyl-3,3''-disulfonatobis(naphthalene-2,1'azobenzene-1,2'-diolato-O(1),O(2'))-chromate (2:1:1) | reaction mass of: trisodium N(1')-N(2):N(1''')-N(2'')-η-6-[2-amino-4-(or 6)-hydroxy-(or 4-amino-2-hydroxy)phenylazo]-6''-(1-carbaniloyl-2-hydroxyprop-1-enylazo)-5',5'''-disulfamoyl-3,3''-disulfonatobis(naphthalene-2,1'-azobenzene-1,2'-diolato-O(1),O(2'))-chromate; trisodium N(1')-N(2):N(1''')-N(2'')-η-6,6''-bis(1-carbaniloyl-2-hydroxyprop-1-enylazo)-5',5'''-disulfamoyl-3,3''-disulfonatobis (naphthalene-2,1'azobenzene-1,2'-diolato-O(1),O(2'))-chromate; trisodium N(1')-N(2):N(1''')-N(2'')-η-6,6''-bis[2-amino-4-(or 6)-hydroxy-(or 4-amino-2-hydroxy)phenylazo]5',5'''-disulfamoyl-3,3''-disulfonatobis(naphthalene-2,1'azobenzene-1,2'-diolato-O(1),O(2'))-chromate (2:1:1) | 402-850-1 | substance | Eye Dam. 1; Aquatic Chronic 3 | Hazard statement codes: H318; H412. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318; H412 | ||
| reaction mass of: tert-alkyl(C12-C14)ammonium bis[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]-chromate(1-); tert-alkyl(C12-C14)ammonium bis[1-[(2-hydroxy-4-nitrophenyl)azo]-2-naphthalenolato(2-)]-chromate(1-); tert-alkyl(C12-C14)ammonium bis[1-[[5-(1,1-dimethylpropyl)-2-hydroxy-3-nitrophenyl]azo]-2-naphthalenolato(2-)]-chromate(1-); tert-alkyl(C12-C14)ammonium [[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]-[1-[(2-hydroxy-5-nitrophenyl)azo]- 2-naphthalenolato(2-)]]-chromate(1-); tert-alkyl(C12-C14)ammonium [[1-[[5-(1,1-dimethylpropyl)-2-hydroxy-3-nitrophenyl]azo]-2-naphthalenolato(2-)]-[1-[(2-hydroxy- 5-nitrophenyl)azo]-2-naphthalenolato(2-)]]-chromate(1-); tert-alkyl(C12-C14)ammonium ((1-(4(or 5)-nitro-2-oxidophenylazo)-2-naphtholato)(1-(3-nitro-2-oxido-5-pentylphenylazo)-2- naphtholato))chromate(1-) | reaction mass of: tert-alkyl(C12-C14)ammonium bis[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]-chromate(1-); tert-alkyl(C12-C14)ammonium bis[1-[(2-hydroxy-4-nitrophenyl)azo]-2-naphthalenolato(2-)]-chromate(1-); tert-alkyl(C12-C14)ammonium bis[1-[[5-(1,1-dimethylpropyl)-2-hydroxy-3-nitrophenyl]azo]-2-naphthalenolato(2-)]-chromate(1-); tert-alkyl(C12-C14)ammonium [[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]-[1-[(2-hydroxy-5-nitrophenyl)azo]- 2-naphthalenolato(2-)]]-chromate(1-); tert-alkyl(C12-C14)ammonium [[1-[[5-(1,1-dimethylpropyl)-2-hydroxy-3-nitrophenyl]azo]-2-naphthalenolato(2-)]-[1-[(2-hydroxy- 5-nitrophenyl)azo]-2-naphthalenolato(2-)]]-chromate(1-); tert-alkyl(C12-C14)ammonium ((1-(4(or 5)-nitro-2-oxidophenylazo)-2-naphtholato)(1-(3-nitro-2-oxido-5-pentylphenylazo)-2- naphtholato))chromate(1-) | 117527-94-3 | 403-720-7 | substance | Aquatic Chronic 2 | Hazard statement codes: H411. Labelling pictogram and signal word: GHS09. Labelling hazard statements: H411 | |
| 2-[4-[N-(4-acetoxybutyl)-N-ethyl]amino-2-methylphenylazo]-3-acetyl-5-nitrothiophene | 2-[4-[N-(4-acetoxybutyl)-N-ethyl]amino-2-methylphenylazo]-3-acetyl-5-nitrothiophene | 404-830-8 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | ||
| 4,4'-diamino-2-methylazobenzene | 4,4'-diamino-2-methylazobenzene | 43151-99-1 | 407-590-2 | substance | Acute Tox. 3 *; STOT RE 2 *; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H301; H373 **; H317; H400; H410. Labelling pictogram and signal word: GHS06; GHS08; GHS09; Dgr. Labelling hazard statements: H301; H373 **; H317; H410 | |
| reaction mass of: 2-[[4-[N-ethyl-N-(2-acetoxyethyl)amino]phenyl]azo]-5,6-dichlorobenzothiazole; 2-[[4-[N-ethyl-N-(2-acetoxyethyl)amino]phenyl]azo]-6,7-dichlorobenzothiazole (1:1) | reaction mass of: 2-[[4-[N-ethyl-N-(2-acetoxyethyl)amino]phenyl]azo]-5,6-dichlorobenzothiazole; 2-[[4-[N-ethyl-N-(2-acetoxyethyl)amino]phenyl]azo]-6,7-dichlorobenzothiazole (1:1) | 111381-11-4 | 407-890-3 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | |
| reaction mass of: 2-[[4-[bis(2-acetoxyethyl)amino]phenyl]azo]-5,6-dichlorobenzothiazole; 2-[[4-[bis(2-acetoxyethyl)amino]phenyl]azo]-6,7-dichlorobenzothiazole (1:1) | reaction mass of: 2-[[4-[bis(2-acetoxyethyl)amino]phenyl]azo]-5,6-dichlorobenzothiazole; 2-[[4-[bis(2-acetoxyethyl)amino]phenyl]azo]-6,7-dichlorobenzothiazole (1:1) | 111381-12-5 | 407-900-6 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | |
| reaction mass of 7-[4-(3-diethylaminopropylamino)-6-(3-diethylammoniopropylamino)-1,3,5-triazin-2-ylamino]-4-hydroxy-3-(4-phenylazophenylazo)-naphthalene-2-sulfonate, acetic acid, lactic acid (2:1:1) | reaction mass of 7-[4-(3-diethylaminopropylamino)-6-(3-diethylammoniopropylamino)-1,3,5-triazin-2-ylamino]-4-hydroxy-3-(4-phenylazophenylazo)-naphthalene-2-sulfonate, acetic acid, lactic acid (2:1:1) | 118658-98-3 | 408-000-6 | substance | STOT RE 2 *; Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H373 **; H317; H412. Labelling pictogram and signal word: GHS08; Wng. Labelling hazard statements: H373 **; H317; H412 | |
| reaction mass of: pentasodium 7-amino-3-[[4-[[4-[[4-[[4-[(6-amino-1-hydroxy-3-sulfonato-2-naphthyl)azo]-7-sulfonato-1-naphthyl]azo]phenyl]amino]-3-sulfonatophenyl]azo]-6-sulfonato-1-naphthyl]azo]-4-hydroxynaphthalen-2-sulfonate; pentasodium 7-amino-8-[4-[4-[4-[4-(2-amino-5-hydroxy-7-sulfonato-naphthalen-1-ylazo)-7-sulfonatonaphthalen-1-ylazo]-phenylamino]-3-sulfonato-phenylazo]-6-sulfonato-naphthalen-1-ylazo]-4-hydroxy-naphthalene-2-sulfonate; pentasodium 7-amino-8-[4-[4-[4-[4-(6-amino-1-hydroxy-3-sulfonato-naphthalen-1-ylazo)-7-sulfonatonaphthalen-1-ylazo]-phenylamino]-3-sulfonato-phenylazo]-6-sulfonato-naphthalen-1-ylazo]-4-hydroxy-naphthalene-2-sulfonate; tetrasodium 7-amino-4-hydroxy-3-[4-[4-[4-(4-hydroxy-7-sulfonato-naphthalen-1-ylazo)-2-sulfonato-phenylamino]phenylazo]-6-sulfonato-naphthalen-1-ylazo]naphthalene-2-sulfonate; tetrasodium 7-amino-4-hydroxy-3-[4-[4-[4-(4-amino-7-sulfonato-naphthalen-1-ylazo)-2-sulfonato-phenylamino]phenylazo]-6-sulfonato-naphthalen-1-ylazo]naphthalene-2-sulfonate | reaction mass of: pentasodium 7-amino-3-[[4-[[4-[[4-[[4-[(6-amino-1-hydroxy-3-sulfonato-2-naphthyl)azo]-7-sulfonato-1-naphthyl]azo]phenyl]amino]-3-sulfonatophenyl]azo]-6-sulfonato-1-naphthyl]azo]-4-hydroxynaphthalen-2-sulfonate; pentasodium 7-amino-8-[4-[4-[4-[4-(2-amino-5-hydroxy-7-sulfonato-naphthalen-1-ylazo)-7-sulfonatonaphthalen-1-ylazo]-phenylamino]-3-sulfonato-phenylazo]-6-sulfonato-naphthalen-1-ylazo]-4-hydroxy-naphthalene-2-sulfonate; pentasodium 7-amino-8-[4-[4-[4-[4-(6-amino-1-hydroxy-3-sulfonato-naphthalen-1-ylazo)-7-sulfonatonaphthalen-1-ylazo]-phenylamino]-3-sulfonato-phenylazo]-6-sulfonato-naphthalen-1-ylazo]-4-hydroxy-naphthalene-2-sulfonate; tetrasodium 7-amino-4-hydroxy-3-[4-[4-[4-(4-hydroxy-7-sulfonato-naphthalen-1-ylazo)-2-sulfonato-phenylamino]phenylazo]-6-sulfonato-naphthalen-1-ylazo]naphthalene-2-sulfonate; tetrasodium 7-amino-4-hydroxy-3-[4-[4-[4-(4-amino-7-sulfonato-naphthalen-1-ylazo)-2-sulfonato-phenylamino]phenylazo]-6-sulfonato-naphthalen-1-ylazo]naphthalene-2-sulfonate | 415-350-3 | substance | Eye Dam. 1; Aquatic Chronic 3 | Hazard statement codes: H318; H412. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318; H412 | ||
| 2-(4-(N-ethyl-N-(2-hydroxy)ethyl)amino-2-methylphenyl)azo-6-methoxy-3-methylbenzothiazolium chloride | 2-(4-(N-ethyl-N-(2-hydroxy)ethyl)amino-2-methylphenyl)azo-6-methoxy-3-methylbenzothiazolium chloride | 136213-74-6 | 411-110-7 | substance | Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H400; H410. Labelling pictogram and signal word: GHS09; Wng. Labelling hazard statements: H410 | |
| monosodium aqua-[5-[[2,4-dihydroxy-5-[(2-hydroxy-3,5-dinitrophenyl)azo]phenyl]azo]-2-naphthalensulfonate], iron complex | monosodium aqua-[5-[[2,4-dihydroxy-5-[(2-hydroxy-3,5-dinitrophenyl)azo]phenyl]azo]-2-naphthalensulfonate], iron complex | 400-720-9 | substance | Aquatic Chronic 3 | Hazard statement codes: H412. Labelling pictogram and signal word: —. Labelling hazard statements: H412 | ||
| 2,2'-azobis[2-methylpropionamidine] dihydrochloride | 2,2'-azobis[2-methylpropionamidine] dihydrochloride | 2997-92-4 | 221-070-0 | substance | Acute Tox. 4 *; Skin Sens. 1 | Hazard statement codes: H302; H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302; H317 | |
| C.I. Disperse Yellow 3; N-[4-[(2-hydroxy-5-methylphenyl)azo]phenyl]acetamide | C.I. Disperse Yellow 3; N-[4-[(2-hydroxy-5-methylphenyl)azo]phenyl]acetamide | 2832-40-8 | 220-600-8 | substance | Carc. 2; Skin Sens. 1 | Hazard statement codes: H351; H317. Labelling pictogram and signal word: GHS08; GHS07; Wng. Labelling hazard statements: H351; H317 | |
| C.I. Solvent Yellow 14; 1-phenylazo-2-naphthol | C.I. Solvent Yellow 14; 1-phenylazo-2-naphthol | 842-07-9 | 212-668-2 | substance | Carc. 2; Muta. 2; Skin Sens. 1; Aquatic Chronic 4 | Hazard statement codes: H351; H341; H317; H413. Labelling pictogram and signal word: GHS08; GHS07; Wng. Labelling hazard statements: H351; H341; H317; H413 | |
| 6-hydroxy-1-(3-isopropoxypropyl)-4-methyl-2-oxo-5-[4-(phenylazo)phenylazo]-1,2-dihydro-3-pyridinecarbonitrile | 6-hydroxy-1-(3-isopropoxypropyl)-4-methyl-2-oxo-5-[4-(phenylazo)phenylazo]-1,2-dihydro-3-pyridinecarbonitrile | 85136-74-9 | 400-340-3 | substance | Carc. 1B; Aquatic Chronic 4 | Hazard statement codes: H350; H413. Labelling pictogram and signal word: GHS08; Wng. Labelling hazard statements: H350; H413 | |
| (6-(4-hydroxy-3-(2-methoxyphenylazo)-2-sulfonato-7-naphthylamino)-1,3,5-triazin-2,4-diyl)bis[(amino-1-methylethyl)ammonium] formate | (6-(4-hydroxy-3-(2-methoxyphenylazo)-2-sulfonato-7-naphthylamino)-1,3,5-triazin-2,4-diyl)bis[(amino-1-methylethyl)ammonium] formate | 108225-03-2 | 402-060-7 | substance | Carc. 1B; Eye Dam. 1; Aquatic Chronic 2 | Hazard statement codes: H350; H318; H411. Labelling pictogram and signal word: GHS08; GHS05; GHS09; Dgr. Labelling hazard statements: H350; H318; H411 | |
| octasodium 2-(6-(4-chloro-6-(3-(N-methyl-N-(4-chloro-6-(3,5-disulfonato-2-naphthylazo)-1-hydroxy-6-naphthylamino)-1,3,5-triazin-2-yl)aminomethyl)phenylamino)-1,3,5-triazin-2-ylamino)-3,5-disulfonato-1-hydroxy-2-naphthylazo)naphthalene-1,5-disulfonate | octasodium 2-(6-(4-chloro-6-(3-(N-methyl-N-(4-chloro-6-(3,5-disulfonato-2-naphthylazo)-1-hydroxy-6-naphthylamino)-1,3,5-triazin-2-yl)aminomethyl)phenylamino)-1,3,5-triazin-2-ylamino)-3,5-disulfonato-1-hydroxy-2-naphthylazo)naphthalene-1,5-disulfonate | 148878-21-1 | 412-960-1 | substance | Eye Dam. 1; Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H318; H317; H412. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H318; H317; H412 | |
| reaction mass of: sodium 5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonatonaphthalen-2-ylazo]-isophthalate; ammonium 5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonatonaphthalen-2-ylazo]-isophthalate; 5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonaphthalen-2-ylazo]-isophthalic acid | reaction mass of: sodium 5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonatonaphthalen-2-ylazo]-isophthalate; ammonium 5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonatonaphthalen-2-ylazo]-isophthalate; 5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonaphthalen-2-ylazo]-isophthalic acid | 187285-15-0 | 413-180-4 | substance | Eye Dam. 1 | Hazard statement codes: H318. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318 | |
| disodium 5-[5-[4-(5-chloro-2,6-difluoropyrimidin-4-ylamino)benzamido]-2-sulfonatophenylazo]-1-ethyl-6-hydroxy-4-methyl- 2-oxo-3-pyridylmethylsulfonate | disodium 5-[5-[4-(5-chloro-2,6-difluoropyrimidin-4-ylamino)benzamido]-2-sulfonatophenylazo]-1-ethyl-6-hydroxy-4-methyl- 2-oxo-3-pyridylmethylsulfonate | 412-530-3 | substance | Eye Dam. 1; Skin Sens. 1 | Hazard statement codes: H318; H317. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H318; H317 | ||
| octasodium 2-(8-(4-chloro-6-(3-((4-chloro-6-(3,6-disulfonato-2-(1,5-disulfonatonaphthalen-2-ylazo)-1-hydroxynaphthalen-8-ylamino)-1,3,5-triazin-2-yl)aminomethyl)phenylamino)-1,3,5-triazin-2-ylamino)-3,6-disulfonato-1-hydroxynaphthalen-2-ylazo) naphthalene-1,5-disulfonate | octasodium 2-(8-(4-chloro-6-(3-((4-chloro-6-(3,6-disulfonato-2-(1,5-disulfonatonaphthalen-2-ylazo)-1-hydroxynaphthalen-8-ylamino)-1,3,5-triazin-2-yl)aminomethyl)phenylamino)-1,3,5-triazin-2-ylamino)-3,6-disulfonato-1-hydroxynaphthalen-2-ylazo) naphthalene-1,5-disulfonate | 413-550-5 | substance | Skin Irrit. 2; Eye Dam. 1 | Hazard statement codes: H315; H318. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H315; H318 | ||
| trisodium [4'-(8-acetylamino-3,6-disulfonato-2-naphthylazo)-4''-(6-benzoylamino-3-sulfonato-2-naphthylazo)-biphenyl-1,3',3'',1'''-tetraolato-O,O',O'',O''']copper(II) | trisodium [4'-(8-acetylamino-3,6-disulfonato-2-naphthylazo)-4''-(6-benzoylamino-3-sulfonato-2-naphthylazo)-biphenyl-1,3',3'',1'''-tetraolato-O,O',O'',O''']copper(II) | 164058-22-4 | 413-590-3 | substance | Carc. 1B | Hazard statement codes: H350. Labelling pictogram and signal word: GHS08; Dgr. Labelling hazard statements: H350 | |
| 4-(3,4-dichlorophenylazo)-2,6-di-sec-butylphenol | 4-(3,4-dichlorophenylazo)-2,6-di-sec-butylphenol | 124719-26-2 | 410-600-8 | substance | STOT RE 2 *; Skin Irrit. 2; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H373 **; H315; H400; H410. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Wng. Labelling hazard statements: H373 **; H315; H410 | |
| 4-(4-nitrophenylazo)-2,6-di-sec-butyl-phenol | 4-(4-nitrophenylazo)-2,6-di-sec-butyl-phenol | 111850-24-9 | 410-610-2 | substance | STOT RE 2 *; Eye Irrit. 2; Skin Irrit. 2; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H373 **; H319; H315; H317; H400; H410. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Wng. Labelling hazard statements: H373 **; H319; H315; H317; H410 | |
| tetrasodium 5-[4-chloro-6-(N-ethyl-anilino)- 1,3,5-triazin-2-ylamino]-4-hydroxy-3-(1,5- disulfonatonaphthalen-2-ylazo)-naphthalene- 2,7-disulfonate | tetrasodium 5-[4-chloro-6-(N-ethyl-anilino)- 1,3,5-triazin-2-ylamino]-4-hydroxy-3-(1,5- disulfonatonaphthalen-2-ylazo)-naphthalene- 2,7-disulfonate | 130201-57-9 | 411-540-5 | substance | Eye Dam. 1; Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H318; H317; H411. Labelling pictogram and signal word: GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H318; H317; H411 | |
| reaction mass of: bis(tris(2-(2-hydroxy (1-methyl)ethoxy)ethyl)ammonium) 7-anilino-4-hydroxy-3-(2-methoxy-5-methyl-4-(4-sulfonatophenylazo)phenylazo) naphthalene-2-sulfonate; bis(tris(2-(2-hydroxy(2-methyl)ethoxy)ethyl)ammonium) 7-anilino-4-hydroxy-3-(2-methoxy-5-methyl-4-(4-sulfonatophenylazo)phenylazo) naphthalene-2-sulfonate | reaction mass of: bis(tris(2-(2-hydroxy (1-methyl)ethoxy)ethyl)ammonium) 7-anilino-4-hydroxy-3-(2-methoxy-5-methyl-4-(4-sulfonatophenylazo)phenylazo) naphthalene-2-sulfonate; bis(tris(2-(2-hydroxy(2-methyl)ethoxy)ethyl)ammonium) 7-anilino-4-hydroxy-3-(2-methoxy-5-methyl-4-(4-sulfonatophenylazo)phenylazo) naphthalene-2-sulfonate | 406-910-8 | substance | Acute Tox. 4 *; Aquatic Chronic 3 | Hazard statement codes: H302; H412. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302; H412 | ||
| tetrasodium 4-amino-3,6-bis(5-[4-chloro-6-(2-hydroxyethylamino)-1,3,5-triazin-2-ylamino]-2-sulfonatophenylazo)-5-hydroxynaphthalene- 2,7-disulfonate | tetrasodium 4-amino-3,6-bis(5-[4-chloro-6-(2-hydroxyethylamino)-1,3,5-triazin-2-ylamino]-2-sulfonatophenylazo)-5-hydroxynaphthalene- 2,7-disulfonate | 85665-98-1 | 400-690-7 | substance | Aquatic Chronic 2 | Hazard statement codes: H411. Labelling pictogram and signal word: GHS09. Labelling hazard statements: H411 | |
| N,N-di-[poly(oxyethylene)-co-poly(oxypropylene)]-4-[(3,5-dicyano-4-methyl-2-thienyl)azo)]-3-methylaniline | N,N-di-[poly(oxyethylene)-co-poly(oxypropylene)]-4-[(3,5-dicyano-4-methyl-2-thienyl)azo)]-3-methylaniline | 413-380-1 | substance | Aquatic Chronic 2 | Hazard statement codes: H411. Labelling pictogram and signal word: GHS09. Labelling hazard statements: H411 | ||
| reaction mass of: disodium (6-(4-anisidino)-3-sulfonato-2-(3,5-dinitro-2-oxidophenylazo)-1-naphtholato)(1-(5-chloro-2-oxidophenylazo)- 2-naphtholato)chromate(1-); trisodium bis(5-(4-anisidino)-3-sulfonato-2-(3,5-dinitro-2-oxidophenylazo)-1-naphtholato)chromate(1-) | reaction mass of: disodium (6-(4-anisidino)-3-sulfonato-2-(3,5-dinitro-2-oxidophenylazo)-1-naphtholato)(1-(5-chloro-2-oxidophenylazo)- 2-naphtholato)chromate(1-); trisodium bis(5-(4-anisidino)-3-sulfonato-2-(3,5-dinitro-2-oxidophenylazo)-1-naphtholato)chromate(1-) | 405-665-4 | substance | Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H317; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H317; H410 | ||
| tris(tetramethylammonium) 5-hydroxy-1-(4-sulphonatophenyl)-4-(4-sulphonatophenylazo)pyrazole-3-carboxylate | tris(tetramethylammonium) 5-hydroxy-1-(4-sulphonatophenyl)-4-(4-sulphonatophenylazo)pyrazole-3-carboxylate | 131013-81-5 | 406-073-9 | substance | Acute Tox. 3 *; Aquatic Chronic 3 | Hazard statement codes: H301; H412. Labelling pictogram and signal word: GHS06; Dgr. Labelling hazard statements: H301; H412 | |
| 2,4-bis[2,2'-[2-(N,N-dimethylamino)ethyloxycarbonyl]phenylazo]-1,3-dihydroxybenzene, dihydrochloride | 2,4-bis[2,2'-[2-(N,N-dimethylamino)ethyloxycarbonyl]phenylazo]-1,3-dihydroxybenzene, dihydrochloride | 118208-02-9 | 407-010-8 | substance | Acute Tox. 4 *; Eye Dam. 1; Aquatic Chronic 2 | Hazard statement codes: H302; H318; H411. Labelling pictogram and signal word: GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H302; H318; H411 | |
| dimethyl 3,3'-(N-(4-(4-bromo-2,6-dicyanophenylazo)-3-hydroxyphenyl)imino)dipropionate | dimethyl 3,3'-(N-(4-(4-bromo-2,6-dicyanophenylazo)-3-hydroxyphenyl)imino)dipropionate | 122630-55-1 | 407-310-9 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | |
| reaction mass of: sodium/potassium (3-(4-(5-(5-chloro-2,6-difluoropyrimidin-4-ylamino)-2-methoxy-3-sulfonatophenylazo)-2- oxidophenylazo)-2,5,7-trisulfonato-4-naphtholato)copper(II); sodium/potassium (3-(4-(5-(5-chloro-4,6-difluoropyrimidin-2-ylamino)-2-methoxy-3-sulfonatophenylazo)-2-oxidophenylazo)- 2,5,7-trisulfonato-4-naphtholato)copper(II) | reaction mass of: sodium/potassium (3-(4-(5-(5-chloro-2,6-difluoropyrimidin-4-ylamino)-2-methoxy-3-sulfonatophenylazo)-2- oxidophenylazo)-2,5,7-trisulfonato-4-naphtholato)copper(II); sodium/potassium (3-(4-(5-(5-chloro-4,6-difluoropyrimidin-2-ylamino)-2-methoxy-3-sulfonatophenylazo)-2-oxidophenylazo)- 2,5,7-trisulfonato-4-naphtholato)copper(II) | 407-100-7 | substance | Skin Sens. 1 | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317 | ||
| reaction mass of: tris(3,5,5-trimethylhexylammonium) 4-amino-3-(4-(4-(2-amino-4-hydroxyphenylazo)anilino)-3-sulfonatophenylazo)- 5,6-dihydro-5-oxo-6-phenylhydrazononaphthalene-2,7-disulfonate; tris(3,5,5-trimethylhexylammonium) 4-amino-3-(4-(4-(4-amino-2-hydroxyphenylazo) anilino)-3-sulfonatophenylazo)-5,6-dihydro-5-oxo-6-phenylhydrazononaphthalene-2,7-disulfonate (2:1) | reaction mass of: tris(3,5,5-trimethylhexylammonium) 4-amino-3-(4-(4-(2-amino-4-hydroxyphenylazo)anilino)-3-sulfonatophenylazo)- 5,6-dihydro-5-oxo-6-phenylhydrazononaphthalene-2,7-disulfonate; tris(3,5,5-trimethylhexylammonium) 4-amino-3-(4-(4-(4-amino-2-hydroxyphenylazo) anilino)-3-sulfonatophenylazo)-5,6-dihydro-5-oxo-6-phenylhydrazononaphthalene-2,7-disulfonate (2:1) | 406-000-0 | substance | Eye Dam. 1; Aquatic Chronic 2 | Hazard statement codes: H318; H411. Labelling pictogram and signal word: GHS05; GHS09; Dgr. Labelling hazard statements: H318; H411 | ||
| 3-(2,6-dichloro-4-nitrophenylazo)-1-methyl-2-phenylindole | 3-(2,6-dichloro-4-nitrophenylazo)-1-methyl-2-phenylindole | 117584-16-4 | 406-280-4 | substance | Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H400; H410. Labelling pictogram and signal word: GHS09; Wng. Labelling hazard statements: H410 | |
| dilithium disodium (5,5'-diamino-(μ-4,4'-dihydroxy-1:2-κ-2,O4,O4',-3,3'-[3,3'-dihydroxy-1:2-κ-2-O3,O3'-biphenyl-4,4'-ylenebisazo- 1:2-(N3,N4-η:N3',N4'-η)]-dinaphthalene-2,7-disulfonato(8)))dicuprate(2-) | dilithium disodium (5,5'-diamino-(μ-4,4'-dihydroxy-1:2-κ-2,O4,O4',-3,3'-[3,3'-dihydroxy-1:2-κ-2-O3,O3'-biphenyl-4,4'-ylenebisazo- 1:2-(N3,N4-η:N3',N4'-η)]-dinaphthalene-2,7-disulfonato(8)))dicuprate(2-) | 126637-70-5 | 407-230-4 | substance | Acute Tox. 4 *; Skin Sens. 1 | Hazard statement codes: H302; H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302; H317 | |
| (2,2'-(3,3'-dioxidobiphenyl-4,4'-diyldiazo)bis(6-(4-(3-(diethylamino)propylamino)-6-(3-(diethylammonio)propylamino)-1,3,5-triazin- 2-ylamino)-3-sulfonato-1-naphtholato))dicopper(II) acetate lactate | (2,2'-(3,3'-dioxidobiphenyl-4,4'-diyldiazo)bis(6-(4-(3-(diethylamino)propylamino)-6-(3-(diethylammonio)propylamino)-1,3,5-triazin- 2-ylamino)-3-sulfonato-1-naphtholato))dicopper(II) acetate lactate | 159604-94-1 | 407-240-9 | substance | Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H317; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H317; H411 | |
| disodium 7-[4-chloro-6-(N-ethyl-o-toluidino)-1,3,5-triazin-2-ylamino]-4-hydroxy-3-(4-methoxy-2-sulfonatophenylazo)-2- naphthalenesulfonate | disodium 7-[4-chloro-6-(N-ethyl-o-toluidino)-1,3,5-triazin-2-ylamino]-4-hydroxy-3-(4-methoxy-2-sulfonatophenylazo)-2- naphthalenesulfonate | 147703-64-8 | 410-390-8 | substance | Eye Dam. 1 | Hazard statement codes: H318. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318 | |
| sodium 3-(2-acetamido-4-(4-(2-hydroxybutoxy)phenylazo)phenylazo)benzenesulfonate | sodium 3-(2-acetamido-4-(4-(2-hydroxybutoxy)phenylazo)phenylazo)benzenesulfonate | 147703-65-9 | 410-150-2 | substance | Skin Sens. 1 | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317 | |
| tetrasodium [7-(2,5-dihydroxy-KO2-7-sulfonato-6-[4-(2,5,6-trichloro-pyrimidin-4-ylamino)phenylazo]-(N1,N7-N)-1-naphthylazo)- 8-hydroxy-KO8-naphthalene-1,3,5-trisulfonato(6-)]cuprate(II) | tetrasodium [7-(2,5-dihydroxy-KO2-7-sulfonato-6-[4-(2,5,6-trichloro-pyrimidin-4-ylamino)phenylazo]-(N1,N7-N)-1-naphthylazo)- 8-hydroxy-KO8-naphthalene-1,3,5-trisulfonato(6-)]cuprate(II) | 141048-13-7 | 411-470-5 | substance | Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H317; H412. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317; H412 | |
| reaction mass of: pentasodium bis(1-(3(or 5)-(4-anilino-3-sulfonatophenylazo)-4-hydroxy-2-oxidophenylazo)-6-nitro-4-sulfonato- 2-naphtholato)ferrate(1-); pentasodium [(1-(3-(4-anilino-3-sulfonatophenylazo)-4-hydroxy-2-oxidophenylazo)-6-nitro-4-sulfonato-2-naphtholato)-(5-(4-anilino-3-sulfonatophenylazo)-4-hydroxy-2-oxidophenylazo)-6-nitro-4-sulfonato-2-naphtholato]ferrate(1-) | reaction mass of: pentasodium bis(1-(3(or 5)-(4-anilino-3-sulfonatophenylazo)-4-hydroxy-2-oxidophenylazo)-6-nitro-4-sulfonato- 2-naphtholato)ferrate(1-); pentasodium [(1-(3-(4-anilino-3-sulfonatophenylazo)-4-hydroxy-2-oxidophenylazo)-6-nitro-4-sulfonato-2-naphtholato)-(5-(4-anilino-3-sulfonatophenylazo)-4-hydroxy-2-oxidophenylazo)-6-nitro-4-sulfonato-2-naphtholato]ferrate(1-) | 407-570-3 | substance | Aquatic Chronic 2 | Hazard statement codes: H411. Labelling pictogram and signal word: GHS09. Labelling hazard statements: H411 | ||
| reaction mass of: 2-[N-ethyl-4-[(5,6-dichlorobenzothiazol-2-yl)azo]-m-toludino]ethyl acetate; 2-[N-ethyl-4-[(6,7-dichlorobenzothiazol-2-yl)azo]-m-toludino]ethyl acetate (1:1) | reaction mass of: 2-[N-ethyl-4-[(5,6-dichlorobenzothiazol-2-yl)azo]-m-toludino]ethyl acetate; 2-[N-ethyl-4-[(6,7-dichlorobenzothiazol-2-yl)azo]-m-toludino]ethyl acetate (1:1) | 411-560-4 | substance | STOT RE 1; Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H372 **; H317; H411. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Dgr. Labelling hazard statements: H372 **; H317; H411 | ||
| reaction mass of: 3-cyano-5-(2-cyano-4-nitro-phenylazo)-2-(2-hydroxy-ethylamino)-4-methyl-6-[3-(2-phenoxyethoxy)propylamino] pyridine; 3-cyano-5-(2-cyano-4-nitro-phenylazo)-6-(2-hydroxy-ethylamino)-4-methyl-2-[3-(2-phenoxyethoxy)propylamino]pyridine; 3-cyano-5-(2-cyano-4-nitro-phenylazo)-2-amino-4-methyl-6-[3-(3-hydroxypropoxy)propylamino]pyridine; 3-cyano-5-(2-cyano-4-nitro-phenylazo)-6-amino-4-methyl-2-[3-(3-methoxypropoxy)propylamino]pyridine | reaction mass of: 3-cyano-5-(2-cyano-4-nitro-phenylazo)-2-(2-hydroxy-ethylamino)-4-methyl-6-[3-(2-phenoxyethoxy)propylamino] pyridine; 3-cyano-5-(2-cyano-4-nitro-phenylazo)-6-(2-hydroxy-ethylamino)-4-methyl-2-[3-(2-phenoxyethoxy)propylamino]pyridine; 3-cyano-5-(2-cyano-4-nitro-phenylazo)-2-amino-4-methyl-6-[3-(3-hydroxypropoxy)propylamino]pyridine; 3-cyano-5-(2-cyano-4-nitro-phenylazo)-6-amino-4-methyl-2-[3-(3-methoxypropoxy)propylamino]pyridine | 411-880-4 | substance | Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H317; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H317; H411 | ||
| monolithium 5-[[2,4-dihydroxy-5-[(2-hydroxy-3,5-dinitrophenyl)azo]phenyl]azo]-2-naphthalenesulfonate], iron complex, monohydrate | monolithium 5-[[2,4-dihydroxy-5-[(2-hydroxy-3,5-dinitrophenyl)azo]phenyl]azo]-2-naphthalenesulfonate], iron complex, monohydrate | 411-360-7 | substance | Aquatic Chronic 3 | Hazard statement codes: H412. Labelling pictogram and signal word: —. Labelling hazard statements: H412 | ||
| reaction mass of: 3-((5-cyano-1,6-dihydro-1,4-dimethyl-2-hydroxyl-6-oxo-3-pyridinyl)azo)-benzoyloxy-2-phenoxyethane; 3-((5-cyano-1,6-dihydro-1,4-dimethyl-2-hydroxy-6-oxo-3-pyridinyl)azo)-benzoyloxy-2-ethyloxy-2-(ethylphenol) | reaction mass of: 3-((5-cyano-1,6-dihydro-1,4-dimethyl-2-hydroxyl-6-oxo-3-pyridinyl)azo)-benzoyloxy-2-phenoxyethane; 3-((5-cyano-1,6-dihydro-1,4-dimethyl-2-hydroxy-6-oxo-3-pyridinyl)azo)-benzoyloxy-2-ethyloxy-2-(ethylphenol) | 411-710-9 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | ||
| reaction mass of: trilithium 4-amino-3-((4-((4-((2-amino-4-hydroxyphenyl)azo)phenyl)amino)-3-sulfophenyl)azo)-5-hydroxy-6- (phenylazo)naphthalene-2,7-disulfonate; trilithium 4-amino-3-((4-((4-((4-amino-2-hydroxyphenyl)azo)phenyl)amino)-3-sulfophenyl)azo)-5-hydroxy-6-(phenylazo) naphthalene-2,7-disulfonate | reaction mass of: trilithium 4-amino-3-((4-((4-((2-amino-4-hydroxyphenyl)azo)phenyl)amino)-3-sulfophenyl)azo)-5-hydroxy-6- (phenylazo)naphthalene-2,7-disulfonate; trilithium 4-amino-3-((4-((4-((4-amino-2-hydroxyphenyl)azo)phenyl)amino)-3-sulfophenyl)azo)-5-hydroxy-6-(phenylazo) naphthalene-2,7-disulfonate | 411-890-9 | substance | Acute Tox. 4 *; Eye Dam. 1; Aquatic Chronic 3 | Hazard statement codes: H302; H318; H412. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H302; H318; H412 | ||
| 2-((4-(ethyl-(2-hydroxyethyl)amino)-2-methylphenyl)azo)-6-methoxy-3-methylbenzothiazolium methylsulfate | 2-((4-(ethyl-(2-hydroxyethyl)amino)-2-methylphenyl)azo)-6-methoxy-3-methylbenzothiazolium methylsulfate | 136213-73-5 | 411-100-2 | substance | STOT RE 2 *; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H373 **; H317; H400; H410. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Wng. Labelling hazard statements: H373 **; H317; H410 | |
| 2,5-dibutoxy-4-(morpholin-4-yl)benzenediazonium 4-methylbenzenesulfonate | 2,5-dibutoxy-4-(morpholin-4-yl)benzenediazonium 4-methylbenzenesulfonate | 93672-52-7 | 413-290-2 | substance | Self-react. C; Acute Tox. 4 *; Eye Dam. 1; Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H242; H302; H318; H317; H412. Labelling pictogram and signal word: GHS02; GHS05; GHS07; Dgr. Labelling hazard statements: H242; H302; H318; H317; H412. Notes: T | |
| sodium (1,0-1,95)/lithium (0,05-1) 5-((5-((5-chloro-6-fluoro-pyrimidin-4-yl)amino)-2-sulfonatophenyl)azo)-1,2-dihydro-6-hydroxy-1,4-dimethyl-2-oxo-3-pyridinemethylsulfonate | sodium (1,0-1,95)/lithium (0,05-1) 5-((5-((5-chloro-6-fluoro-pyrimidin-4-yl)amino)-2-sulfonatophenyl)azo)-1,2-dihydro-6-hydroxy-1,4-dimethyl-2-oxo-3-pyridinemethylsulfonate | 134595-59-8 | 413-470-0 | substance | Skin Sens. 1 | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317 | |
| tert-(dodecyl/tetradecyl)-ammonium bis(3-(4-((5-(1,1-dimethyl-propyl)-2-hydroxy-3-nitrophenyl)azo)-3-methyl-5-hydroxy-(1H) pyrazol-1-yl)benzenesulfonamidato)chromate | tert-(dodecyl/tetradecyl)-ammonium bis(3-(4-((5-(1,1-dimethyl-propyl)-2-hydroxy-3-nitrophenyl)azo)-3-methyl-5-hydroxy-(1H) pyrazol-1-yl)benzenesulfonamidato)chromate | 413-210-6 | substance | Aquatic Chronic 2 | Hazard statement codes: H411. Labelling pictogram and signal word: GHS09. Labelling hazard statements: H411 | ||
| sodium 2-(4-(4-fluoro-6-(2-sulfo-ethylamino)-[1,3,5]triazin-2-ylamino)-2-ureidophenylazo)-5-(4-sulfophenylazo)benzene-1-sulfonate | sodium 2-(4-(4-fluoro-6-(2-sulfo-ethylamino)-[1,3,5]triazin-2-ylamino)-2-ureidophenylazo)-5-(4-sulfophenylazo)benzene-1-sulfonate | 146177-84-6 | 410-770-3 | substance | Skin Sens. 1 | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317 | |
| reaction mass of: 2-[2-acetylamino-4-[N,Nbis[2-ethoxy-carbonyloxy)ethyl]amino]phenylazo]-5,6-dichloro-1,3-benzothiazole; 2-[2-acetylamino-4-[N,N-bis[2-ethoxy-carbonyloxy) ethyl]amino]phenylazo]-6,7-dichloro-1,3-benzotriazole (1:1) | reaction mass of: 2-[2-acetylamino-4-[N,Nbis[2-ethoxy-carbonyloxy)ethyl]amino]phenylazo]-5,6-dichloro-1,3-benzothiazole; 2-[2-acetylamino-4-[N,N-bis[2-ethoxy-carbonyloxy) ethyl]amino]phenylazo]-6,7-dichloro-1,3-benzotriazole (1:1) | 143145-93-1 | 411-600-0 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | |
| hexasodium 1,1'-[(1-amino-8-hydroxy-3,6-disulfonate-2,7-naphthalenediyl)bis(azo(4-sulfonate-1,3-phenyl)imino[6-[(4-chloro- 3-sulfonatophenyl)amino]-1,3,5-triazin-2,4-diyl]]]bis[3-carboxypyridinium] dihydroxide | hexasodium 1,1'-[(1-amino-8-hydroxy-3,6-disulfonate-2,7-naphthalenediyl)bis(azo(4-sulfonate-1,3-phenyl)imino[6-[(4-chloro- 3-sulfonatophenyl)amino]-1,3,5-triazin-2,4-diyl]]]bis[3-carboxypyridinium] dihydroxide | 89797-03-5 | 412-240-7 | substance | Aquatic Chronic 2 | Hazard statement codes: H411. Labelling pictogram and signal word: GHS09. Labelling hazard statements: H411 | |
| methyl N-[3-acetylamino)-4-(2-cyano-4-nitrophenylazo)phenyl]-N-[(1-methoxy)acetyl]glycinate | methyl N-[3-acetylamino)-4-(2-cyano-4-nitrophenylazo)phenyl]-N-[(1-methoxy)acetyl]glycinate | 149850-30-6 | 413-040-2 | substance | Skin Sens. 1 | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317 | |
| reaction mass of iron complexes of: 1,3-dihydroxy-4-[(5-phenylaminosulfonyl)-2-hydroxyphenylazo]-n-(5-amino-sulfonyl-2- hydroxyphenylazo)benzene and: 1,3-dihydroxy-4-[(5-phenylaminosulfonyl)-2-hydroxyphenylazo]-n-[4-(4-nitro-2-sulfophenylamino) phenylazo]benzene (n=2,5,6) | reaction mass of iron complexes of: 1,3-dihydroxy-4-[(5-phenylaminosulfonyl)-2-hydroxyphenylazo]-n-(5-amino-sulfonyl-2- hydroxyphenylazo)benzene and: 1,3-dihydroxy-4-[(5-phenylaminosulfonyl)-2-hydroxyphenylazo]-n-[4-(4-nitro-2-sulfophenylamino) phenylazo]benzene (n=2,5,6) | 414-150-3 | substance | Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H317; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H317; H411 | ||
| tetrakis(tetramethylammonium)3,3'-(6-(2-hydroxyethylamino)1,3,5-triazine-2,4-diylbisimino(2-methyl-4,1-phenyleneazo))bisnaphthalene- 1,5-disulfonate | tetrakis(tetramethylammonium)3,3'-(6-(2-hydroxyethylamino)1,3,5-triazine-2,4-diylbisimino(2-methyl-4,1-phenyleneazo))bisnaphthalene- 1,5-disulfonate | 131013-83-7 | 405-950-3 | substance | Acute Tox. 3 *; Aquatic Chronic 3 | Hazard statement codes: H301; H412. Labelling pictogram and signal word: GHS06; Dgr. Labelling hazard statements: H301; H412 | |
| (methylenebis(4,1-phenylenazo(1-(3-(dimethylamino)propyl)-1,2-dihydro-6-hydroxy-4-methyl-2-oxopyridine-5,3-diyl)))-1,1'-dipyridinium dichloride dihydrochloride | (methylenebis(4,1-phenylenazo(1-(3-(dimethylamino)propyl)-1,2-dihydro-6-hydroxy-4-methyl-2-oxopyridine-5,3-diyl)))-1,1'-dipyridinium dichloride dihydrochloride | 118658-99-4 | 401-500-5 | substance | Carc. 1B; Aquatic Chronic 2 | Hazard statement codes: H350; H411. Labelling pictogram and signal word: GHS08; GHS09; Dgr. Labelling hazard statements: H350; H411 | |
| potassium sodium 3,3'-(3(or4)-methyl-1,2-phenylenebis(imino(6-chloro)-1,3,5-triazine-4,2-diylimino(2-acetamido-5-methoxy)- 4,1-phenylenazo)dinaphthalene-1,5-disulfonate | potassium sodium 3,3'-(3(or4)-methyl-1,2-phenylenebis(imino(6-chloro)-1,3,5-triazine-4,2-diylimino(2-acetamido-5-methoxy)- 4,1-phenylenazo)dinaphthalene-1,5-disulfonate | 140876-13-7 | 403-810-6 | substance | Eye Dam. 1 | Hazard statement codes: H318. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318 | |
| 2'-(4-chloro-3-cyano-5-formyl-2-thienyl)azo-5'-diethylaminoacetanilide | 2'-(4-chloro-3-cyano-5-formyl-2-thienyl)azo-5'-diethylaminoacetanilide | 104366-25-8 | 405-200-5 | substance | Skin Sens. 1 | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317 | |
| reaction product of: C.I. Leuco Sulfur Black 1 and reaction mass of: disodium-4-{]4-[}8-amino-1-hydroxy-7-(4-sulfamoylphenylazo)-3,6-disulfonato-2-naphthylazo{]phenylsulfonylamino[} benzendiazoniumchlorid; disodium-4-{]4-[}2,6-dihydroxy-3-(8-hydroxy-3,6-disulfonato-1-naphthylazo)phenylazo{] phenylsulfonylamino[}benzen-diazoniumchlorid | reaction product of: C.I. Leuco Sulfur Black 1 and reaction mass of: disodium-4-{]4-[}8-amino-1-hydroxy-7-(4-sulfamoylphenylazo)-3,6-disulfonato-2-naphthylazo{]phenylsulfonylamino[} benzendiazoniumchlorid; disodium-4-{]4-[}2,6-dihydroxy-3-(8-hydroxy-3,6-disulfonato-1-naphthylazo)phenylazo{] phenylsulfonylamino[}benzen-diazoniumchlorid | 424-500-7 | substance | Aquatic Chronic 3 | Hazard statement codes: H412. Labelling pictogram and signal word: —. Labelling hazard statements: H412 | ||
| trisodium (1-(3-carboxylato-2-oxido-5-sulfonatophenylazo)-5-hydroxy-7-sulfonatonaphthalen-2-amido)nickel(II) | trisodium (1-(3-carboxylato-2-oxido-5-sulfonatophenylazo)-5-hydroxy-7-sulfonatonaphthalen-2-amido)nickel(II) | 407-110-1 | substance | Eye Dam. 1; Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H318; H317; H411. Labelling pictogram and signal word: GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H318; H317; H411 | ||
| reaction mass of: trisodium (2,4(or 2,6 or 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)(2(or 4or 6)-(3,5-dinitro- 2-oxidophenylazo)-5-hydroxy-4(or 2or 6)-(4-(4-nitro-2-sulfonatoanilino)phenylazo) phenolato)ferrate(1-); trisodium bis(2,4(or 2,6 or 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato) ferrate(1-); trisodium (2,4(or 2,6 or 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)(2(or 4 or 6)-(3,5-dinitro-2-oxidophenylazo)- 5-hydroxy-4(or 2 or 6)-(4-nitro-2-sulfonatophenylazo) phenolato)ferrate(1-); trisodium (2,4(or 2,6 or 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)(2(or 4 or 6)-(3,5-dinitro-2-oxidophenylazo)- 5-hydroxy-4(or 2 or 6)-(3-sulfonatophenylazo)phenolato)ferrate(1-); disodium 3,3'-(2,4-dihydroxy-1,3(or 1,5 or3,5)-phenylenediazo)dibenzenesulfonate | reaction mass of: trisodium (2,4(or 2,6 or 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)(2(or 4or 6)-(3,5-dinitro- 2-oxidophenylazo)-5-hydroxy-4(or 2or 6)-(4-(4-nitro-2-sulfonatoanilino)phenylazo) phenolato)ferrate(1-); trisodium bis(2,4(or 2,6 or 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato) ferrate(1-); trisodium (2,4(or 2,6 or 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)(2(or 4 or 6)-(3,5-dinitro-2-oxidophenylazo)- 5-hydroxy-4(or 2 or 6)-(4-nitro-2-sulfonatophenylazo) phenolato)ferrate(1-); trisodium (2,4(or 2,6 or 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)(2(or 4 or 6)-(3,5-dinitro-2-oxidophenylazo)- 5-hydroxy-4(or 2 or 6)-(3-sulfonatophenylazo)phenolato)ferrate(1-); disodium 3,3'-(2,4-dihydroxy-1,3(or 1,5 or3,5)-phenylenediazo)dibenzenesulfonate | 406-870-1 | substance | Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H317; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H317; H411 | ||
| sodium 4-(4-chloro-6-(N-ethylanilino)-1,3,5-triazin-2-ylamino)-2-(1-(2-chlorophenyl)-5-hydroxy-3-methyl-1H-pyrazol-4- ylazo)benzenesulfonate | sodium 4-(4-chloro-6-(N-ethylanilino)-1,3,5-triazin-2-ylamino)-2-(1-(2-chlorophenyl)-5-hydroxy-3-methyl-1H-pyrazol-4- ylazo)benzenesulfonate | 136213-75-7 | 407-800-2 | substance | Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H317; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H317; H411 | |
| hexasodium 4,4'-dihydroxy-3,3'-bis[2-sulfonato-4-(4-sulfonatophenylazo)phenylazo]-7,7'[p-phenylenebis[imino(6-chloro-1,3,5- triazine-4,2-diyl)imino]]dinaphthalene-2-sulfonate | hexasodium 4,4'-dihydroxy-3,3'-bis[2-sulfonato-4-(4-sulfonatophenylazo)phenylazo]-7,7'[p-phenylenebis[imino(6-chloro-1,3,5- triazine-4,2-diyl)imino]]dinaphthalene-2-sulfonate | 157627-99-1 | 410-180-6 | substance | Eye Dam. 1 | Hazard statement codes: H318. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318 | |
| potassium sodium 4-(4-chloro-6-(3,6-disulfonato-7-(5,8-disulfonato-naphthalen-2-ylazo)-8-hydroxy-naphthalen-1-ylamino)- 1,3,5-triazin-2-ylamino)-5-hydroxy-6-(4-(2-sulfatoethanesulfonyl)-phenylazo)-naphthalene-1,7-disulfonate | potassium sodium 4-(4-chloro-6-(3,6-disulfonato-7-(5,8-disulfonato-naphthalen-2-ylazo)-8-hydroxy-naphthalen-1-ylamino)- 1,3,5-triazin-2-ylamino)-5-hydroxy-6-(4-(2-sulfatoethanesulfonyl)-phenylazo)-naphthalene-1,7-disulfonate | 412-490-7 | substance | Skin Sens. 1 | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317 | ||
| disodium 5-((4-((4-chloro-3-sulfonatophenyl)azo)-1-naphthyl)azo)-8-(phenylamino)-1-naphthalenesulfonate | disodium 5-((4-((4-chloro-3-sulfonatophenyl)azo)-1-naphthyl)azo)-8-(phenylamino)-1-naphthalenesulfonate | 6527-62-4 | 413-600-6 | substance | Aquatic Chronic 3 | Hazard statement codes: H412. Labelling pictogram and signal word: —. Labelling hazard statements: H412 | |
| reaction products of: copper(II) sulfate and tetrasodium 2,4-bis[6-(2-methoxy-5-sulfonatophenylazo)-5-hydroxy-7-sulfonato-2- naphthylamino]-6-(2-hydroxyethylamino)-1,3,5-triazine (2:1) | reaction products of: copper(II) sulfate and tetrasodium 2,4-bis[6-(2-methoxy-5-sulfonatophenylazo)-5-hydroxy-7-sulfonato-2- naphthylamino]-6-(2-hydroxyethylamino)-1,3,5-triazine (2:1) | 407-710-3 | substance | Aquatic Chronic 2 | Hazard statement codes: H411. Labelling pictogram and signal word: GHS09. Labelling hazard statements: H411 | ||
| tetra-sodium/lithium 4,4'-bis-(8-amino-3,6-disulfonato-1-naphthol-2-ylazo)-3-methylazobenzene | tetra-sodium/lithium 4,4'-bis-(8-amino-3,6-disulfonato-1-naphthol-2-ylazo)-3-methylazobenzene | 124605-82-9 | 408-210-8 | substance | Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H317; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H317; H411 | |
| disodium 2-[[4-(2-chloroethylsulfonyl)phenyl]-[(2-hydroxy-5-sulfo-3-[3-[2-(2-(sulfooxy)ethylsulfonyl)ethylazo]-4-sulfobenzoato( 3-)cuprate(1-) | disodium 2-[[4-(2-chloroethylsulfonyl)phenyl]-[(2-hydroxy-5-sulfo-3-[3-[2-(2-(sulfooxy)ethylsulfonyl)ethylazo]-4-sulfobenzoato( 3-)cuprate(1-) | 414-230-8 | substance | Skin Sens. 1 | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317 | ||
| tetrasodium 4-hydroxy-5-[4-[3-(2-sulfatoethanesulfonyl) phenylamino]-6-morpholin-4-yl-1,3,5-triazin-2-ylamino]-3-(1-sulfonatonaphthalen-2-ylazo)naphthalene-2,7- disulfonate | tetrasodium 4-hydroxy-5-[4-[3-(2-sulfatoethanesulfonyl) phenylamino]-6-morpholin-4-yl-1,3,5-triazin-2-ylamino]-3-(1-sulfonatonaphthalen-2-ylazo)naphthalene-2,7- disulfonate | 413-070-6 | substance | Skin Sens. 1 | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317 | ||
| lithium sodium (2-(((5-((2,5-dichlorophenyl)azo)-2-hydroxyphenyl)methylene)amino)benzoato(2-))(2-((4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo)-5-sulfobenzoato(3-)) chromate(2-) | lithium sodium (2-(((5-((2,5-dichlorophenyl)azo)-2-hydroxyphenyl)methylene)amino)benzoato(2-))(2-((4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo)-5-sulfobenzoato(3-)) chromate(2-) | 149626-00-6 | 414-280-0 | substance | Aquatic Chronic 2 | Hazard statement codes: H411. Labelling pictogram and signal word: GHS09. Labelling hazard statements: H411 | |
| lithium sodium (4-((5-chloro-2-hydroxyphenyl)azo)-2,4-dihydro-5-methyl-3H-pyrazol-3-onato(2-))(3-((4,5-dihydro-3-methyl-1-(4-methylphenyl)-5-oxo-1H-pyrazol-4-yl)azo)-4-hydroxy-5-nitrobenzenesulfonato(3-)) chromate(2-) | lithium sodium (4-((5-chloro-2-hydroxyphenyl)azo)-2,4-dihydro-5-methyl-3H-pyrazol-3-onato(2-))(3-((4,5-dihydro-3-methyl-1-(4-methylphenyl)-5-oxo-1H-pyrazol-4-yl)azo)-4-hydroxy-5-nitrobenzenesulfonato(3-)) chromate(2-) | 149564-66-9 | 414-250-7 | substance | Acute Tox. 4 *; Eye Dam. 1; Aquatic Chronic 3 | Hazard statement codes: H302; H318; H412. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H302; H318; H412 | |
| trilithium bis(4-((4-(diethylamino)-2-hydroxyphenyl)azo)-3-hydroxy-1-naphthalenesulfonato(3-))chromate(3-) | trilithium bis(4-((4-(diethylamino)-2-hydroxyphenyl)azo)-3-hydroxy-1-naphthalenesulfonato(3-))chromate(3-) | 149564-65-8 | 414-290-5 | substance | Acute Tox. 4 *; Aquatic Chronic 3 | Hazard statement codes: H302; H412. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302; H412 | |
| reaction mass of: trisodium 5-{4-chloro-6-[2-(2,6-dichloro-5-cyanopyrimidin-4-ylamino)-propylamino]-1,3,5-triazin-2-ylamino}- 4-hydroxy-3-(1-sulfonatonaphthalene-2-ylazo)-naphthalene-2,7-disulfonate; trisodium 5-{4-chloro-6-[2-(2,6-dichloro-5-cyanopyrimidin-4-ylamino)-1-methyl-ethylamino]-1,3,5-triazin-2-ylamino}- 4-hydroxy-3-(1-sulfonatonaphthalene-2-ylazo)-naphthalene-2,7-disulfonate; trisodium 5-{4-chloro-6-[2-(4,6-dichloro-5-cyanopyrimidin-2-ylamino)-propylamino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1- sulfonatonaphthalen-2-ylazo)-naphthalene-2,7-disulfonate; trisodium 5-{4-chloro-6-[2-(4,6-dichloro-5-cyanopyrimidin-2-ylamino)-1-methyl-ethylamino]-1,3,5-triazin-2-ylamino}-4- hydroxy-3-(1-sulfonatonaphthalen-2-ylazo)-naphthalene-2,7-disulfonate | reaction mass of: trisodium 5-{4-chloro-6-[2-(2,6-dichloro-5-cyanopyrimidin-4-ylamino)-propylamino]-1,3,5-triazin-2-ylamino}- 4-hydroxy-3-(1-sulfonatonaphthalene-2-ylazo)-naphthalene-2,7-disulfonate; trisodium 5-{4-chloro-6-[2-(2,6-dichloro-5-cyanopyrimidin-4-ylamino)-1-methyl-ethylamino]-1,3,5-triazin-2-ylamino}- 4-hydroxy-3-(1-sulfonatonaphthalene-2-ylazo)-naphthalene-2,7-disulfonate; trisodium 5-{4-chloro-6-[2-(4,6-dichloro-5-cyanopyrimidin-2-ylamino)-propylamino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1- sulfonatonaphthalen-2-ylazo)-naphthalene-2,7-disulfonate; trisodium 5-{4-chloro-6-[2-(4,6-dichloro-5-cyanopyrimidin-2-ylamino)-1-methyl-ethylamino]-1,3,5-triazin-2-ylamino}-4- hydroxy-3-(1-sulfonatonaphthalen-2-ylazo)-naphthalene-2,7-disulfonate | 414-620-8 | substance | Eye Dam. 1; Skin Sens. 1 | Hazard statement codes: H318; H317. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H318; H317 | ||
| 1,3-bis{6-fluoro-4-[1,5-disulfo-4-(3-aminocarbonyl-1-ethyl-6-hydroxy-4-methyl-pyrid-2-on-5-ylazo)-phenyl-2-ylamino]-1,3,5-triazin- 2-ylamino}propane lithium-, sodium salt | 1,3-bis{6-fluoro-4-[1,5-disulfo-4-(3-aminocarbonyl-1-ethyl-6-hydroxy-4-methyl-pyrid-2-on-5-ylazo)-phenyl-2-ylamino]-1,3,5-triazin- 2-ylamino}propane lithium-, sodium salt | 149850-29-3 | 415-100-3 | substance | Skin Sens. 1 | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317 | |
| sodium 1,2-bis[4-[4-{4-(4-sulfophenylazo)-2-sulfophenylazo}-2-ureido-phenyl-amino]-6-fluoro-1,3,5-triazin-2-ylamino]-propane, sodium salt | sodium 1,2-bis[4-[4-{4-(4-sulfophenylazo)-2-sulfophenylazo}-2-ureido-phenyl-amino]-6-fluoro-1,3,5-triazin-2-ylamino]-propane, sodium salt | 413-990-8 | substance | Skin Sens. 1 | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317 | ||
| tetrasodium 4-[4-chloro-6-(4-methyl-2-sulfophenylamino)-1,3,5-triazin-2-ylamino]-6-(4,5-dimethyl-2-sulfophenylazo)-5-hydroxynaphthalene-2,7-disulfonate | tetrasodium 4-[4-chloro-6-(4-methyl-2-sulfophenylamino)-1,3,5-triazin-2-ylamino]-6-(4,5-dimethyl-2-sulfophenylazo)-5-hydroxynaphthalene-2,7-disulfonate | 148878-22-2 | 415-400-4 | substance | Eye Dam. 1; Skin Sens. 1 | Hazard statement codes: H318; H317. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H318; H317 | |
| 5-{4-[5-amino-2-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-sulfo-phenylamino]-6-chloro-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1- sulfo-naphthalen-2-ylazo)-naphthalene-2,7-disulfonicacid sodium salt | 5-{4-[5-amino-2-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-sulfo-phenylamino]-6-chloro-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1- sulfo-naphthalen-2-ylazo)-naphthalene-2,7-disulfonicacid sodium salt | 157707-94-3 | 418-340-7 | substance | Eye Dam. 1; Aquatic Chronic 3 | Hazard statement codes: H318; H412. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318; H412 | |
| main component 6 (isomer): asym. 1:2 Cr(III)-complex of: A: 3-hydroxy-4-(2-hydroxy-naphthalene-1-ylazo)naphthalene-1-sulfonic acid, Na-salt and B: 1-[2-hydroxy-5-(4-methoxy-phenylazo)phenylazo]naphthalene-2-ol; main component 8 (isomer): asym. 1:2 Crcomplex of: A: 3-hydroxy-4-(2-hydroxynaphthalene-1-ylazo)-naphthalene-1-sulfonic acid, Na-salt and B: 1-[2-hydroxy-5-(4-methoxy-phenylazo)-phenylazo]-naphthalene-2-ol | main component 6 (isomer): asym. 1:2 Cr(III)-complex of: A: 3-hydroxy-4-(2-hydroxy-naphthalene-1-ylazo)naphthalene-1-sulfonic acid, Na-salt and B: 1-[2-hydroxy-5-(4-methoxy-phenylazo)phenylazo]naphthalene-2-ol; main component 8 (isomer): asym. 1:2 Crcomplex of: A: 3-hydroxy-4-(2-hydroxynaphthalene-1-ylazo)-naphthalene-1-sulfonic acid, Na-salt and B: 1-[2-hydroxy-5-(4-methoxy-phenylazo)-phenylazo]-naphthalene-2-ol | 30785-74-1 | 417-280-9 | substance | Eye Dam. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H318; H400; H410. Labelling pictogram and signal word: GHS05; GHS09; Dgr. Labelling hazard statements: H318; H410 | |
| hexasodium (di[N-(3-(4-[5-(5-amino-3-methyl-1-phenylpyrazol-4-yl-azo)-2,4-disulfo-anilino]-6-chloro-1,3,5-triazin-2-ylamino) phenyl)-sulfamoyl](di-sulfo)-phthalocyaninato)nickel | hexasodium (di[N-(3-(4-[5-(5-amino-3-methyl-1-phenylpyrazol-4-yl-azo)-2,4-disulfo-anilino]-6-chloro-1,3,5-triazin-2-ylamino) phenyl)-sulfamoyl](di-sulfo)-phthalocyaninato)nickel | 151436-99-6 | 417-250-5 | substance | Eye Dam. 1; Skin Sens. 1 | Hazard statement codes: H318; H317. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H318; H317 | |
| 3-(2,4-bis(4-((5-(4,6-bis(2-aminopropylamino)-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-disulfonaphthalen-3-yl)azo)phenylamino)- 1,3,5-triazin-6-ylamino)propyldiethylammonium lactate | 3-(2,4-bis(4-((5-(4,6-bis(2-aminopropylamino)-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-disulfonaphthalen-3-yl)azo)phenylamino)- 1,3,5-triazin-6-ylamino)propyldiethylammonium lactate | 178452-66-9 | 424-310-4 | substance | Eye Dam. 1 | Hazard statement codes: H318. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318 | |
| reaction mass of: pentasodium 5-amino- 3-(5-{4-chloro-6-[4-(2-sulfoxyethoxysulfonato) phenylamino]-1,3,5-triazin-2-ylamino}- 2-sulfonatophenylazo)-6-[5-(2,3- dibromopropionylamino)-2-sulfonatophenylazo]- 4-hydroxynaphthalene-2,7-disulfonate; pentasodium 5-amino-6-[5-(2-bromoacryloylamino)- 2-sulfonatophenylazo]-3-(5-{4- chloro-6-[4-(2-sulfoxyethoxysulfonato)phenylamino]- 1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)- 4-hydroxynaphthalene-2,7- disulfonate; tetrasodium 5-amino-3-[5-{4-chloro-6-[4- (vinylsulfonyl)phenylamino]-1,3,5-triazin-2- ylamino}-2-sulfonatophenylazo]-6-[5-(2,3- dibromopropionylamino)-2-sulfonatophenylazo]- 4-hydroxynaphthalene-2,7-disulfonate | reaction mass of: pentasodium 5-amino- 3-(5-{4-chloro-6-[4-(2-sulfoxyethoxysulfonato) phenylamino]-1,3,5-triazin-2-ylamino}- 2-sulfonatophenylazo)-6-[5-(2,3- dibromopropionylamino)-2-sulfonatophenylazo]- 4-hydroxynaphthalene-2,7-disulfonate; pentasodium 5-amino-6-[5-(2-bromoacryloylamino)- 2-sulfonatophenylazo]-3-(5-{4- chloro-6-[4-(2-sulfoxyethoxysulfonato)phenylamino]- 1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)- 4-hydroxynaphthalene-2,7- disulfonate; tetrasodium 5-amino-3-[5-{4-chloro-6-[4- (vinylsulfonyl)phenylamino]-1,3,5-triazin-2- ylamino}-2-sulfonatophenylazo]-6-[5-(2,3- dibromopropionylamino)-2-sulfonatophenylazo]- 4-hydroxynaphthalene-2,7-disulfonate | 424-320-9 | substance | Eye Dam. 1; Aquatic Chronic 2 | Hazard statement codes: H318; H411. Labelling pictogram and signal word: GHS05; GHS09; Dgr. Labelling hazard statements: H318; H411 | ||
| reaction mass of: Disodium 6-[3-carboxy-4,5-dihydro-5-oxo-4-sulfonatophenyl)pyrazolin-4-yl-azo]-3-[2-oxido-4-(ethensulfonyl)- 5-methoxyphenylazo]-4-oxidonaphthalene-2-sulfonate copper (II) complex; Disodium 6-[3-carboxy-4,5-dihydro-5-oxo-4-sulfonatophenyl)pyrazolin-4-yl-azo]-3-[2-oxido-4-(2-hydroxyethylsulfonyl)-5-methoxyphenylazo]- 4-oxidonaphthalene-2-sulfonate copper (II) complex | reaction mass of: Disodium 6-[3-carboxy-4,5-dihydro-5-oxo-4-sulfonatophenyl)pyrazolin-4-yl-azo]-3-[2-oxido-4-(ethensulfonyl)- 5-methoxyphenylazo]-4-oxidonaphthalene-2-sulfonate copper (II) complex; Disodium 6-[3-carboxy-4,5-dihydro-5-oxo-4-sulfonatophenyl)pyrazolin-4-yl-azo]-3-[2-oxido-4-(2-hydroxyethylsulfonyl)-5-methoxyphenylazo]- 4-oxidonaphthalene-2-sulfonate copper (II) complex | 423-940-7 | substance | Eye Dam. 1; Aquatic Chronic 2 | Hazard statement codes: H318; H411. Labelling pictogram and signal word: GHS05; GHS09; Dgr. Labelling hazard statements: H318; H411 | ||
| 2,6-bis-(2-(4-(4-amino-phenylamino)-phenylazo)-1,3-dimethyl-3H-imidazolium)-4-dimethylamino-1,3,5-triazine, dichloride | 2,6-bis-(2-(4-(4-amino-phenylamino)-phenylazo)-1,3-dimethyl-3H-imidazolium)-4-dimethylamino-1,3,5-triazine, dichloride | 174514-06-8 | 424-120-1 | substance | Eye Dam. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H318; H400; H410. Labelling pictogram and signal word: GHS05; GHS09; Dgr. Labelling hazard statements: H318; H410 | |
| pentasodium 4-amino-6-(5-(4-(2-ethyl-phenylamino)-6-(2-sulfatoethanesulfonyl)-1,3,5-triazin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(2-sulfatoethanesulfonyl)phenylazo)naphthalene-2,7-disulfonate | pentasodium 4-amino-6-(5-(4-(2-ethyl-phenylamino)-6-(2-sulfatoethanesulfonyl)-1,3,5-triazin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(2-sulfatoethanesulfonyl)phenylazo)naphthalene-2,7-disulfonate | 423-790-2 | substance | Eye Dam. 1; Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H318; H317; H412. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H318; H317; H412. Notes: G | ||
| N,N'-bis{6-chloro-4-[6-(4-vinylsulfonylphenylazo)-2,7-disulfonicacid-5-hydroxynapht-4-ylamino]-1,3,5-triazin-2-yl}-N-(2-hydroxyethyl) ethane-1,2-diamine, sodium salt | N,N'-bis{6-chloro-4-[6-(4-vinylsulfonylphenylazo)-2,7-disulfonicacid-5-hydroxynapht-4-ylamino]-1,3,5-triazin-2-yl}-N-(2-hydroxyethyl) ethane-1,2-diamine, sodium salt | 171599-85-2 | 419-500-9 | substance | Eye Dam. 1; Skin Sens. 1 | Hazard statement codes: H318; H317. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H318; H317 | |
| reaction mass of: 5-[(4-[(7-amino-1-hydroxy-3-sulfo-2-naphthyl)azo]-2,5-diethoxyphenyl)azo]-2-[(3-phosphonophenyl) azo]benzoic acid; 5-[(4-[(7-amino-1-hydroxy-3-sulfo-2-naphthyl)azo]-2,5-diethoxyphenyl)azo]-3-[(3-phosphonophenyl)azo]benzoic acid | reaction mass of: 5-[(4-[(7-amino-1-hydroxy-3-sulfo-2-naphthyl)azo]-2,5-diethoxyphenyl)azo]-2-[(3-phosphonophenyl) azo]benzoic acid; 5-[(4-[(7-amino-1-hydroxy-3-sulfo-2-naphthyl)azo]-2,5-diethoxyphenyl)azo]-3-[(3-phosphonophenyl)azo]benzoic acid | 163879-69-4 | 418-230-9 | substance | Expl. 1.3 ****; Repr. 2; STOT RE 2 *; Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H203; H361f ***; H373 **; H317; H411. Labelling pictogram and signal word: GHS01; GHS08; GHS07; GHS09; Dgr. Labelling hazard statements: H203; H361f ***; H373 **; H317; H411 | |
| tetra-ammonium 2-[6-[7-(2-carboxylato-phenylazo)-8-hydroxy-3,6-disulfonato-1-naphthylamino]-4-hydroxy-1,3,5-triazin-2-ylamino]benzoate | tetra-ammonium 2-[6-[7-(2-carboxylato-phenylazo)-8-hydroxy-3,6-disulfonato-1-naphthylamino]-4-hydroxy-1,3,5-triazin-2-ylamino]benzoate | 183130-96-3 | 418-520-5 | substance | Eye Irrit. 2; Aquatic Chronic 3 | Hazard statement codes: H319; H412. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H319; H412 | |
| 2-[2-hydroxy-3-(2-chlorophenyl)carbamoyl-1-naphthylazo]-7-[2-hydroxy-3-(3-methylphenyl)carbamoyl-1-naphthylazo]fluoren-9-one | 2-[2-hydroxy-3-(2-chlorophenyl)carbamoyl-1-naphthylazo]-7-[2-hydroxy-3-(3-methylphenyl)carbamoyl-1-naphthylazo]fluoren-9-one | 151798-26-4 | 420-580-2 | substance | Repr. 1B; Aquatic Chronic 4 | Hazard statement codes: H360D ***; H413. Labelling pictogram and signal word: GHS08; Dgr. Labelling hazard statements: H360D ***; H413 | |
| pentasodium bis{7-[4-(1-butyl-5-cyano-1,2-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo) phenylsulfonylamino]-5'-nitro-3,3'-disulfonatonaphthalene-2-azobenzene-1,2'-diolato} chromate (III) | pentasodium bis{7-[4-(1-butyl-5-cyano-1,2-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo) phenylsulfonylamino]-5'-nitro-3,3'-disulfonatonaphthalene-2-azobenzene-1,2'-diolato} chromate (III) | 178452-71-6 | 419-210-2 | substance | Eye Dam. 1; Aquatic Chronic 3 | Hazard statement codes: H318; H412. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318; H412 | |
| Product by process iron complex of azo dyestuffs obtained by coupling a mixture of diazotized 2-amino-1-hydroxybenzene-4-sulfanilide and 2-amino-1-hydroxybenzene-4-sulfonamide with resorcin, the obtained mixture being subsequently submitted to a second coupling reaction with a mixture of diazotized 3-aminobenzene-1-sulfonic acid (metanilic acid) and 4'-amino-4-nitro-1,1'-diphenylamine-2-sulfonic acid and metallization with ferric chloride, sodium salt | Product by process iron complex of azo dyestuffs obtained by coupling a mixture of diazotized 2-amino-1-hydroxybenzene-4-sulfanilide and 2-amino-1-hydroxybenzene-4-sulfonamide with resorcin, the obtained mixture being subsequently submitted to a second coupling reaction with a mixture of diazotized 3-aminobenzene-1-sulfonic acid (metanilic acid) and 4'-amino-4-nitro-1,1'-diphenylamine-2-sulfonic acid and metallization with ferric chloride, sodium salt | 419-260-5 | substance | Eye Dam. 1; Aquatic Chronic 2 | Hazard statement codes: H318; H411. Labelling pictogram and signal word: GHS05; GHS09; Dgr. Labelling hazard statements: H318; H411 | ||
| trisodium 2-{α[2-hydroxy-3-[4-chloro-6-[4-(2,3-dibromopropionylamino)-2-sulfonatophenylamino]-1,3,5-triazin-2-ylamino]-5- sulfonatophenylazo]-benzylidenehydrazino}-4-sulfonatobenzoate, copper complex | trisodium 2-{α[2-hydroxy-3-[4-chloro-6-[4-(2,3-dibromopropionylamino)-2-sulfonatophenylamino]-1,3,5-triazin-2-ylamino]-5- sulfonatophenylazo]-benzylidenehydrazino}-4-sulfonatobenzoate, copper complex | 423-770-3 | substance | Eye Dam. 1; Aquatic Chronic 2 | Hazard statement codes: H318; H411. Labelling pictogram and signal word: GHS05; GHS09; Dgr. Labelling hazard statements: H318; H411 | ||
| reaction product of: 2-[[4-amino-2-ureidophenylazo]-5-[(2-(sulfooxy)ethyl)sulfonyl]]benzenesulfonic acid with 2,4,6-trifluoropyrimidine and partial hydrolysis to the corresponding vinylsulfonyl derivative, mixed potassium/sodium salt | reaction product of: 2-[[4-amino-2-ureidophenylazo]-5-[(2-(sulfooxy)ethyl)sulfonyl]]benzenesulfonic acid with 2,4,6-trifluoropyrimidine and partial hydrolysis to the corresponding vinylsulfonyl derivative, mixed potassium/sodium salt | 424-250-9 | substance | Eye Dam. 1; Aquatic Chronic 3 | Hazard statement codes: H318; H412. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318; H412 | ||
| 2-{4-(2-ammoniopropylamino)-6-[4-hydroxy-3-(5-methyl-2-methoxy-4-sulfamoylphenylazo)-2-sulfonatonaphth-7-ylamino]- 1,3,5-triazin-2-ylamino}-2-aminopropyl formate | 2-{4-(2-ammoniopropylamino)-6-[4-hydroxy-3-(5-methyl-2-methoxy-4-sulfamoylphenylazo)-2-sulfonatonaphth-7-ylamino]- 1,3,5-triazin-2-ylamino}-2-aminopropyl formate | 424-260-3 | substance | Repr. 2; Eye Dam. 1; Aquatic Chronic 2 | Hazard statement codes: H361f ***; H318; H411. Labelling pictogram and signal word: GHS05; GHS08; GHS09; Dgr. Labelling hazard statements: H361f ***; H318; H411 | ||
| 6-tert-butyl-7-chloro-3-tridecyl-7,7a-dihydro-1H-pyrazolo[5,1-c]-1,2,4-triazole | 6-tert-butyl-7-chloro-3-tridecyl-7,7a-dihydro-1H-pyrazolo[5,1-c]-1,2,4-triazole | 159038-16-1 | 419-870-1 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | |
| 2-(4-aminophenyl)-6-tert-butyl-1H-pyrazolo[1,5-b][1,2,4]triazole | 2-(4-aminophenyl)-6-tert-butyl-1H-pyrazolo[1,5-b][1,2,4]triazole | 152828-25-6 | 415-910-7 | substance | Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H317; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H317; H411 | |
| reaction product of: C.I. Leuco Sulfur Black 1 with (3-chloro-2-hydroxypropyl)trimethylammonium chloride | reaction product of: C.I. Leuco Sulfur Black 1 with (3-chloro-2-hydroxypropyl)trimethylammonium chloride | 424-510-1 | substance | Eye Dam. 1; Aquatic Chronic 2 | Hazard statement codes: H318; H411. Labelling pictogram and signal word: GHS05; GHS09; Dgr. Labelling hazard statements: H318; H411 | ||
| azafenidin (ISO); 2-(2,4-dichloro-5-prop-2-ynyloxyphenyl)-5,6,7,8-tetrahydro-1,2,4-triazolo[4,3-a]pyridin-3(2H)-one | azafenidin (ISO); 2-(2,4-dichloro-5-prop-2-ynyloxyphenyl)-5,6,7,8-tetrahydro-1,2,4-triazolo[4,3-a]pyridin-3(2H)-one | 68049-83-2 | substance | Repr. 1B; STOT RE 2 *; Aquatic Acute 1; Aquatic Chronic 1 | M = 1 000 | Hazard statement codes: H360Df; H373 **; H400; H410. Labelling pictogram and signal word: GHS08; GHS09; Dgr. Labelling hazard statements: H360Df; H373 **; H410 | |
| 5-(4-[4-[4-(3,5-dicarboxy-phenyl-azo)phenylamino]-6-morpholin-4-yl-1,3,5-triazin-2-ylamino]phenylazo)isophthalic acid, mixed monosodium and diammonium salt | 5-(4-[4-[4-(3,5-dicarboxy-phenyl-azo)phenylamino]-6-morpholin-4-yl-1,3,5-triazin-2-ylamino]phenylazo)isophthalic acid, mixed monosodium and diammonium salt | 414-410-6 | substance | Eye Dam. 1; Skin Sens. 1 | Hazard statement codes: H318; H317. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H318; H317 | ||
| product-by-process definition polyazodyestuff obtained by coupling 4-[4-(1-amino-8-hydroxy-3,6-disulfo-2-naphthylazo)phenylsulfonylamino] benzenediazonium with reaction mass of 4-carboxybenzenediazonium and diphenylamine-3-sulfo-4,4’-bisdiazonium, and further coupling of the obtained compounds with reaction mass of naphth-2-ol and 3-aminophenol, sodium salts; sodium chloride | product-by-process definition polyazodyestuff obtained by coupling 4-[4-(1-amino-8-hydroxy-3,6-disulfo-2-naphthylazo)phenylsulfonylamino] benzenediazonium with reaction mass of 4-carboxybenzenediazonium and diphenylamine-3-sulfo-4,4’-bisdiazonium, and further coupling of the obtained compounds with reaction mass of naphth-2-ol and 3-aminophenol, sodium salts; sodium chloride | 425-740-5 | substance | Eye Dam. 1; Aquatic Chronic 3 | Hazard statement codes: H318; H412. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318; H412 | ||
| reaction mass of: trisodium 2-(2-[α-(2-carboxylato-κ-O-4-sulfonatophenylazo)benzylidene] hydrazino-κ-N’)-6-(2,6-difluoropyrimidin-4-ylamino)-4-sulfonatophenolatocuprate (II); trisodium 2-(2-[α-(2-carboxylato-κ-O-4-sulfonatophenylazo)benzylidene] hydrazino-κ-N’)-6-(4,6-difluoropyrimidin-2-ylamino)-4-sulfonatophenolatocuprate (II) | reaction mass of: trisodium 2-(2-[α-(2-carboxylato-κ-O-4-sulfonatophenylazo)benzylidene] hydrazino-κ-N’)-6-(2,6-difluoropyrimidin-4-ylamino)-4-sulfonatophenolatocuprate (II); trisodium 2-(2-[α-(2-carboxylato-κ-O-4-sulfonatophenylazo)benzylidene] hydrazino-κ-N’)-6-(4,6-difluoropyrimidin-2-ylamino)-4-sulfonatophenolatocuprate (II) | 428-260-4 | substance | Eye Dam. 1 | Hazard statement codes: H318. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318 | ||
| reaction mass of: 7-amino-3,8-bis-[4-(2-sulfoxyethylsulfonyl) phenylazo]-4-hydroxynaphthalene-2-sulfonic acid, Na/K salt; 7-amino-3-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-hydroxy-8-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]naphthalene-2-sulfonic acid, Na/K salt; 7-amino-8-[4-(2-sulfoxyethylsulfonyl)-phenylazo]-4-hydroxy-3-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]naphthalene-2-sulfonic acid, Na/K salt; 7-amino-3,8-bis-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]-4-hydroxynaphthalene-2-sulfonic acid, Na/K salt | reaction mass of: 7-amino-3,8-bis-[4-(2-sulfoxyethylsulfonyl) phenylazo]-4-hydroxynaphthalene-2-sulfonic acid, Na/K salt; 7-amino-3-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-hydroxy-8-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]naphthalene-2-sulfonic acid, Na/K salt; 7-amino-8-[4-(2-sulfoxyethylsulfonyl)-phenylazo]-4-hydroxy-3-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]naphthalene-2-sulfonic acid, Na/K salt; 7-amino-3,8-bis-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]-4-hydroxynaphthalene-2-sulfonic acid, Na/K salt | 214362-06-8 | 429-070-4 | substance | Eye Dam. 1 | Hazard statement codes: H318. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318 | |
| reaction mass of: tetrasodium 3-(1,5-disulfonatonaphthalene-2-ylazo)-4-hydroxy-7-{]4-chloro-6-[}4-(2-sulfoxyethylsulfonyl)phenylamino{]-1,3,5-triazine-2-ylamino[}naphthalene-2-sulfonate; 3-(2,5-disulfophenylazo)-4-hydroxy-7-{]4-chloro-6-[}4-(2-sulfoxyethylsulfonyl)phenylamino{]-1,3,5-triazine-2-ylamino[}naphthalene-2-sulfonic acid, sodium salt | reaction mass of: tetrasodium 3-(1,5-disulfonatonaphthalene-2-ylazo)-4-hydroxy-7-{]4-chloro-6-[}4-(2-sulfoxyethylsulfonyl)phenylamino{]-1,3,5-triazine-2-ylamino[}naphthalene-2-sulfonate; 3-(2,5-disulfophenylazo)-4-hydroxy-7-{]4-chloro-6-[}4-(2-sulfoxyethylsulfonyl)phenylamino{]-1,3,5-triazine-2-ylamino[}naphthalene-2-sulfonic acid, sodium salt | 429-440-5 | substance | Eye Dam. 1 | Hazard statement codes: H318. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318 | ||
| reaction mass of: pentasodium 3-(4-(4-(7-(2,4-diamino-5-sulfonato-3-(4-sulfonatophenylazo)phenylazo)-1-hydroxy-3-sulfonatonaphthalen-2-ylazo)-2-sulfonatophenylamino)phenylazo)-4-hydroxy-6-(2-oxo-1-phenylcarbamoylpropylazo) naphthalene-2-sulfonate; pentasodium 6-((2,4-diamino-5-sulfonatophenyl)azo)-3-((4-((4-((7-((2,4-diamino-5-sulfonatophenyl)azo)-1-hydroxy-3-sulfonatonaphthalen-2-yl)azo)phenyl)amino)-2-sulfonatophenyl)azo)-4-hydroxynaphthalene-2-sulfonate; pentasodium 6-((2,4-diamino-5-sulfonato-3-((4-sulfonatophenyl)azo)phenyl)azo)-3-((4-((4-((1,7-dihydroxy-3-sulfonatonaphthalen-2-yl)azo)-2-sulfonatophenyl)amino)phenyl)azo)-4-hydroxynaphthalene-2-sulfonate; hexasodium 6-((2,4-diamino-5-sulfonatophenyl)azo)-3-((4-((4-((7-((2,4-diamino-5-sulfonato-3-((4-sulfonatophenyl)azo)phenyl)azo)-1-hydroxy-3-sulfonatonaphthalen-2-yl)azo)-2-sulfonatophenyl)amino)phenyl)azo)-4-hydroxynaphthalene-2-sulfonate | reaction mass of: pentasodium 3-(4-(4-(7-(2,4-diamino-5-sulfonato-3-(4-sulfonatophenylazo)phenylazo)-1-hydroxy-3-sulfonatonaphthalen-2-ylazo)-2-sulfonatophenylamino)phenylazo)-4-hydroxy-6-(2-oxo-1-phenylcarbamoylpropylazo) naphthalene-2-sulfonate; pentasodium 6-((2,4-diamino-5-sulfonatophenyl)azo)-3-((4-((4-((7-((2,4-diamino-5-sulfonatophenyl)azo)-1-hydroxy-3-sulfonatonaphthalen-2-yl)azo)phenyl)amino)-2-sulfonatophenyl)azo)-4-hydroxynaphthalene-2-sulfonate; pentasodium 6-((2,4-diamino-5-sulfonato-3-((4-sulfonatophenyl)azo)phenyl)azo)-3-((4-((4-((1,7-dihydroxy-3-sulfonatonaphthalen-2-yl)azo)-2-sulfonatophenyl)amino)phenyl)azo)-4-hydroxynaphthalene-2-sulfonate; hexasodium 6-((2,4-diamino-5-sulfonatophenyl)azo)-3-((4-((4-((7-((2,4-diamino-5-sulfonato-3-((4-sulfonatophenyl)azo)phenyl)azo)-1-hydroxy-3-sulfonatonaphthalen-2-yl)azo)-2-sulfonatophenyl)amino)phenyl)azo)-4-hydroxynaphthalene-2-sulfonate | 430-070-1 | substance | Aquatic Chronic 2 | Hazard statement codes: H411. Labelling pictogram and signal word: GHS09. Labelling hazard statements: H411 | ||
| sodium, potassium, lithium 5-amino-3,6-bis(5-(4-chloro-6-(methyl-(2-methylaminoacetyl)amino) -1,3,5-triazin-2-ylamino)-2-sulfonatophenylazo)-4-hydroxynaphthalene-2,7-disulfonate | sodium, potassium, lithium 5-amino-3,6-bis(5-(4-chloro-6-(methyl-(2-methylaminoacetyl)amino) -1,3,5-triazin-2-ylamino)-2-sulfonatophenylazo)-4-hydroxynaphthalene-2,7-disulfonate | 205764-96-1 | 430-090-0 | substance | Eye Dam. 1; Skin Sens. 1 | Hazard statement codes: H318; H317. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H318; H317 | |
| reaction mass of: 2-(3-(2,6-dichloro-4-nitrophenylazo)carbazol-9-yl)ethanol; 2-(2-(3-(2,6-dichloro-4-nitro-phenylazo)-carbazol-9-yl)-ethoxy)ethanol; 3-(2,6-dichloro-4-nitrophenylazo)carbazol | reaction mass of: 2-(3-(2,6-dichloro-4-nitrophenylazo)carbazol-9-yl)ethanol; 2-(2-(3-(2,6-dichloro-4-nitro-phenylazo)-carbazol-9-yl)-ethoxy)ethanol; 3-(2,6-dichloro-4-nitrophenylazo)carbazol | 429-590-1 | substance | Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H317; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H317; H410 | ||
| 2-(2-chloroacetoxy)ethyl 3-((4-(2,5-dichloro-4-fluorosulfonylphenylazo)-3-methylphenyl)ethylamino) propionate | 2-(2-chloroacetoxy)ethyl 3-((4-(2,5-dichloro-4-fluorosulfonylphenylazo)-3-methylphenyl)ethylamino) propionate | 193486-83-8 | 427-570-7 | substance | Aquatic Chronic 2 | Hazard statement codes: H411. Labelling pictogram and signal word: GHS09. Labelling hazard statements: H411 | |
| tetralithium 2-[6-[7-[2-(carboxylato)phenylazo]-8-hydroxy-3,6-disulfonato-1-naphthylamino]-4-hydroxy-1,3,5-triazine-2-ylamino]benzoate | tetralithium 2-[6-[7-[2-(carboxylato)phenylazo]-8-hydroxy-3,6-disulfonato-1-naphthylamino]-4-hydroxy-1,3,5-triazine-2-ylamino]benzoate | 440-460-3 | substance | Eye Irrit. 2; Aquatic Chronic 3 | Hazard statement codes: H319; H412. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H319; H412 | ||
| chrysoidine; 4-(phenylazo)benzene-1,3-diamine | chrysoidine; 4-(phenylazo)benzene-1,3-diamine | 495-54-5 | 207-803-7 | substance | Muta. 2; Acute Tox. 4 *; Skin Irrit. 2; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H341; H302; H315; H400; H410. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Wng. Labelling hazard statements: H341; H302; H315; H410 | |
| chrysoidine monohydrochloride; 4-phenylazophenylene-1,3-diamine monohydrochloride; [1] chrysoidine monoacetate; 4-(phenylazo)benzene-1,3-diamine monoacetate; [2] chrysoidine acetate; 4-(phenylazo)benzene-1,3-diamine acetate; [3] chrysoidine-p-dodecylbenzenesulfonate; dodecylbenzenesulfonic acid, compound with 4-(phenylazo)benzene-1,3-diamine (1:1); [4] chrysoidine dihydrochloride; 4-(phenylazo)benzene-1,3-diamine dihydrochloride; [5] chrysoidine sulfate; bis[4-(phenylazo)benzene-1,3-diamine] sulfate [6] | chrysoidine monohydrochloride; 4-phenylazophenylene-1,3-diamine monohydrochloride; [1] chrysoidine monoacetate; 4-(phenylazo)benzene-1,3-diamine monoacetate; [2] chrysoidine acetate; 4-(phenylazo)benzene-1,3-diamine acetate; [3] chrysoidine-p-dodecylbenzenesulfonate; dodecylbenzenesulfonic acid, compound with 4-(phenylazo)benzene-1,3-diamine (1:1); [4] chrysoidine dihydrochloride; 4-(phenylazo)benzene-1,3-diamine dihydrochloride; [5] chrysoidine sulfate; bis[4-(phenylazo)benzene-1,3-diamine] sulfate [6] | 532-82-1 [1] 75660-25-2 [2] 79234-33-6 [3] 63681-54-9 [4] 83968-67-6 [5] 84196-22-5 [6] | 208-545-8 [1] 278-290-5 [2] 279-116-0 [3] 264-409-8 [4] 281-549-5 [5] 282-432-1 [6] | substance | Muta. 2; Acute Tox. 4 *; Skin Irrit. 2; Eye Dam. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H341; H302; H315; H318; H400; H410. Labelling pictogram and signal word: GHS05; GHS08; GHS07; GHS09; Dgr. Labelling hazard statements: H341; H302; H315; H318; H410 | |
| chrysoidine C10-14-alkyl derivatives; benzenesulfonic acid, mono-C10-14-alkyl derivatives, compounds with 4-(phenylazo)-1,3-benzenediamine; [1] chrysoidine compound with dibutylnaphthalene sulfonic acid; dibutylnaphthalenesulfonic acid, compound with 4-(phenylazo)benzene-1,3-diamine (1:1) [2] | chrysoidine C10-14-alkyl derivatives; benzenesulfonic acid, mono-C10-14-alkyl derivatives, compounds with 4-(phenylazo)-1,3-benzenediamine; [1] chrysoidine compound with dibutylnaphthalene sulfonic acid; dibutylnaphthalenesulfonic acid, compound with 4-(phenylazo)benzene-1,3-diamine (1:1) [2] | 85407-90-5 [1] 94247-67-3 [2] | 286-946-7 [1] 304-236-8 [2] | substance | Muta. 2; Acute Tox. 4 *; Skin Irrit. 2; Eye Dam. 1 | Hazard statement codes: H341; H302; H315; H318. Labelling pictogram and signal word: GHS05; GHS08; GHS07; Dgr. Labelling hazard statements: H341; H302; H315; H318 | |
| trisodium 5-benzamido-4-hydroxy-3-(4-methyl-2-sulfonatophenylazo) naphthalene-2,7-disulfonate | trisodium 5-benzamido-4-hydroxy-3-(4-methyl-2-sulfonatophenylazo) naphthalene-2,7-disulfonate | 92408-46-3 | 403-670-6 | substance | Aquatic Chronic 3 | Hazard statement codes: H412. Labelling pictogram and signal word: —. Labelling hazard statements: H412 | |
| 4,4’-oxybis(benzenesulfonylazide) | 4,4’-oxybis(benzenesulfonylazide) | 7456-68-0 | 431-850-4 | substance | Expl. 1.1****; STOT RE 2 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H201; H373**; H400; H410. Labelling pictogram and signal word: GHS01; GHS08; GHS09; Dgr. Labelling hazard statements: H201; H373**; H410 | |
| triammonium 4-[4-[7-(4-carboxylatoanilino)-1-hydroxy-3-sulfonato-2-naphthylazo] -2,5-dimethoxyphenylazo]benzoate | triammonium 4-[4-[7-(4-carboxylatoanilino)-1-hydroxy-3-sulfonato-2-naphthylazo] -2,5-dimethoxyphenylazo]benzoate | 221354-37-6 | 432-270-4 | substance | Repr. 2; STOT RE 2 *; Aquatic Chronic 2 | Hazard statement codes: H361f***; H373**; H411. Labelling pictogram and signal word: GHS08; GHS09; Wng. Labelling hazard statements: H361f***; H373**; H411 | |
| benzenesulfonic acid, 3,3’-(methylenebis((dihydroxyphenylene) azo))bis-, potassium sodium salt; potassium sodium 3-[(E)-(6-{]3,4-dihydroxy-2-[}(Z)-(3-sulfonatophenyl)diazenyl{]benzyl[}-2,3-dihydroxyphenyl)diazenyl] benzenesulfonate | benzenesulfonic acid, 3,3’-(methylenebis((dihydroxyphenylene) azo))bis-, potassium sodium salt; potassium sodium 3-[(E)-(6-{]3,4-dihydroxy-2-[}(Z)-(3-sulfonatophenyl)diazenyl{]benzyl[}-2,3-dihydroxyphenyl)diazenyl] benzenesulfonate | 243869-48-9 | 432-590-4 | substance | Eye Irrit. 2; Aquatic Chronic 3 | Hazard statement codes: H319; H412. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H319; H412 | |
| reaction product of: 2,3,4,2’, 3’, 4’-hexahydroxy-5,5’-diacethyl-diphenylmethane and 6-diazo-5,6-dihydro-5-oxo-1-naphthalenesulfonylchloride and 3-diazo-3,4-dihydro-6-methoxy-4-oxo-1-naphthalenesulfonylchloride | reaction product of: 2,3,4,2’, 3’, 4’-hexahydroxy-5,5’-diacethyl-diphenylmethane and 6-diazo-5,6-dihydro-5-oxo-1-naphthalenesulfonylchloride and 3-diazo-3,4-dihydro-6-methoxy-4-oxo-1-naphthalenesulfonylchloride | 421-520-8 | substance | ****; Aquatic Chronic 4 | Hazard statement codes: ****; H413. Labelling pictogram and signal word: ****. Labelling hazard statements: ****; H413 | ||
| reaction mass of: 1,1,1-tris(phenyl-4’-(3’’-diazo-3’’, 4’’-dihydro-4’’-oxo-naphthalene-1’’-sulfonato)ethane; 1,1,1-tris(phenyl-4’-(6’’-diazo-5’’, 6’’-dihydro-5’’-oxo-naphthalene-1’’-sulfonato)ethane; reaction product of 1,1,1-tris(p-hydroxyphenyl)ethane with 6-diazo-5,6-dihydro-5-oxo-1-naphthylsulfonylchloride and 3-diazo-3,4-dihydro-4-oxo-1-naphthylsulfonylchloride (2:1); reaction product of 1,1,1-tris(p-hydroxyphenyl)ethane with 6-diazo-5,6-dihydro-5-oxo-1-naphthylsulfonylchloride and 3-diazo-3,4-dihydro-4-oxo-1-naphthylsulfonylchloride (1:2) | reaction mass of: 1,1,1-tris(phenyl-4’-(3’’-diazo-3’’, 4’’-dihydro-4’’-oxo-naphthalene-1’’-sulfonato)ethane; 1,1,1-tris(phenyl-4’-(6’’-diazo-5’’, 6’’-dihydro-5’’-oxo-naphthalene-1’’-sulfonato)ethane; reaction product of 1,1,1-tris(p-hydroxyphenyl)ethane with 6-diazo-5,6-dihydro-5-oxo-1-naphthylsulfonylchloride and 3-diazo-3,4-dihydro-4-oxo-1-naphthylsulfonylchloride (2:1); reaction product of 1,1,1-tris(p-hydroxyphenyl)ethane with 6-diazo-5,6-dihydro-5-oxo-1-naphthylsulfonylchloride and 3-diazo-3,4-dihydro-4-oxo-1-naphthylsulfonylchloride (1:2) | 422-760-6 | substance | ****; Aquatic Chronic 4 | Hazard statement codes: ****; H413. Labelling pictogram and signal word: ****. Labelling hazard statements: ****; H413 | ||
| trisodium [1,2’-(2-(8-amino-3,5-disulfonatonaphthalene)azo)-(4’-nitrobenzene)diolato-O,O,N][(Z) -2,2-((phenylcarbamoylprop-1’-enyl)azo)-5-sulfamoylbenzene) diolato-O,O,N]chromate(III) | trisodium [1,2’-(2-(8-amino-3,5-disulfonatonaphthalene)azo)-(4’-nitrobenzene)diolato-O,O,N][(Z) -2,2-((phenylcarbamoylprop-1’-enyl)azo)-5-sulfamoylbenzene) diolato-O,O,N]chromate(III) | 423-100-1 | substance | Eye Dam. 1 | Hazard statement codes: H318. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318 | ||
| 2,4-bis(((2-(dimethylammonio)ethyloxy) carbonyl)phen-2-ylazo)benzene-1,3-diolbis(methanesulfonate) | 2,4-bis(((2-(dimethylammonio)ethyloxy) carbonyl)phen-2-ylazo)benzene-1,3-diolbis(methanesulfonate) | 429-600-4 | substance | Acute Tox. 4 *; Eye Dam. 1; Aquatic Chronic 2 | Hazard statement codes: H302; H318; H411. Labelling pictogram and signal word: GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H302; H318; H411 | ||
| 2,4-bis(((2-(dimethylammonio)ethyloxy) carbonyl)phen-2-ylazo)benzene-1,3-diol sulfate | 2,4-bis(((2-(dimethylammonio)ethyloxy) carbonyl)phen-2-ylazo)benzene-1,3-diol sulfate | 429-610-9 | substance | Acute Tox. 4 *; Eye Dam. 1; Aquatic Chronic 2 | Hazard statement codes: H302; H318; H411. Labelling pictogram and signal word: GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H302; H318; H411 | ||
| reaction mass of: 2,2’-dimethyl-2,2’- azobutanenitrile; 2-methylpentanenitrile-2-azo-2’-(2’- methylpropanenitrile); 2,2’-dimethyl-2,2’-azoheptanenitrile; 2-methylheptanenitrile-2-azo-2’-(2’- methylpropanenitrile); 2-methylheptanenitrile-2-azo-2’-(2’- methylbutanenitrile) | reaction mass of: 2,2’-dimethyl-2,2’- azobutanenitrile; 2-methylpentanenitrile-2-azo-2’-(2’- methylpropanenitrile); 2,2’-dimethyl-2,2’-azoheptanenitrile; 2-methylheptanenitrile-2-azo-2’-(2’- methylpropanenitrile); 2-methylheptanenitrile-2-azo-2’-(2’- methylbutanenitrile) | 429-710-2 | substance | Self-react. D; Acute Tox. 4 *; Aquatic Chronic 2 | Hazard statement codes: H242; H302; H411. Labelling pictogram and signal word: GHS02; GHS07; GHS09; Dgr. Labelling hazard statements: H242; H302; H411 | ||
| reaction mass of: tetrasodium 4-amino-6-(5-(2,6-difluoropyrimidin-4-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(sulfatoethylsulfonyl)phenylazo) naphthalene-2,7-disulfonate; tetrasodium 4-amino-6-(5-(4,6-difluoropyrimidin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(2-sulfatoethylsulfonyl)phenylazo) naphthalene-2,7-disulfonate | reaction mass of: tetrasodium 4-amino-6-(5-(2,6-difluoropyrimidin-4-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(sulfatoethylsulfonyl)phenylazo) naphthalene-2,7-disulfonate; tetrasodium 4-amino-6-(5-(4,6-difluoropyrimidin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(2-sulfatoethylsulfonyl)phenylazo) naphthalene-2,7-disulfonate | 431-830-5 | substance | Aquatic Chronic 3 | Hazard statement codes: H412. Labelling pictogram and signal word: —. Labelling hazard statements: H412 | ||
| reaction mass of: pentasodium 4-amino-5-hydroxy-3-{](E)-4-[}2-(sulfonatooxy)ethylsulfonyl{] phenylazo[}-6-{](E)-2-sulfonato-4-[}2-(sulfonatooxy)ethylsulfonyl{] phenylazo[}naphthalene-2,7-disulfonate; tetrasodium 4-amino-5-hydroxy-3-{](E)-4-[}2-(sulfonatooxy)ethylsulfonyl{] phenylazo[}-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo{]naphthalene-2,7-disulfonate; tetrasodium 4-amino-5-hydroxy-6-(E)-2-sulfonato-4-[}2-(sulfonatooxy)ethylsulfonyl{] phenylazo[}-3-[(E)-4-(vinylsulfonyl)phenylazo] naphthalene-2,7-disulfonate | reaction mass of: pentasodium 4-amino-5-hydroxy-3-{](E)-4-[}2-(sulfonatooxy)ethylsulfonyl{] phenylazo[}-6-{](E)-2-sulfonato-4-[}2-(sulfonatooxy)ethylsulfonyl{] phenylazo[}naphthalene-2,7-disulfonate; tetrasodium 4-amino-5-hydroxy-3-{](E)-4-[}2-(sulfonatooxy)ethylsulfonyl{] phenylazo[}-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo{]naphthalene-2,7-disulfonate; tetrasodium 4-amino-5-hydroxy-6-(E)-2-sulfonato-4-[}2-(sulfonatooxy)ethylsulfonyl{] phenylazo[}-3-[(E)-4-(vinylsulfonyl)phenylazo] naphthalene-2,7-disulfonate | 432-100-9 | substance | Eye Dam. 1; Aquatic Chronic 3 | Hazard statement codes: H318; H412. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318; H412 | ||
| sodium bis[tris(2-hydroxyethyl)ammonium][6-anilino-4’-(4,8-disulfonato-2-naphthylazo)-5’-methyl-3-sulfonatonaphthalene-2-azobenzene-1,2’-diolato]cuprate(II) | sodium bis[tris(2-hydroxyethyl)ammonium][6-anilino-4’-(4,8-disulfonato-2-naphthylazo)-5’-methyl-3-sulfonatonaphthalene-2-azobenzene-1,2’-diolato]cuprate(II) | 435-240-9 | substance | Aquatic Chronic 3 | Hazard statement codes: H412. Labelling pictogram and signal word: —. Labelling hazard statements: H412 | ||
| reaction mass of: 3-[[4-chloro-6-[[7-[(1,5-disulfo-2-naphthalenyl)azo]-8-hydroxy-3,6-disulfo-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]-5-[[4-chloro-6-[[8-hydroxy-3,6-disulfo-7-[(2-sulfophenyl)azo]-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]benzoic acid; 3,5-bis[[4-chloro-6-[[7-[(1,5-disulfo-2-naphthalenyl)azo]-8-hydroxy-3,6-disulfo-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]benzoic acid | reaction mass of: 3-[[4-chloro-6-[[7-[(1,5-disulfo-2-naphthalenyl)azo]-8-hydroxy-3,6-disulfo-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]-5-[[4-chloro-6-[[8-hydroxy-3,6-disulfo-7-[(2-sulfophenyl)azo]-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]benzoic acid; 3,5-bis[[4-chloro-6-[[7-[(1,5-disulfo-2-naphthalenyl)azo]-8-hydroxy-3,6-disulfo-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]benzoic acid | 435-440-6 | substance | Eye Dam. 1 | Hazard statement codes: H318. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318 | ||
| sodium 5-(2-carboxyphenylazo)-6-hydroxynaphthalene-2-sulfonate | sodium 5-(2-carboxyphenylazo)-6-hydroxynaphthalene-2-sulfonate | 435-800-2 | substance | Aquatic Chronic 3 | Hazard statement codes: H412. Labelling pictogram and signal word: —. Labelling hazard statements: H412 | ||
| reaction mass of: trisodium 2-((1-(2-hydroxy-κ-O-5-(2-sulfonatoethansulfonyl)phenylazo-κ-N2)-1-phenylmethyl)azo-κ-N1)-4-sulfonatobenzoate(5-)-κ-O)cuprate(II); disodium 2-((1-(5-ethenesulfonyl-2-hydroxy-κ-O-phenylazo-κ-N2)-1-phenylmethyl)azo-κ-N1)-4-sulfonatobenzoate-κ-O-(5-)) cuprate(II) | reaction mass of: trisodium 2-((1-(2-hydroxy-κ-O-5-(2-sulfonatoethansulfonyl)phenylazo-κ-N2)-1-phenylmethyl)azo-κ-N1)-4-sulfonatobenzoate(5-)-κ-O)cuprate(II); disodium 2-((1-(5-ethenesulfonyl-2-hydroxy-κ-O-phenylazo-κ-N2)-1-phenylmethyl)azo-κ-N1)-4-sulfonatobenzoate-κ-O-(5-)) cuprate(II) | 435-880-9 | substance | Aquatic Chronic 3 | Hazard statement codes: H412. Labelling pictogram and signal word: —. Labelling hazard statements: H412 | ||
| reaction mass of: trisodium 3-(5-(2,6-difluoropyrimidin-4-ylamino)-2-sulfonatophenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-naphthalenedisulfonate; trisodium 3-(5-(4,6-difluoropyrimidin-2-ylamino)-2-sulfonatophenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-naphthalenedisulfonate | reaction mass of: trisodium 3-(5-(2,6-difluoropyrimidin-4-ylamino)-2-sulfonatophenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-naphthalenedisulfonate; trisodium 3-(5-(4,6-difluoropyrimidin-2-ylamino)-2-sulfonatophenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-naphthalenedisulfonate | 436-890-6 | substance | Eye Dam. 1; Aquatic Chronic 3 | Hazard statement codes: H318; H412. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318; H412 | ||
| reaction mass of: triammonium 6-amino-3-((2,5-diethoxy-4-(3-phosphonophenyl)azo) phenyl)azo-4-hydroxy-2-naphthalenesulfonate; diammonium 3-((4-((7-amino-1-hydroxy-3-sulfo-naphthalen-2-yl) azo)-2,5-diethoxyphenyl) azo)benzoate | reaction mass of: triammonium 6-amino-3-((2,5-diethoxy-4-(3-phosphonophenyl)azo) phenyl)azo-4-hydroxy-2-naphthalenesulfonate; diammonium 3-((4-((7-amino-1-hydroxy-3-sulfo-naphthalen-2-yl) azo)-2,5-diethoxyphenyl) azo)benzoate | 438-310-7 | substance | Self-react. C****; Repr. 2; Acute Tox. 4 *; STOT RE 2 *; Aquatic Chronic 3 | Hazard statement codes: H242; H361f***; H302; H373**; H412. Labelling pictogram and signal word: GHS02; GHS08; GHS07; Dgr. Labelling hazard statements: H242; H361f***; H302; H373**; H412 | ||
| reaction mass of: 3-[3-carbamoyl-5-(5-{]4-chloro-6-[}4-(2-sulfonatooxyethylsulfonyl)anilino{]-1,3,5-triazin-2-ylamino[}-2-sulfonatophenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl]propanoic acid, trisodium salt; 3-[3-carbamoyl-5-(5-{]4-chloro-6-[}4-(vinylsulfonyl)anilino{]-1,3,5-triazin-2-ylamino[}-2-sulfonatophenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl]propanoic acid, disodium salt | reaction mass of: 3-[3-carbamoyl-5-(5-{]4-chloro-6-[}4-(2-sulfonatooxyethylsulfonyl)anilino{]-1,3,5-triazin-2-ylamino[}-2-sulfonatophenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl]propanoic acid, trisodium salt; 3-[3-carbamoyl-5-(5-{]4-chloro-6-[}4-(vinylsulfonyl)anilino{]-1,3,5-triazin-2-ylamino[}-2-sulfonatophenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl]propanoic acid, disodium salt | 440-510-4 | substance | Eye Dam. 1; Skin Sens. 1 | Hazard statement codes: H318; H317. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H318; H317 | ||
| reaction mass of: 3-[5-(4-ethenesulfonylbutyrylamino)-2-sulfophenylazo{]-5-4-chloro-[}6-(4-(3-amino-5-hydroxy-2,7-disulfonaphthalene-4-ylazo)-3-sulfophenylamino{]-1,3,5-triazin-2-ylamino[}-4-hydroxynaphthalene-2,7-disulfonic acid, sodium salt; 3-[5-(4-(2-chloroethanesulfonyl)butyrylamino)-2-sulfophenylazo{]-5-4-chloro-[}6-(4-(3-amino-5-hydroxy-2,7-disulfonaphthalene-4-ylazo)-3-sulfophenylamino{]-1,3,5-triazin-2-ylamino[}-4-hydroxynaphthalene-2,7-disulfonic acid, sodium salt | reaction mass of: 3-[5-(4-ethenesulfonylbutyrylamino)-2-sulfophenylazo{]-5-4-chloro-[}6-(4-(3-amino-5-hydroxy-2,7-disulfonaphthalene-4-ylazo)-3-sulfophenylamino{]-1,3,5-triazin-2-ylamino[}-4-hydroxynaphthalene-2,7-disulfonic acid, sodium salt; 3-[5-(4-(2-chloroethanesulfonyl)butyrylamino)-2-sulfophenylazo{]-5-4-chloro-[}6-(4-(3-amino-5-hydroxy-2,7-disulfonaphthalene-4-ylazo)-3-sulfophenylamino{]-1,3,5-triazin-2-ylamino[}-4-hydroxynaphthalene-2,7-disulfonic acid, sodium salt | 457624-86-1 | 442-290-5 | substance | Eye Dam. 1 | Hazard statement codes: H318. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318 | |
| reaction mass of: trisodium 5-{]4-chloro-6-[}N-ethyl-(3-(2-sulfonatooxy)ethylsulfonyl)anilino{]-1,3,5-triazin-2-ylamino[}-4-hydroxy-3-[4-(vinylsulfonyl)phenylazo{]naphthalene-2,7-disulfonate; trisodium 5-4-chloro-6-[}N-ethyl-3-(vinylsulfonyl)anilino{]-1,3,5-triazin-2-ylamino[}-4-hydroxy-3-[4-(2-(sulfonatooxy)ethylsulfonyl) phenylazo{]naphthalene-2,7-disulfonate; disodium 5-4-chloro-6-[}N-ethyl-3-(vinylsulfonyl)anilino{]-1,3,5-triazin-2-ylamino[}-4-hydroxy-3-[(4-vinylsulfonyl)phenylazo{]naphthalene-2,7-disulfonate; tetrasodium 5-4-chloro-6-[}N-ethyl-3-(2-(sulfonatooxy)ethylsulfonyl)anilino{]-1,3,5-triazin-2-ylamino[}-3-[4-(2-(sulfonatooxy)ethylsulfonyl) phenylazo]-4-hydroxynaphthalene-2,7-disulfonate | reaction mass of: trisodium 5-{]4-chloro-6-[}N-ethyl-(3-(2-sulfonatooxy)ethylsulfonyl)anilino{]-1,3,5-triazin-2-ylamino[}-4-hydroxy-3-[4-(vinylsulfonyl)phenylazo{]naphthalene-2,7-disulfonate; trisodium 5-4-chloro-6-[}N-ethyl-3-(vinylsulfonyl)anilino{]-1,3,5-triazin-2-ylamino[}-4-hydroxy-3-[4-(2-(sulfonatooxy)ethylsulfonyl) phenylazo{]naphthalene-2,7-disulfonate; disodium 5-4-chloro-6-[}N-ethyl-3-(vinylsulfonyl)anilino{]-1,3,5-triazin-2-ylamino[}-4-hydroxy-3-[(4-vinylsulfonyl)phenylazo{]naphthalene-2,7-disulfonate; tetrasodium 5-4-chloro-6-[}N-ethyl-3-(2-(sulfonatooxy)ethylsulfonyl)anilino{]-1,3,5-triazin-2-ylamino[}-3-[4-(2-(sulfonatooxy)ethylsulfonyl) phenylazo]-4-hydroxynaphthalene-2,7-disulfonate | 444-050-5 | substance | Eye Dam. 1; Aquatic Chronic 3 | Hazard statement codes: H318; H412. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318; H412 | ||
| 2,6-bis(2,3,4-trihydroxybenzyl)-p-cresol ester with 6-diazo-5,6-dihydro-5-oxo-1-naphthalenesulfonate | 2,6-bis(2,3,4-trihydroxybenzyl)-p-cresol ester with 6-diazo-5,6-dihydro-5-oxo-1-naphthalenesulfonate | 444-250-2 | substance | Self-react. C****; Aquatic Chronic 2 | Hazard statement codes: H242; H411. Labelling pictogram and signal word: GHS02; GHS09; Dgr. Labelling hazard statements: H242; H411 | ||
| reaction mass of: pentasodium bis[6-anilino-3,5’-disulfonatonaphthalene-2-azobenzene-1,2’-diolato]cobaltate(III); tetrasodium [6-anilino-3,5’-disulfonatonaphthalene-2-azobenzene-1,2’-diolato][6-anilino-5’-sulfamoyl-3-sulfonatonaphthalene-2-azobenzene-1,2’-diolato]cobaltate(III); trisodium bis[6-anilino-5’-sulfamoyl-3-sulfonatonaphthalene-2-azobenzene-1,2’-diolato]cobaltate(III) | reaction mass of: pentasodium bis[6-anilino-3,5’-disulfonatonaphthalene-2-azobenzene-1,2’-diolato]cobaltate(III); tetrasodium [6-anilino-3,5’-disulfonatonaphthalene-2-azobenzene-1,2’-diolato][6-anilino-5’-sulfamoyl-3-sulfonatonaphthalene-2-azobenzene-1,2’-diolato]cobaltate(III); trisodium bis[6-anilino-5’-sulfamoyl-3-sulfonatonaphthalene-2-azobenzene-1,2’-diolato]cobaltate(III) | 508202-43-5 | 444-290-0 | substance | Eye Dam. 1; Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H318; H317; H412. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H318; H317; H412 | |
| reaction mass of: pentasodium 4-amino-5-hydroxy-3-{](E)-4-[}2-(sulfonatooxy)ethylsulfonyl{] phenylazo[}-6-{](E)-2-sulfonato-4-[}2-(sulfonatooxy)ethylsulfonyl{] phenylazo[}naphthalene-2,7-disulfonate; tetrasodium 4-amino-5-hydroxy-3-{](E)-4-[}2-(sulfonatooxy)ethylsulfonyl{] phenylazo[}-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate; tetrasodium 4-amino-5-hydroxy-6-[(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl{] phenylazo[}-3-[(E)-4-(vinylsulfonyl)phenylazo] naphthalene-2,7-disulfonate; trisodium 4-amino-5-hydroxy-3-[(E)-4-(vinylsulfonyl)phenylazo]-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo] naphthalene-2,7-disulfonate; trisodium 4-amino-5-hydroxy-3-[(2-hydroxyethylsulfonyl)-phenylazo]-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo] naphthalene-2,7-disulfonate; trisodium 4-amino-5-hydroxy-3-[(E)-4-(vinylsulfonyl)phenylazo]-6-[-2-sulfonato-4-(2-hydroxyethylsulfonyl) phenylazo]naphthalene-2,7-disulfonate | reaction mass of: pentasodium 4-amino-5-hydroxy-3-{](E)-4-[}2-(sulfonatooxy)ethylsulfonyl{] phenylazo[}-6-{](E)-2-sulfonato-4-[}2-(sulfonatooxy)ethylsulfonyl{] phenylazo[}naphthalene-2,7-disulfonate; tetrasodium 4-amino-5-hydroxy-3-{](E)-4-[}2-(sulfonatooxy)ethylsulfonyl{] phenylazo[}-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate; tetrasodium 4-amino-5-hydroxy-6-[(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl{] phenylazo[}-3-[(E)-4-(vinylsulfonyl)phenylazo] naphthalene-2,7-disulfonate; trisodium 4-amino-5-hydroxy-3-[(E)-4-(vinylsulfonyl)phenylazo]-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo] naphthalene-2,7-disulfonate; trisodium 4-amino-5-hydroxy-3-[(2-hydroxyethylsulfonyl)-phenylazo]-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo] naphthalene-2,7-disulfonate; trisodium 4-amino-5-hydroxy-3-[(E)-4-(vinylsulfonyl)phenylazo]-6-[-2-sulfonato-4-(2-hydroxyethylsulfonyl) phenylazo]naphthalene-2,7-disulfonate | 445-280-9 | substance | Eye Dam. 1; Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H318; H317; H412. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H318; H317; H412 | ||
| reaction mass of: pentasodium 2-[[8-[[4-chloro-6-[[4-(2-sulfonato ethylsulfonyl)]phenyl]amino]-1,3,5-triazin-2-yl]amino-1- hydroxy-3,6-disulfonato-2-naphthalenyl]azo]naphthalene-1,5-disulfonate; 2-[[8-[[4-chloro-6-[[4-[[2-ethenyl]sulfonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]-1-hydroxy-3,6-disulfonato-2-naphthalenyl]azo]naphthalene-1,5-disulfonate | reaction mass of: pentasodium 2-[[8-[[4-chloro-6-[[4-(2-sulfonato ethylsulfonyl)]phenyl]amino]-1,3,5-triazin-2-yl]amino-1- hydroxy-3,6-disulfonato-2-naphthalenyl]azo]naphthalene-1,5-disulfonate; 2-[[8-[[4-chloro-6-[[4-[[2-ethenyl]sulfonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]-1-hydroxy-3,6-disulfonato-2-naphthalenyl]azo]naphthalene-1,5-disulfonate | 450-010-8 | substance | Eye Dam. 1; Skin Sens. 1 | Hazard statement codes: H318; H317. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H318; H317 | ||
| iron, complexes with diazotised 4-aminobenzenesulfonamide, diazotised 3-aminobenzenesulfonic acid, diazotised 3-amino-4-hydroxybenzenesulfonamide, diazotised 3-amino-4-hydroxy-N-phenylbenzenesulfonamide, diazotised 5-amino-2-(phenylamino)benzenesulfonic acid and resorcinol, sodium salts | iron, complexes with diazotised 4-aminobenzenesulfonamide, diazotised 3-aminobenzenesulfonic acid, diazotised 3-amino-4-hydroxybenzenesulfonamide, diazotised 3-amino-4-hydroxy-N-phenylbenzenesulfonamide, diazotised 5-amino-2-(phenylamino)benzenesulfonic acid and resorcinol, sodium salts | 417-850-7 | substance | Aquatic Chronic 2 | Hazard statement codes: H411. Labelling pictogram and signal word: GHS09. Labelling hazard statements: H411 | ||
| potassium (oxido-NNO-azoxy)cyclohexane; cyclohexylhydroxydiazene 1-oxide, potassium salt; [K-HDO] | potassium (oxido-NNO-azoxy)cyclohexane; cyclohexylhydroxydiazene 1-oxide, potassium salt; [K-HDO] | 66603- 10-9 | substance | Flam. Sol. 1; Acute Tox. 3; STOT RE 2; Skin Irrit. 2; Eye Dam. 1; Aquatic Chronic 2 | oral: ATE = 136 mg/kg bw | Hazard statement codes: H228; H301; H373 (liver); H315; H318; H411. Labelling pictogram and signal word: GHS02; GHS06; GHS08; GHS05; GHS09; Dgr. Labelling hazard statements: H228; H301; H373 (liver); H315; H318; H411 | |
| 2-[ethyl[3-methyl-4-[(5-nitrothiazol-2-yl)azo]phenyl]amino]ethanol | 2-[ethyl[3-methyl-4-[(5-nitrothiazol-2-yl)azo]phenyl]amino]ethanol | 68516-81-4 | 271-183-4 | substance | Skin Sens. 1A | Skin Sens. 1A; H317; C ≥ 0.001% | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317. Date of Secretary of State decision: 2025-01-15. Date of entry into legal effect: 2025-02-15. Final compliance date: 2026-08-15 |
| mono-methylamine; [1] di-methylamine; [2] tri-methylamine [3] | mono-methylamine; [1] di-methylamine; [2] tri-methylamine [3] | 74-89-5 [1] 124-40-3 [2] 75-50-3 [3] | 200-820-0 [1] 204-697-4 [2] 200-875-0 [3] | substance | Flam. Gas 1; Press. Gas; Acute Tox. 4 *; STOT SE 3; Skin Irrit. 2; Eye Dam. 1 | * | Skin Irrit. 2; | H315: C ≥ 5 % | Eye Dam. 1; | H318: C ≥ 5 % | Eye Irrit. 2; H319: | 0.5 % ≤ C < 5 % | STOT SE 3; | H335: C ≥ 5 % | Hazard statement codes: H220; H332; H335; H315; H318. Labelling pictogram and signal word: GHS02; GHS04; GHS05; GHS07; Dgr. Labelling hazard statements: H220; H332; H335; H315; H318. Notes: U; 5 |
| mono-methylamine ... %; [1] di-methylamine ... %; [2] tri-methylamine ... % [3] | mono-methylamine ... %; [1] di-methylamine ... %; [2] tri-methylamine ... % [3] | 74-89-5 [1] 124-40-3 [2] 75-50-3 [3] | 200-820-0 [1] 204-697-4 [2] 200-875-0 [3] | substance | Flam. Liq. 1; Acute Tox. 4 *; Acute Tox. 4 *; Skin Corr. 1B | * | STOT SE 3; | H335: C ≥ 5 % | Hazard statement codes: H224; H332; H302; H314. Labelling pictogram and signal word: GHS02; GHS05; GHS07; Dgr. Labelling hazard statements: H224; H332; H302; H314. Notes: B |
| ethylamine | ethylamine | 75-04-7 | 200-834-7 | substance | Flam. Gas 1; Press. Gas; Eye Irrit. 2; STOT SE 3 | Hazard statement codes: H220; H319; H335. Labelling pictogram and signal word: GHS02; GHS04; GHS07; Dgr. Labelling hazard statements: H220; H319; H335. Notes: U | |
| diethylamine | diethylamine | 109-89-7 | 203-716-3 | substance | Flam. Liq. 2; Acute Tox. 4 *; Acute Tox. 4 *; Acute Tox. 4 *; Skin Corr. 1A | STOT SE 3; | H335: C ≥ 1 % | Hazard statement codes: H225; H332; H312; H302; H314. Labelling pictogram and signal word: GHS02; GHS05; GHS07; Dgr. Labelling hazard statements: H225; H332; H312; H302; H314 |
| triethylamine | triethylamine | 121-44-8 | 204-469-4 | substance | Flam. Liq. 2; Acute Tox. 3; Acute Tox. 3; Acute Tox. 3; Skin Corr. 1A; Eye Dam 1 | Oral: ATE = 100 mg/kg bw | Dermal: ATE = 300 mg/kg bw | Inhalation: ATE = 7.2 mg/L (vapours) | STOT SE 3; H335: C ≥ 1% | Hazard statement codes: H225; H331; H311; H301; H314; H318. Labelling pictogram and signal word: GHS02; GHS05; GHS06; Dgr. Labelling hazard statements: H225; H331; H311; H301; H314. Date of Secretary of State decision: 2024-02-02. Date of entry into legal effect: 2024-03-02. Final compliance date: 2025-09-02 |
| butylamine | butylamine | 109-73-9 | 203-699-2 | substance | Flam. Liq. 2; Acute Tox. 4 *; Acute Tox. 4 *; Acute Tox. 4 *; Skin Corr. 1A | STOT SE 3; | H335: C ≥ 1 % | Hazard statement codes: H225; H332; H312; H302; H314. Labelling pictogram and signal word: GHS02; GHS05; GHS07; Dgr. Labelling hazard statements: H225; H332; H312; H302; H314 |
| ethylenediamine; 1,2-diaminoethane | ethylenediamine; 1,2-diaminoethane | 107-15-3 | 203-468-6 | substance | Flam. Liq. 3; Acute Tox. 4 *; Acute Tox. 4 *; Skin Corr. 1B; Resp. Sens. 1; Skin Sens. 1 | Hazard statement codes: H226; H312; H302; H314; H334; H317. Labelling pictogram and signal word: GHS02; GHS08; GHS05; GHS07; Dgr. Labelling hazard statements: H226; H312; H302; H314; H334; H317 | |
| 2-aminopropane; isopropylamine | 2-aminopropane; isopropylamine | 75-31-0 | 200-860-9 | substance | Flam. Liq. 1; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2 | Hazard statement codes: H224; H319; H335; H315. Labelling pictogram and signal word: GHS02; GHS07; Dgr. Labelling hazard statements: H224; H319; H335; H315 | |
| aniline | aniline | 62-53-3 | 200-539-3 | substance | Carc. 2; Muta. 2; Acute Tox. 3 *; Acute Tox. 3 *; Acute Tox. 3 *; STOT RE 1; Eye Dam. 1; Skin Sens. 1; Aquatic Acute 1 | * | STOT RE 1; H372: C ≥ 1 % | STOT RE 2; H373: 0.2 % ≤ C < 1 % | Hazard statement codes: H351; H341; H331; H311; H301; H372 **; H318; H317; H400. Labelling pictogram and signal word: GHS06; GHS08; GHS05; GHS09; Dgr. Labelling hazard statements: H351; H341; H331; H311; H301; H372 **; H318; H317; H400 |
| salts of aniline | salts of aniline | substance | Carc. 2; Muta. 2; Acute Tox. 3 *; Acute Tox. 3 *; Acute Tox. 3 *; STOT RE 1; Eye Dam. 1; Skin Sens. 1; Aquatic Acute 1 | * | STOT RE 1; H372: C ≥ 1 % | STOT RE 2; H373: 0.2 % ≤ C < 1 % | Hazard statement codes: H351; H341; H331; H311; H301; H372 **; H318; H317; H400. Labelling pictogram and signal word: GHS06; GHS08; GHS05; GHS09; Dgr. Labelling hazard statements: H351; H341; H331; H311; H301; H372 **; H318; H317; H400. Notes: A | ||
| chloroanilines (with exception of those specified elsewhere in this Annex) | chloroanilines (with exception of those specified elsewhere in this Annex) | substance | Acute Tox. 3 *; Acute Tox. 3 *; Acute Tox. 3 *; STOT RE 2 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H331; H311; H301; H373 **; H400; H410. Labelling pictogram and signal word: GHS06; GHS08; GHS09; Dgr. Labelling hazard statements: H331; H311; H301; H373 **; H410. Notes: C | |||
| 4-nitrosoaniline | 4-nitrosoaniline | 659-49-4 | 211-535-6 | substance | Acute Tox. 4 *; Acute Tox. 4 *; Acute Tox. 4 * | Hazard statement codes: H332; H312; H302. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H332; H312; H302 | |
| o-nitroaniline; [1] m-nitroaniline; [2] p-nitroaniline [3] | o-nitroaniline; [1] m-nitroaniline; [2] p-nitroaniline [3] | 88-74-4 [1] 99-09-2 [2] 100-01-6 [3] | 201-855-4 [1] 202-729-1 [2] 202-810-1 [3] | substance | Acute Tox. 3 *; Acute Tox. 3 *; Acute Tox. 3 *; STOT RE 2 *; Aquatic Chronic 3 | Hazard statement codes: H331; H311; H301; H373 **; H412. Labelling pictogram and signal word: GHS06; GHS08; Dgr. Labelling hazard statements: H331; H311; H301; H373 **; H412. Notes: C | |
| 3-aminobenzene sulphonic acid; metanilic acid | 3-aminobenzene sulphonic acid; metanilic acid | 121-47-1 | 204-473-6 | substance | Acute Tox. 4 *; Acute Tox. 4 *; Acute Tox. 4 * | Hazard statement codes: H332; H312; H302. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H332; H312; H302 | |
| sulphanilic acid; 4-aminobenzenesulphonic acid | sulphanilic acid; 4-aminobenzenesulphonic acid | 121-57-3 | 204-482-5 | substance | Eye Irrit. 2; Skin Irrit. 2; Skin Sens. 1 | Hazard statement codes: H319; H315; H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H319; H315; H317 | |
| N-methylaniline | N-methylaniline | 100-61-8 | 202-870-9 | substance | Acute Tox. 3 *; Acute Tox. 3 *; Acute Tox. 3 *; STOT RE 2 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H331; H311; H301; H373 **; H400; H410. Labelling pictogram and signal word: GHS06; GHS08; GHS09; Dgr. Labelling hazard statements: H331; H311; H301; H373 **; H410 | |
| N,N-dimethylaniline | N,N-dimethylaniline | 121-69-7 | 204-493-5 | substance | Carc. 2; Acute Tox. 3 *; Acute Tox. 3 *; Acute Tox. 3 *; Aquatic Chronic 2 | Hazard statement codes: H351; H331; H311; H301; H411. Labelling pictogram and signal word: GHS06; GHS08; GHS09; Dgr. Labelling hazard statements: H351; H331; H311; H301; H411 | |
| N-methyl-N-2,4,6-tetranitroaniline; tetryl | N-methyl-N-2,4,6-tetranitroaniline; tetryl | 479-45-8 | 207-531-9 | substance | Expl. 1.1; Acute Tox. 3 *; Acute Tox. 3 *; Acute Tox. 3 *; STOT RE 2 | Hazard statement codes: H201; H331; H311; H301; H373**. Labelling pictogram and signal word: GHS01; GHS06; GHS08; Dgr. Labelling hazard statements: H201; H331; H311; H301; H373** | |
| bis(2,4,6-trinitrophenyl)amine; hexyl | bis(2,4,6-trinitrophenyl)amine; hexyl | 131-73-7 | 205-037-8 | substance | Expl. 1.1; Acute Tox. 2 *; Acute Tox. 1; Acute Tox. 2 *; STOT RE 2; Aquatic Chronic 2 | Hazard statement codes: H201; H330; H310; H300; H373**; H411. Labelling pictogram and signal word: GHS01; GHS06; GHS08; GHS09; Dgr. Labelling hazard statements: H201; H330; H310; H300; H373**; H411 | |
| dipicrylamine, ammonium salt | dipicrylamine, ammonium salt | 2844-92-0 | 220-639-0 | substance | Expl. 1.1; Acute Tox. 2 *; Acute Tox. 1; Acute Tox. 2 *; STOT RE 2; Aquatic Chronic 2 | Hazard statement codes: H201; H330; H310; H300; H373**; H411. Labelling pictogram and signal word: GHS01; GHS06; GHS08; GHS09; Dgr. Labelling hazard statements: H201; H330; H310; H300; H373**; H411 | |
| 1-naphthylamine | 1-naphthylamine | 134-32-7 | 205-138-7 | substance | Acute Tox. 4 *; Aquatic Chronic 2 | Hazard statement codes: H302; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H411 | |
| 2-naphthylamine | 2-naphthylamine | 91-59-8 | 202-080-4 | substance | Carc. 1A; Acute Tox. 4 *; Aquatic Chronic 2 | Carc. 1A; H350: | C ≥ 0.01 % | Hazard statement codes: H350; H302; H411. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Dgr. Labelling hazard statements: H350; H302; H411 |
| phenylhydrazine; [1] phenylhydrazinium chloride; [2] phenylhydrazine hydrochloride; [3] phenylhydrazinium sulphate (2:1) [4] | phenylhydrazine; [1] phenylhydrazinium chloride; [2] phenylhydrazine hydrochloride; [3] phenylhydrazinium sulphate (2:1) [4] | 100-63-0 [1] 59-88-1 [2] 27140-08-5 [3] 52033-74-6 [4] | 202-873-5 [1] 200-444-7 [2] 248-259-0 [3] 257-622-2 [4] | substance | Carc. 1B; Muta. 2; Acute Tox. 3 *; Acute Tox. 3 *; Acute Tox. 3 *; STOT RE 1; Eye Irrit. 2; Skin Irrit. 2; Skin Sens. 1; Aquatic Acute 1 | Hazard statement codes: H350; H341; H331; H311; H301; H372 **; H319; H315; H317; H400. Labelling pictogram and signal word: GHS06; GHS08; GHS09; Dgr. Labelling hazard statements: H350; H341; H331; H311; H301; H372 **; H319; H315; H317; H400 | |
| m-toluidine; 3-aminotoluene | m-toluidine; 3-aminotoluene | 108-44-1 | 203-583-1 | substance | Acute Tox. 3 *; Acute Tox. 3 *; Acute Tox. 3 *; STOT RE 2 *; Aquatic Acute 1 | Hazard statement codes: H331; H311; H301; H373 **; H400. Labelling pictogram and signal word: GHS06; GHS08; GHS09; Dgr. Labelling hazard statements: H331; H311; H301; H373 **; H400 | |
| nitrotoluidines, with the exception of those specified elsewhere in this Annex | nitrotoluidines, with the exception of those specified elsewhere in this Annex | substance | Acute Tox. 3 *; Acute Tox. 3 *; Acute Tox. 3 *; STOT RE 2 *; Aquatic Chronic 2 | Hazard statement codes: H331; H311; H301; H373 **; H411. Labelling pictogram and signal word: GHS06; GHS08; GHS09; Dgr. Labelling hazard statements: H331; H311; H301; H373 **; H411. Notes: C | |||
| diphenylamine | diphenylamine | 122-39-4 | 204-539-4 | substance | Acute Tox. 3 *; Acute Tox. 3 *; Acute Tox. 3 *; STOT RE 2 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H331; H311; H301; H373 **; H400; H410. Labelling pictogram and signal word: GHS06; GHS08; GHS09; Dgr. Labelling hazard statements: H331; H311; H301; H373 **; H410 | |
| xylidines with the exception of those specified elsewhere in this Annex; dimethyl anilines with the exception of those specified elsewhere in this Annex | xylidines with the exception of those specified elsewhere in this Annex; dimethyl anilines with the exception of those specified elsewhere in this Annex | substance | Acute Tox. 3 *; Acute Tox. 3 *; Acute Tox. 3 *; STOT RE 2 *; Aquatic Chronic 2 | Hazard statement codes: H331; H311; H301; H373 **; H411. Labelling pictogram and signal word: GHS06; GHS08; GHS09; Dgr. Labelling hazard statements: H331; H311; H301; H373 **; H411. Notes: C | |||
| p-phenylenediamine | p-phenylenediamine | 106-50-3 | 203-404-7 | substance | Acute Tox. 3 *; Acute Tox. 3 *; Acute Tox. 3 *; Eye Irrit. 2; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H331; H311; H301; H319; H317; H400; H410. Labelling pictogram and signal word: GHS06; GHS09; Dgr. Labelling hazard statements: H331; H311; H301; H319; H317; H410 | |
| benzene-1,4-diamine dihydrochloride; p-phenylenediamine dihydrochloride | benzene-1,4-diamine dihydrochloride; p-phenylenediamine dihydrochloride | 624-18-0 | 210-834-9 | substance | Acute Tox. 3 *; Acute Tox. 3 *; Acute Tox. 3 *; Eye Irrit. 2; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H331; H311; H301; H319; H317; H400; H410. Labelling pictogram and signal word: GHS06; GHS09; Dgr. Labelling hazard statements: H331; H311; H301; H319; H317; H410 | |
| 2-methyl-p-phenylenediamine sulphate [1] | 2-methyl-p-phenylenediamine sulphate [1] | 615-50-9 [1] 6369-59-1 [2]` | 210-431-8 [1] 228-871-4 [2] | substance | Acute Tox. 3 *; Acute Tox. 4 *; Acute Tox. 4 *; Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H301; H332; H312; H317; H411. Labelling pictogram and signal word: GHS06; GHS09; Dgr. Labelling hazard statements: H301; H332; H312; H317; H411 | |
| N,N-dimethylbenzene-1,3-diamine; [1] 4-amino-N,N-dimethylaniline; 3-amino-N,N'-dimethylaniline [2] | N,N-dimethylbenzene-1,3-diamine; [1] 4-amino-N,N-dimethylaniline; 3-amino-N,N'-dimethylaniline [2] | 2836-04-6 [1] 99-98-9 [2] | 220-623-3 [1] 202-807-5 [2] | substance | Acute Tox. 3 *; Acute Tox. 3 *; Acute Tox. 3 * | Hazard statement codes: H331; H311; H301. Labelling pictogram and signal word: GHS06; Dgr. Labelling hazard statements: H331; H311; H301. Notes: C | |
| N,N,N',N'-tetramethyl-p-phenylenediamine | N,N,N',N'-tetramethyl-p-phenylenediamine | 100-22-1 | 202-831-6 | substance | Acute Tox. 4 *; Acute Tox. 4 *; Acute Tox. 4 * | Hazard statement codes: H332; H312; H302. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H332; H312; H302 | |
| 2-aminophenol | 2-aminophenol | 95-55-6 | 202-431-1 | substance | Muta. 2; Acute Tox. 4 *; Acute Tox. 4 * | Hazard statement codes: H341; H332; H302. Labelling pictogram and signal word: GHS08; GHS07; Wng. Labelling hazard statements: H341; H332; H302 | |
| 2-amino-4,6-dinitrophenol; picramic acid | 2-amino-4,6-dinitrophenol; picramic acid | 96-91-3 | 202-544-6 | substance | Expl. 1.1; Acute Tox. 4 *; Acute Tox. 4 *; Acute Tox. 4 *; Aquatic Chronic 3 | Hazard statement codes: H201; H332; H312; H302; H412. Labelling pictogram and signal word: GHS01; GHS07; Dgr. Labelling hazard statements: H201; H332; H312; H302; H412 | |
| 2-amino-4,6-dinitrophenol; picramic acid; [≥ 20 % water] | 2-amino-4,6-dinitrophenol; picramic acid; [≥ 20 % water] | 96-91-3 | 202-544-6 | substance | Acute Tox. 4 *; Acute Tox. 4 *; Acute Tox. 4 *; Aquatic Chronic 3 | Hazard statement codes: H332; H312; H302; H412. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H332; H312; H302; H412. Notes: G | |
| 2-methoxyaniline; o-anisidine | 2-methoxyaniline; o-anisidine | 90-04-0 | 201-963-1 | substance | Carc. 1B; Muta. 2; Acute Tox. 3 *; Acute Tox. 3 *; Acute Tox. 3 * | Hazard statement codes: H350; H341; H331; H311; H301. Labelling pictogram and signal word: GHS06; GHS08; Dgr. Labelling hazard statements: H350; H341; H331; H311; H301 | |
| 3,3'-dimethoxybenzidine; o-dianisidine | 3,3'-dimethoxybenzidine; o-dianisidine | 119-90-4 | 204-355-4 | substance | Carc. 1B; Acute Tox. 4 * | Hazard statement codes: H350; H302. Labelling pictogram and signal word: GHS08; GHS07; Dgr. Labelling hazard statements: H350; H302 | |
| salts of 3,3'-dimethoxybenzidine; salts of o-dianisidine | salts of 3,3'-dimethoxybenzidine; salts of o-dianisidine | substance | Carc. 1B; Acute Tox. 4 * | Hazard statement codes: H350; H302. Labelling pictogram and signal word: GHS08; GHS07; Dgr. Labelling hazard statements: H350; H302. Notes: A | |||
| 2-nitro-p-anisidine; 4-methoxy-2-nitroaniline | 2-nitro-p-anisidine; 4-methoxy-2-nitroaniline | 96-96-8 | 202-547-2 | substance | Acute Tox. 2 *; Acute Tox. 1; Acute Tox. 2 *; STOT RE 2 *; Aquatic Chronic 3 | Hazard statement codes: H330; H310; H300; H373 **; H412. Labelling pictogram and signal word: GHS06; GHS08; Dgr. Labelling hazard statements: H330; H310; H300; H373 **; H412 | |
| 2-ethoxyaniline; o-phenetidine | 2-ethoxyaniline; o-phenetidine | 94-70-2 | 202-356-4 | substance | Acute Tox. 3 *; Acute Tox. 3 *; Acute Tox. 3 *; STOT RE 2 * | Hazard statement codes: H331; H311; H301; H373 **. Labelling pictogram and signal word: GHS06; GHS08; Dgr. Labelling hazard statements: H331; H311; H301; H373 ** | |
| 2,4-dinitroaniline | 2,4-dinitroaniline | 97-02-9 | 202-553-5 | substance | Acute Tox. 2 *; Acute Tox. 1; Acute Tox. 2 *; STOT RE 2 *; Aquatic Chronic 2 | Hazard statement codes: H330; H310; H300; H373 **; H411. Labelling pictogram and signal word: GHS06; GHS08; GHS09; Dgr. Labelling hazard statements: H330; H310; H300; H373 **; H411 | |
| 4,4'-bi-o-toluidine | 4,4'-bi-o-toluidine | 119-93-7 | 204-358-0 | substance | Carc. 1B; Acute Tox. 4 *; Aquatic Chronic 2 | Hazard statement codes: H350; H302; H411. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Dgr. Labelling hazard statements: H350; H302; H411 | |
| benzidine; 1,1'-biphenyl-4,4'-diamine; 4,4'-diaminobiphenyl; biphenyl-4,4'-ylenediamine | benzidine; 1,1'-biphenyl-4,4'-diamine; 4,4'-diaminobiphenyl; biphenyl-4,4'-ylenediamine | 92-87-5 | 202-199-1 | substance | Carc. 1A; Acute Tox. 4 *; Aquatic Acute 1; Aquatic Chronic 1 | Carc. 1A; H350: | C ≥ 0.01 % | Hazard statement codes: H350; H302; H400; H410. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Dgr. Labelling hazard statements: H350; H302; H410 |
| N,N'-dimethylbenzidine | N,N'-dimethylbenzidine | 2810-74-4 | substance | Acute Tox. 4 *; Acute Tox. 4 *; Acute Tox. 4 * | Hazard statement codes: H332; H312; H302. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H332; H312; H302 | ||
| N,N’-diacetylbenzidine | N,N’-diacetylbenzidine | 613-35-4 | 210-338-2 | substance | Carc. 1B; Muta. 2; Acute Tox. 4 *; Acute Tox. 4 *; Acute Tox. 4 * | Hazard statement codes: H350; H341; H332; H312; H302. Labelling pictogram and signal word: GHS08; GHS07; Dgr. Labelling hazard statements: H350; H341; H332; H312; H302 | |
| allylamine | allylamine | 107-11-9 | 203-463-9 | substance | Flam. Liq. 2; Acute Tox. 3 *; Acute Tox. 3 *; Acute Tox. 3 *; Aquatic Chronic 2 | Hazard statement codes: H225; H331; H311; H301; H411. Labelling pictogram and signal word: GHS02; GHS06; GHS09; Dgr. Labelling hazard statements: H225; H331; H311; H301; H411 | |
| benzylamine | benzylamine | 100-46-9 | 202-854-1 | substance | Acute Tox. 4 *; Acute Tox. 4 *; Skin Corr. 1B | Hazard statement codes: H312; H302; H314. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H312; H302; H314 | |
| dipropylamine | dipropylamine | 142-84-7 | 205-565-9 | substance | Flam. Liq. 2; Acute Tox. 4 *; Acute Tox. 4 *; Acute Tox. 4 *; Skin Corr. 1A | STOT SE 3; | H335: C ≥ 1 % | Hazard statement codes: H225; H332; H312; H302; H314. Labelling pictogram and signal word: GHS02; GHS05; GHS07; Dgr. Labelling hazard statements: H225; H332; H312; H302; H314 |
| di-n-butylamine | di-n-butylamine | 111-92-2 | 203-921-8 | substance | Flam. Liq. 3; Acute Tox. 2; Acute Tox. 3; Acute Tox. 3; Skin Corr. 1B; Eye Dam. 1 | Oral: ATE = 220 mg/kg bw | Dermal: ATE = 300 mg/kg bw | Inhalation: ATE = 1.2 mg/L (vapours) | Hazard statement codes: H226; H330; H311; H301; H314; H318. Labelling pictogram and signal word: GHS02; GHS05; GHS06; Dgr. Labelling hazard statements: H226; H330; H311; H301; H314. Supplementary hazard statements: EUH071. Date of Secretary of State decision: 2024-02-02. Date of entry into legal effect: 2024-03-02. Final compliance date: 2025-09-02 |
| cyclohexylamine | cyclohexylamine | 108-91-8 | 203-629-0 | substance | Flam. Liq. 3; Repr. 2; Acute Tox. 4 *; Acute Tox. 4 *; Skin Corr. 1B | Hazard statement codes: H226; H361f***; H312; H302; H314. Labelling pictogram and signal word: GHS02; GHS05; GHS08; GHS07; Dgr. Labelling hazard statements: H226; H361f***; H312; H302; H314 | |
| 4,4'-diaminodiphenylmethane; 4,4'-methylenedianiline | 4,4'-diaminodiphenylmethane; 4,4'-methylenedianiline | 101-77-9 | 202-974-4 | substance | Carc. 1B; Muta. 2; STOT SE 1; STOT RE 2 *; Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H350; H341; H370 **; H373 **; H317; H411. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Dgr. Labelling hazard statements: H350; H341; H370 **; H373 **; H317; H411 | |
| (S)-sec-butylamine; (S)-2-aminobutane; [1] (R)-sec-butylamine; (R)-2-aminobutane; [2] sec-butylamine; 2-aminobutane [3] | (S)-sec-butylamine; (S)-2-aminobutane; [1] (R)-sec-butylamine; (R)-2-aminobutane; [2] sec-butylamine; 2-aminobutane [3] | 513-49-5 [1] 13250-12-9 [2] 13952-84-6 [3] | 208-164-7 [1] 236-232-6 [2] 237-732-7 [3] | substance | Flam. Liq. 2; Acute Tox. 4 *; Acute Tox. 4 *; Skin Corr. 1A; Aquatic Acute 1 | Hazard statement codes: H225; H332; H302; H314; H400. Labelling pictogram and signal word: GHS02; GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H225; H332; H302; H314; H400. Notes: C | |
| N-ethylaniline | N-ethylaniline | 103-69-5 | 203-135-5 | substance | Acute Tox. 3 *; Acute Tox. 3 *; Acute Tox. 3 *; STOT RE 2 * | Hazard statement codes: H331; H311; H301; H373 **. Labelling pictogram and signal word: GHS06; GHS08; Dgr. Labelling hazard statements: H331; H311; H301; H373 ** | |
| N,N-diethylaniline | N,N-diethylaniline | 91-66-7 | 202-088-8 | substance | Acute Tox. 3 *; Acute Tox. 3 *; Acute Tox. 3 *; STOT RE 2 *; Aquatic Chronic 2 | * | Hazard statement codes: H331; H311; H301; H373 **; H411. Labelling pictogram and signal word: GHS06; GHS08; GHS09; Dgr. Labelling hazard statements: H331; H311; H301; H373 **; H411 |
| N-methyl-o-toluidine; [1] N-methyl-m-toluidine; [2] N-methyl-p-toluidine [3] | N-methyl-o-toluidine; [1] N-methyl-m-toluidine; [2] N-methyl-p-toluidine [3] | 611-21-2 [1] 696-44-6 [2] 623-08-5 [3] | 210-260-9 [1] 211-795-0 [2] 210-769-6 [3] | substance | Acute Tox. 3 *; Acute Tox. 3 *; Acute Tox. 3 *; STOT RE 2 *; Aquatic Chronic 3 | Hazard statement codes: H331; H311; H301; H373 **; H412. Labelling pictogram and signal word: GHS06; GHS08; Dgr. Labelling hazard statements: H331; H311; H301; H373 **; H412. Notes: C | |
| N,N-dimethyl-m-toluidine; [1] N,N-dimethyl-o-toluidine [2] | N,N-dimethyl-m-toluidine; [1] N,N-dimethyl-o-toluidine [2] | 121-72-2 [1] 609-72-3 [2] | 204-495-6 [1] 210-199-8 [2] | substance | Acute Tox. 3 *; Acute Tox. 3 *; Acute Tox. 3 *; STOT RE 2 *; Aquatic Chronic 3 | * | Hazard statement codes: H331; H311; H301; H373 **; H412. Labelling pictogram and signal word: GHS06; GHS08; Dgr. Labelling hazard statements: H331; H311; H301; H373 **; H412. Notes: C |
| piperazine; [solid] | piperazine; [solid] | 110-85-0 | 203-808-3 | substance | Repr. 2; Skin Corr. 1B; Resp. Sens. 1; Skin Sens. 1 | Hazard statement codes: H361fd; H314; H334; H317. Labelling pictogram and signal word: GHS05; GHS08; Dgr. Labelling hazard statements: H361fd; H314; H334; H317 | |
| piperazine; [liquid] | piperazine; [liquid] | 110-85-0 | 203-808-3 | substance | Repr. 2; Skin Corr. 1B; Resp. Sens. 1; Skin Sens. 1 | Hazard statement codes: H361fd; H314; H334; H317. Labelling pictogram and signal word: GHS05; GHS08; Dgr. Labelling hazard statements: H361fd; H314; H334; H317 | |
| 2,2'-iminodiethylamine; diethylenetriamine | 2,2'-iminodiethylamine; diethylenetriamine | 111-40-0 | 203-865-4 | substance | Acute Tox. 4 *; Acute Tox. 4 *; Skin Corr. 1B; Skin Sens. 1 | Hazard statement codes: H312; H302; H314; H317. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H312; H302; H314; H317 | |
| 3,6-diazaoctanethylenediamin; triethylenetetramine | 3,6-diazaoctanethylenediamin; triethylenetetramine | 112-24-3 | 203-950-6 | substance | Acute Tox. 4 *; Skin Corr. 1B; Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H312; H314; H317; H412. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H312; H314; H317; H412 | |
| 3,6,9-triazaundecamethylenediamine; tetraethylenepentamine | 3,6,9-triazaundecamethylenediamine; tetraethylenepentamine | 112-57-2 | 203-986-2 | substance | Acute Tox. 4 *; Acute Tox. 4 *; Skin Corr. 1B; Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H312; H302; H314; H317; H411. Labelling pictogram and signal word: GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H312; H302; H314; H317; H411 | |
| 3-aminopropyldimethylamine; N,N-dimethyl-1,3-diaminopropane | 3-aminopropyldimethylamine; N,N-dimethyl-1,3-diaminopropane | 109-55-7 | 203-680-9 | substance | Flam. Liq. 3; Acute Tox. 4 *; Skin Corr. 1B; Skin Sens. 1 | Hazard statement codes: H226; H302; H314; H317. Labelling pictogram and signal word: GHS02; GHS05; GHS07; Dgr. Labelling hazard statements: H226; H302; H314; H317 | |
| 3-aminopropyldiethylamine; N,N-diethyl-1,3-diaminopropane | 3-aminopropyldiethylamine; N,N-diethyl-1,3-diaminopropane | 104-78-9 | 203-236-4 | substance | Flam. Liq. 3; Acute Tox. 4 *; Acute Tox. 4 *; Skin Corr. 1B; Skin Sens. 1 | Hazard statement codes: H226; H312; H302; H314; H317. Labelling pictogram and signal word: GHS02; GHS05; GHS07; Dgr. Labelling hazard statements: H226; H312; H302; H314; H317 | |
| 3,3'-iminodi(propylamine); dipropylenetriamine | 3,3'-iminodi(propylamine); dipropylenetriamine | 56-18-8 | 200-261-2 | substance | Acute Tox. 2 *; Acute Tox. 3 *; Acute Tox. 4 *; Skin Corr. 1A; Skin Sens. 1 | Hazard statement codes: H330; H311; H302; H314; H317. Labelling pictogram and signal word: GHS06; GHS05; Dgr. Labelling hazard statements: H330; H311; H302; H314; H317 | |
| 3,6,9,12-tetra-azatetradecamethylenediamine; pentacthylenehexamine | 3,6,9,12-tetra-azatetradecamethylenediamine; pentacthylenehexamine | 4067-16-7 | 223-775-9 | substance | Skin Corr. 1B; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H314; H317; H400; H410. Labelling pictogram and signal word: GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H314; H317; H410 | |
| polyethlyenepolyamines with the exception of those specified elsewhere in this Annex | polyethlyenepolyamines with the exception of those specified elsewhere in this Annex | substance | Acute Tox. 4 *; Acute Tox. 4 *; Skin Corr. 1B; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H312; H302; H314; H317; H400; H410. Labelling pictogram and signal word: GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H312; H302; H314; H317; H410 | |||
| dicyclohexylamine | dicyclohexylamine | 101-83-7 | 202-980-7 | substance | Acute Tox. 4 *; Skin Corr. 1B; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H302; H314; H400; H410. Labelling pictogram and signal word: GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H302; H314; H410 | |
| 3-aminomethyl-3,5,5-trimethylcyclohexylamine | 3-aminomethyl-3,5,5-trimethylcyclohexylamine | 2855-13-2 | 220-666-8 | substance | Acute Tox. 4; Skin Corr. 1B; Eye Dam. 1; Skin Sens. 1A | Oral: ATE = 1030 mg/kg bw | Skin Sens. 1A; H317: C ≥ 0.001 % | Hazard statement codes: H302; H314; H318; H317. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H302; H314; H317. Date of Secretary of State decision: 2023-09-23. Date of entry into legal effect: 2023-10-20. Final compliance date: 2025-04-20 |
| 3,3'-dichlorobenzidine; 3,3'-dichlorobiphenyl-4,4'-ylenediamine | 3,3'-dichlorobenzidine; 3,3'-dichlorobiphenyl-4,4'-ylenediamine | 91-94-1 | 202-109-0 | substance | Carc. 1B; Acute Tox. 4 *; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H350; H312; H317; H400; H410. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Dgr. Labelling hazard statements: H350; H312; H317; H410 | |
| salts of 3,3'-dichlorobenzidine; salts of 3,3'-dichlorobiphenyl-4,4'-ylenediamine | salts of 3,3'-dichlorobenzidine; salts of 3,3'-dichlorobiphenyl-4,4'-ylenediamine | substance | Carc. 1B; Acute Tox. 4 *; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H350; H312; H317; H400; H410. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Dgr. Labelling hazard statements: H350; H312; H317; H410. Notes: A | |||
| salts of benzidine | salts of benzidine | 531-85-1 531-86-2 21136-70-9 36341-27-2 | 208-519-6 208-520-1 244-236-4 252-984-8 | substance | Carc. 1A; Acute Tox. 4 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H350; H302; H400; H410. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Dgr. Labelling hazard statements: H350; H302; H410. Notes: A | |
| salts of 2-naphthylamine | salts of 2-naphthylamine | 553-00-4 612-52-2 | 209-030-0 210-313-6 | substance | Carc. 1A; Acute Tox. 4 *; Aquatic Chronic 2 | Hazard statement codes: H350; H302; H411. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Dgr. Labelling hazard statements: H350; H302; H411. Notes: A | |
| biphenyl-4-ylamine; xenylamine; 4-aminobiphenyl | biphenyl-4-ylamine; xenylamine; 4-aminobiphenyl | 92-67-1 | 202-177-1 | substance | Carc. 1A; Acute Tox. 4 * | Hazard statement codes: H350; H302. Labelling pictogram and signal word: GHS08; GHS07; Dgr. Labelling hazard statements: H350; H302 | |
| salts of biphenyl-4-ylamine; salts of xenylamine; salts of 4-aminobiphenyl | salts of biphenyl-4-ylamine; salts of xenylamine; salts of 4-aminobiphenyl | substance | Carc. 1A; Acute Tox. 4 * | Hazard statement codes: H350; H302. Labelling pictogram and signal word: GHS08; GHS07; Dgr. Labelling hazard statements: H350; H302. Notes: A | |||
| benzyldimethylamine | benzyldimethylamine | 103-83-3 | 203-149-1 | substance | Flam. Liq. 3; Acute Tox. 4 *; Acute Tox. 4 *; Acute Tox. 4 *; Skin Corr. 1B; Aquatic Chronic 3 | Hazard statement codes: H226; H332; H312; H302; H314; H412. Labelling pictogram and signal word: GHS02; GHS05; GHS07; Dgr. Labelling hazard statements: H226; H332; H312; H302; H314; H412 | |
| 2-aminoethyldimethylamine; 2-dimethylaminoethylamine | 2-aminoethyldimethylamine; 2-dimethylaminoethylamine | 108-00-9 | 203-541-2 | substance | Flam. Liq. 2; Acute Tox. 4 *; Acute Tox. 4 *; Skin Corr. 1A | Hazard statement codes: H225; H312; H302; H314. Labelling pictogram and signal word: GHS02; GHS05; GHS07; Dgr. Labelling hazard statements: H225; H312; H302; H314 | |
| ethyldimethylamine | ethyldimethylamine | 598-56-1 | 209-940-8 | substance | Flam. Liq. 2; Acute Tox. 4 *; Acute Tox. 4 *; Skin Corr. 1B | Hazard statement codes: H225; H332; H302; H314. Labelling pictogram and signal word: GHS02; GHS05; GHS07; Dgr. Labelling hazard statements: H225; H332; H302; H314 | |
| dimethylnitrosoamine; N-nitrosodimethylamine | dimethylnitrosoamine; N-nitrosodimethylamine | 62-75-9 | 200-549-8 | substance | Carc. 1B; Acute Tox. 2 *; Acute Tox. 3 *; STOT RE 1; Aquatic Chronic 2 | Carc. 1B; H350: | C ≥ 0.001 % | Hazard statement codes: H350; H330; H301; H372 **; H411. Labelling pictogram and signal word: GHS06; GHS08; GHS09; Dgr. Labelling hazard statements: H350; H330; H301; H372 **; H411 |
| 2,2'-dichloro-4,4'-methylenedianiline; 4,4'-methylene bis(2-chloroaniline) | 2,2'-dichloro-4,4'-methylenedianiline; 4,4'-methylene bis(2-chloroaniline) | 101-14-4 | 202-918-9 | substance | Carc. 1B; Acute Tox. 4 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H350; H302; H400; H410. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Dgr. Labelling hazard statements: H350; H302; H410 | |
| salts of 2,2'-dichloro-4,4'-methylenedianiline; salts of 4,4'-methylenebis(2-chloroaniline) | salts of 2,2'-dichloro-4,4'-methylenedianiline; salts of 4,4'-methylenebis(2-chloroaniline) | substance | Carc. 1B; Acute Tox. 4 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H350; H302; H400; H410. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Dgr. Labelling hazard statements: H350; H302; H410. Notes: A | |||
| 4-amino-N,N-diethylaniline; N,N-diethyl-p-phenylendiamine | 4-amino-N,N-diethylaniline; N,N-diethyl-p-phenylendiamine | 93-05-0 | 202-214-1 | substance | Acute Tox. 3 *; Skin Corr. 1B | Hazard statement codes: H301; H314. Labelling pictogram and signal word: GHS06; GHS05; Dgr. Labelling hazard statements: H301; H314 | |
| salts of 4,4'-bi-o-toluidine; salts of 3,3'-dimethylbenzidine; salts of o-tolidine | salts of 4,4'-bi-o-toluidine; salts of 3,3'-dimethylbenzidine; salts of o-tolidine | 612-82-8 64969-36-4 74753-18-7 | 210-322-5 265-294-7 277-985-0 | substance | Carc. 1B; Acute Tox. 4 *; Aquatic Chronic 2 | Hazard statement codes: H350; H302; H411. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Dgr. Labelling hazard statements: H350; H302; H411. Notes: A | |
| thiourea; thiocarbamide | thiourea; thiocarbamide | 62-56-6 | 200-543-5 | substance | Carc. 2; Repr. 2; Acute Tox. 4 *; Aquatic Chronic 2 | Hazard statement codes: H351; H361d ***; H302; H411. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Wng. Labelling hazard statements: H351; H361d ***; H302; H411 | |
| 1-methyl-3-nitro-1-nitrosoguanidine | 1-methyl-3-nitro-1-nitrosoguanidine | 70-25-7 | 200-730-1 | substance | Carc. 1B; Acute Tox. 4 *; Eye Irrit. 2; Skin Irrit. 2; Aquatic Chronic 2 | Carc. 1B; | H350: C ≥ | 0.01 % | Hazard statement codes: H350; H332; H319; H315; H411. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Dgr. Labelling hazard statements: H350; H332; H319; H315; H411 |
| dapsone; 4,4'-diamino diphenyl sulfone | dapsone; 4,4'-diamino diphenyl sulfone | 80-08-0 | 201-248-4 | substance | Acute Tox. 4 * | Hazard statement codes: H302. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302 | |
| 4,4'-methylenedi-o-toluidine | 4,4'-methylenedi-o-toluidine | 838-88-0 | 212-658-8 | substance | Carc. 1B; Acute Tox. 4 *; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H350; H302; H317; H400; H410. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Dgr. Labelling hazard statements: H350; H302; H317; H410 | |
| amitraz (ISO); N,N-bis(2,4-xylyliminomethyl) methylamine | amitraz (ISO); N,N-bis(2,4-xylyliminomethyl) methylamine | 33089-61-1 | 251-375-4 | substance | Acute Tox. 4 *; STOT RE 2 *; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | M = 10 | Hazard statement codes: H302; H373 **; H317; H400; H410. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Wng. Labelling hazard statements: H302; H373 **; H317; H410 |
| guazatine (ISO) | guazatine (ISO) | 108173-90-6 | substance | Acute Tox. 2 *; Acute Tox. 4 *; Acute Tox. 4 *; STOT SE 3; Skin Irrit. 2; Eye Dam. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H330; H312; H302; H335; H315; H318; H400; H410. Labelling pictogram and signal word: GHS06; GHS05; GHS09; Dgr. Labelling hazard statements: H330; H312; H302; H335; H315; H318; H410 | ||
| simazine (ISO); 6-chloro-N,N'-diethyl-1,3,5-triazine-2,4-diamine | simazine (ISO); 6-chloro-N,N'-diethyl-1,3,5-triazine-2,4-diamine | 122-34-9 | 204-535-2 | substance | Carc. 2; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H351; H400; H410. Labelling pictogram and signal word: GHS08; GHS09; Wng. Labelling hazard statements: H351; H410 | |
| 1,5-naphthylenediamine | 1,5-naphthylenediamine | 2243-62-1 | 218-817-8 | substance | Carc. 2; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H351; H400; H410. Labelling pictogram and signal word: GHS08; GHS09; Wng. Labelling hazard statements: H351; H410 | |
| 2,2'-(nitrosoimino)bisethanol | 2,2'-(nitrosoimino)bisethanol | 1116-54-7 | 214-237-4 | substance | Carc. 1B | Hazard statement codes: H350. Labelling pictogram and signal word: GHS08; Dgr. Labelling hazard statements: H350 | |
| o-toluidine; 2-aminotoluene | o-toluidine; 2-aminotoluene | 95-53-4 | 202-429-0 | substance | Carc. 1B; Acute Tox. 3 *; Acute Tox. 3 *; Eye Irrit. 2; Aquatic Acute 1 | Hazard statement codes: H350; H331; H301; H319; H400. Labelling pictogram and signal word: GHS06; GHS08; GHS09; Dgr. Labelling hazard statements: H350; H331; H301; H319; H400 | |
| N,N'-(2,2-dimethylpropylidene)hexamethylenediamine | N,N'-(2,2-dimethylpropylidene)hexamethylenediamine | 1000-78-8 | 401-660-6 | substance | Skin Irrit. 2; Skin Sens. 1 | Hazard statement codes: H315; H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H315; H317 | |
| 3,5-dichloro-4-(1,1,2,2-tetrafluoroethoxy) aniline | 3,5-dichloro-4-(1,1,2,2-tetrafluoroethoxy) aniline | 104147-32-2 | 401-790-3 | substance | Acute Tox. 4 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H302; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H410 | |
| 4-(2-chloro-4-trifluoromethyl)phenoxy-2-fluoroaniline hydrochloride | 4-(2-chloro-4-trifluoromethyl)phenoxy-2-fluoroaniline hydrochloride | 113674-95-6 | 402-190-4 | substance | STOT RE 1; Acute Tox. 4 *; STOT RE 2 *; Eye Dam. 1; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H372**; H302; H373**; H318; H317; H400; H410. Labelling pictogram and signal word: GHS05; GHS08; GHS07; GHS09; Dgr. Labelling hazard statements: H372**; H302; H373**; H318; H317; H410 | |
| benzyl-2-hydroxydodecyldimethylammonium benzoate | benzyl-2-hydroxydodecyldimethylammonium benzoate | 113694-52-3 | 402-610-6 | substance | Skin Corr. 1B; Acute Tox. 4 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H314; H302; H400; H410. Labelling pictogram and signal word: GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H314; H302; H410 | |
| 4,4'-carbonimidoylbis[N,N-dimethylaniline] | 4,4'-carbonimidoylbis[N,N-dimethylaniline] | 492-80-8 | 207-762-5 | substance | Carc. 2; Acute Tox. 4 *; Eye Irrit. 2; Aquatic Chronic 2 | Hazard statement codes: H351; H302; H319; H411. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Wng. Labelling hazard statements: H351; H302; H319; H411 | |
| salts of 4,4'-carbonimidoylbis[N,N-dimethylaniline] | salts of 4,4'-carbonimidoylbis[N,N-dimethylaniline] | substance | Carc. 2; Acute Tox. 4 *; Eye Irrit. 2; Aquatic Chronic 2 | Hazard statement codes: H351; H302; H319; H411. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Wng. Labelling hazard statements: H351; H302; H319; H411. Notes: A | |||
| nitrosodipropylamine | nitrosodipropylamine | 621-64-7 | 210-698-0 | substance | Carc. 1B; Acute Tox. 4 *; Aquatic Chronic 2 | Carc. 1B; | H350: C ≥ | 0.001 % | Hazard statement codes: H350; H302; H411. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Dgr. Labelling hazard statements: H350; H302; H411 |
| 4-methyl-m-phenylenediamine; 2,4-toluenediamine | 4-methyl-m-phenylenediamine; 2,4-toluenediamine | 95-80-7 | 202-453-1 | substance | Carc. 1B; Muta. 2; Repr. 2; Acute Tox. 3 *; Acute Tox. 4 *; STOT RE 2 *; Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H350; H341; H361f***; H301; H312; H373**; H317; H411. Labelling pictogram and signal word: GHS06; GHS08; GHS09; Dgr. Labelling hazard statements: H350; H341; H361f***; H301; H312; H373**; H317; H411 | |
| propylenediamine | propylenediamine | 78-90-0 | 201-155-9 | substance | Flam. Liq. 3; Acute Tox. 4 *; Acute Tox. 4 *; Skin Corr. 1A | Hazard statement codes: H226; H312; H302; H314. Labelling pictogram and signal word: GHS02; GHS05; GHS07; Dgr. Labelling hazard statements: H226; H312; H302; H314 | |
| methenamine; hexamethylenetetramine | methenamine; hexamethylenetetramine | 100-97-0 | 202-905-8 | substance | Flam. Sol. 2; Skin Sens. 1 | Hazard statement codes: H228; H317. Labelling pictogram and signal word: GHS02; GHS07; Wng. Labelling hazard statements: H228; H317 | |
| N,N-bis(3-aminopropyl)methylamine | N,N-bis(3-aminopropyl)methylamine | 105-83-9 | 203-336-8 | substance | Acute Tox. 3 *; Acute Tox. 3 *; Acute Tox. 4 *; Skin Corr. 1B | Hazard statement codes: H331; H311; H302; H314. Labelling pictogram and signal word: GHS06; GHS05; Dgr. Labelling hazard statements: H331; H311; H302; H314 | |
| N,N,N',N'-tetramethylethylenediamine | N,N,N',N'-tetramethylethylenediamine | 110-18-9 | 203-744-6 | substance | Flam. Liq. 2; Acute Tox. 4 *; Acute Tox. 4 *; Skin Corr. 1B | Hazard statement codes: H225; H332; H302; H314. Labelling pictogram and signal word: GHS02; GHS05; GHS07; Dgr. Labelling hazard statements: H225; H332; H302; H314 | |
| hexamethylenediamine | hexamethylenediamine | 124-09-4 | 204-679-6 | substance | Acute Tox. 4 *; Acute Tox. 4 *; STOT SE 3; Skin Corr. 1B | Hazard statement codes: H312; H302; H335; H314. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H312; H302; H335; H314 | |
| 2-piperazin-1-ylethylamine | 2-piperazin-1-ylethylamine | 140-31-8 | 205-411-0 | substance | Acute Tox. 4 *; Acute Tox. 4 *; Skin Corr. 1B; Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H312; H302; H314; H317; H412. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H312; H302; H314; H317; H412 | |
| 2,6-diethylaniline | 2,6-diethylaniline | 579-66-8 | 209-445-7 | substance | Acute Tox. 4 * | Hazard statement codes: H302. Labelling pictogram and signal word: —. Labelling hazard statements: H302 | |
| 1-phenylethylamine; [1] DL-α-methylbenzylamine [2] | 1-phenylethylamine; [1] DL-α-methylbenzylamine [2] | 98-84-0 [1] 618-36-0 [2] | 202-706-6 [1] 210-545-8 [2] | substance | Acute Tox. 4 *; Acute Tox. 4 *; Skin Corr. 1B | Hazard statement codes: H312; H302; H314. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H312; H302; H314 | |
| 3-aminopropyltriethoxysilane | 3-aminopropyltriethoxysilane | 919-30-2 | 213-048-4 | substance | Acute Tox. 4 *; Skin Corr. 1B | Hazard statement codes: H302; H314. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H302; H314 | |
| bis(2-dimethylaminoethyl)(methyl)amine | bis(2-dimethylaminoethyl)(methyl)amine | 3030-47-5 | 221-201-1 | substance | Acute Tox. 3 *; Acute Tox. 4 *; Skin Corr. 1B | Hazard statement codes: H311; H302; H314. Labelling pictogram and signal word: GHS06; GHS05; Dgr. Labelling hazard statements: H311; H302; H314 | |
| 2,2'-dimethyl-4,4'-methylenebis(cyclohexylamine) | 2,2'-dimethyl-4,4'-methylenebis(cyclohexylamine) | 6864-37-5 | 229-962-1 | substance | Acute Tox. 3 *; Acute Tox. 3 *; Acute Tox. 4 *; Skin Corr. 1A; Aquatic Chronic 2 | Hazard statement codes: H331; H311; H302; H314; H411. Labelling pictogram and signal word: GHS06; GHS05; GHS09; Dgr. Labelling hazard statements: H331; H311; H302; H314; H411 | |
| 2-methyl-m-phenylenediamine; 2,6-toluenediamine | 2-methyl-m-phenylenediamine; 2,6-toluenediamine | 823-40-5 | 212-513-9 | substance | Muta. 2; Acute Tox. 4 *; Acute Tox. 4 *; Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H341; H312; H302; H317; H411. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Wng. Labelling hazard statements: H341; H312; H302; H317; H411 | |
| p-anisidine; 4-methoxyaniline | p-anisidine; 4-methoxyaniline | 104-94-9 | 203-254-2 | substance | Acute Tox. 2 *; Acute Tox. 1; Acute Tox. 2 *; STOT RE 2 *; Aquatic Acute 1 | Hazard statement codes: H330; H310; H300; H373 **; H400. Labelling pictogram and signal word: GHS06; GHS08; GHS09; Dgr. Labelling hazard statements: H330; H310; H300; H373 **; H400 | |
| 6-methyl-2,4-bis(methylthio)phenylene-1,3- diamine | 6-methyl-2,4-bis(methylthio)phenylene-1,3- diamine | 106264-79-3 | 403-240-8 | substance | Acute Tox. 4 *; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H302; H317; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H317; H410 | |
| R,R-2-hydroxy-5-(1-hydroxy-2-(4-phenylbut-2-ylamino)ethyl)benzamide hydrogen 2,3-bis(benzoyloxy)succinate | R,R-2-hydroxy-5-(1-hydroxy-2-(4-phenylbut-2-ylamino)ethyl)benzamide hydrogen 2,3-bis(benzoyloxy)succinate | 404-390-7 | substance | Flam. Sol. 1; Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H228; H317; H412. Labelling pictogram and signal word: GHS02; GHS07; Wng. Labelling hazard statements: H228; H317; H412 | ||
| dimethyldioctadecylammonium hydrogen sulfate | dimethyldioctadecylammonium hydrogen sulfate | 123312-54-9 | 404-050-8 | substance | Eye Irrit. 2; Aquatic Chronic 4 | Hazard statement codes: H319; H413. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H319; H413 | |
| C8-18alkylbis(2-hydroxyethyl)ammonium bis(2-ethylhexyl)phosphate | C8-18alkylbis(2-hydroxyethyl)ammonium bis(2-ethylhexyl)phosphate | 68132-19-4 | 404-690-8 | substance | Acute Tox. 3 *; Skin Corr. 1B; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H331; H314; H317; H400; H410. Labelling pictogram and signal word: GHS06; GHS05; GHS09; Dgr. Labelling hazard statements: H331; H314; H317; H410 | |
| C12-14-tert-alkylamine, methylphosphonic acid salt | C12-14-tert-alkylamine, methylphosphonic acid salt | 119415-07-5 | 404-750-3 | substance | Acute Tox. 4 *; Skin Corr. 1B; Aquatic Chronic 2 | Hazard statement codes: H302; H314; H411. Labelling pictogram and signal word: GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H302; H314; H411 | |
| A reaction mass of: (1,3-dioxo-2H-benz(de)isoquinolin-2-ylpropyl)hexadecyldimethylammonium 4-toluenesulfonate; (1,3-dioxo-2H-benz(de)isoquinolin-2-ylpropyl)hexadecyldimethylammonium bromide | A reaction mass of: (1,3-dioxo-2H-benz(de)isoquinolin-2-ylpropyl)hexadecyldimethylammonium 4-toluenesulfonate; (1,3-dioxo-2H-benz(de)isoquinolin-2-ylpropyl)hexadecyldimethylammonium bromide | 405-080-4 | substance | Eye Dam. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H318; H400; H410. Labelling pictogram and signal word: GHS05; GHS09; Dgr. Labelling hazard statements: H318; H410 | ||
| benzyldimethyloctadecylammonium 3-nitrobenzenesulfonate | benzyldimethyloctadecylammonium 3-nitrobenzenesulfonate | 405-330-2 | substance | Skin Irrit. 2; Eye Dam. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H315; H318; H400; H410. Labelling pictogram and signal word: GHS05; GHS09; Dgr. Labelling hazard statements: H315; H318; H410 | ||
| aclonifen (ISO); 2-chloro-6-nitro-3-phenoxyaniline | aclonifen (ISO); 2-chloro-6-nitro-3-phenoxyaniline | 74070-46-5 | 277-704-1 | substance | Carc. 2; Skin Sens. 1A; Aquatic Acute 1; Aquatic Chronic 1 | M = 100 | M = 10 | Hazard statement codes: H351; H317; H400; H410. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Wng. Labelling hazard statements: H410; H317; H410 |
| amines, polyethylenepoly-; HEPA | amines, polyethylenepoly-; HEPA | 68131-73-7 | 268-626-9 | substance | Acute Tox. 4 *; Acute Tox. 4 *; Skin Corr. 1B; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H312; H302; H314; H317; H400; H410. Labelling pictogram and signal word: GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H312; H302; H314; H317; H410 | |
| hydroxylamine … % [> 55 % in aqueous solution] | hydroxylamine … % [> 55 % in aqueous solution] | 7803-49-8 | 232-259-2 | substance | Unst. Expl.; Met. Corr. 1; Carc. 2; Acute Tox. 4 *; Acute Tox. 4 *; STOT RE 2 *; STOT SE 3; Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1; Aquatic Acute 1 | Hazard statement codes: H200; H290; H351; H312; H302; H373**; H335; H315; H318; H317; H400. Labelling pictogram and signal word: GHS01; GHS05; GHS08; GHS07; GHS09; Dgr. Labelling hazard statements: H200; H290; H351; H312; H302; H373**; H335; H315; H318; H317; H400. Notes: B | |
| hydroxylamine …% [≤ 55 % in aqueous solution] | hydroxylamine …% [≤ 55 % in aqueous solution] | 7803-49-8 | 232-259-2 | substance | Met. Corr. 1; Carc. 2; Acute Tox. 4 *; Acute Tox. 4 *; STOT RE 2 *; STOT SE 3; Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1; Aquatic Acute 1 | Hazard statement codes: H290; H351; H312; H302; H373**; H335; H315; H318; H317; H400. Labelling pictogram and signal word: GHS05; GHS08; GHS07; GHS09; Dgr. Labelling hazard statements: H290; H351; H312; H302; H373**; H335; H315; H318; H317; H400. Notes: B | |
| hydroxylammonium chloride; hydroxylamine hydrochloride; [1] bis(hydroxylammonium) sulfate; hydroxylamine sulfate (2:1) [2] | hydroxylammonium chloride; hydroxylamine hydrochloride; [1] bis(hydroxylammonium) sulfate; hydroxylamine sulfate (2:1) [2] | 5470-11-1 [1] 10039-54-0 [2] | 226-798-2 [1] 233-118-8 [2] | substance | Met. Corr. 1; Carc. 2; Acute Tox. 4 *; Acute Tox. 4 *; STOT RE 2 *; Eye Irrit. 2; Skin Irrit. 2; Skin Sens. 1; Aquatic Acute 1 | Hazard statement codes: H290; H351; H312; H302; H373**; H319; H315; H317; H400. Labelling pictogram and signal word: GHS05; GHS08; GHS07; GHS09; Wng. Labelling hazard statements: H290; H351; H312; H302; H373**; H319; H315; H317; H400 | |
| N,N,N-trimethylanilinium chloride | N,N,N-trimethylanilinium chloride | 138-24-9 | 205-319-0 | substance | Acute Tox. 3 *; Acute Tox. 3 * | Hazard statement codes: H311; H301. Labelling pictogram and signal word: GHS06; Dgr. Labelling hazard statements: H311; H301 | |
| 2-methyl-p-phenylenediamine; 2,5-toluenediamine | 2-methyl-p-phenylenediamine; 2,5-toluenediamine | 95-70-5 | 202-442-1 | substance | Acute Tox. 3 *; Acute Tox. 4 *; Acute Tox. 4 *; Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H301; H332; H312; H317; H411. Labelling pictogram and signal word: GHS06; GHS09; Dgr. Labelling hazard statements: H301; H332; H312; H317; H411 | |
| toluene-2,4-diammonium sulphate; 4-methyl-m-phenylenediamine sulfate | toluene-2,4-diammonium sulphate; 4-methyl-m-phenylenediamine sulfate | 65321-67-7 | 265-697-8 | substance | Carc. 1B; Acute Tox. 3 *; Acute Tox. 4 *; Eye Irrit. 2; Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H350; H301; H312; H319; H317; H411. Labelling pictogram and signal word: GHS06; GHS08; GHS09; Dgr. Labelling hazard statements: H350; H301; H312; H319; H317; H411 | |
| 3-aminophenol | 3-aminophenol | 591-27-5 | 209-711-2 | substance | Acute Tox. 4 *; Acute Tox. 4 *; Aquatic Chronic 2 | Hazard statement codes: H332; H302; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H332; H302; H411 | |
| 4-aminophenol | 4-aminophenol | 123-30-8 | 204-616-2 | substance | Muta. 2; Acute Tox. 4 *; Acute Tox. 4 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H341; H332; H302; H400; H410. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Wng. Labelling hazard statements: H341; H332; H302; H410 | |
| diisopropylamine | diisopropylamine | 108-18-9 | 203-558-5 | substance | Flam. Liq. 2; Acute Tox. 4 *; Acute Tox. 4 *; Skin Corr. 1B | STOT SE 3; | H335: C ≥ 5 % | Hazard statement codes: H225; H332; H302; H314. Labelling pictogram and signal word: GHS02; GHS05; GHS07; Dgr. Labelling hazard statements: H225; H332; H302; H314 |
| 2,6-diamino-3,5-diethyltoluene; 4,6-diethyl-2-methyl-1,3-benzenediamine; [1] 2,4-diamino-3,5-diethyltoluene; 2,4-diethyl-6-methyl-1,3-benzenediamine; [2] diethylmethylbenzenediamine [3] | 2,6-diamino-3,5-diethyltoluene; 4,6-diethyl-2-methyl-1,3-benzenediamine; [1] 2,4-diamino-3,5-diethyltoluene; 2,4-diethyl-6-methyl-1,3-benzenediamine; [2] diethylmethylbenzenediamine [3] | 2095-01-4 [1] 2095-02-5 [2] 68479-98-1 [3] | 218-255-3 [1] 218-256-9 [2] 270-877-4 [3] | substance | Acute Tox. 4 *; Acute Tox. 4 *; STOT RE 2 *; Eye Irrit. 2; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H312; H302; H373 **; H319; H400; H410. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Wng. Labelling hazard statements: H312; H302; H373 **; H319; H410. Notes: C | |
| didecyldimethylammonium chloride | didecyldimethylammonium chloride | 7173-51-5 | 230-525-2 | substance | Acute Tox. 4 *; Skin Corr. 1B | Hazard statement codes: H302; H314. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H302; H314 | |
| N,N'-diphenyl-p-phenylenediamine; N,N'-diphenyl-1,4-benzenediamine | N,N'-diphenyl-p-phenylenediamine; N,N'-diphenyl-1,4-benzenediamine | 74-31-7 | 200-806-4 | substance | Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H317; H412. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317; H412 | |
| 4-ammonio-m-tolyl)ethyl(2-hydroxyethyl)ammonium sulphate; 4-(N-ethyl-N-2-hydroxyethyl)-2-methylphenylenediamine sulphate | 4-ammonio-m-tolyl)ethyl(2-hydroxyethyl)ammonium sulphate; 4-(N-ethyl-N-2-hydroxyethyl)-2-methylphenylenediamine sulphate | 25646-77-9 | 247-162-0 | substance | Acute Tox. 3 *; STOT RE 2 *; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H301; H373 **; H317; H400; H410. Labelling pictogram and signal word: GHS06; GHS08; GHS09; Dgr. Labelling hazard statements: H301; H373 **; H317; H410 | |
| N-(2-(4-amino-N-ethyl-m-toluidino)ethyl)methanesulphonamide sesquisulphate; 4-(N-ethyl-N-2-methanesulphonylaminoethyl)-2-methylphenylenediamine sesquisulphate monohydrate | N-(2-(4-amino-N-ethyl-m-toluidino)ethyl)methanesulphonamide sesquisulphate; 4-(N-ethyl-N-2-methanesulphonylaminoethyl)-2-methylphenylenediamine sesquisulphate monohydrate | 25646-71-3 | 247-161-5 | substance | Acute Tox. 4 *; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H302; H317; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H317; H410 | |
| N-2-naphthylaniline; N-phenyl-2-naphthylamine | N-2-naphthylaniline; N-phenyl-2-naphthylamine | 135-88-6 | 205-223-9 | substance | Carc. 2; Eye Irrit. 2; Skin Irrit. 2; Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H351; H319; H315; H317; H411. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Wng. Labelling hazard statements: H351; H319; H315; H317; H411 | |
| N-isopropyl-N'-phenyl-p-phenylenediamine | N-isopropyl-N'-phenyl-p-phenylenediamine | 101-72-4 | 202-969-7 | substance | Acute Tox. 4 *; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Skin Sens. 1; | H317: C ≥ 0.1 % | Hazard statement codes: H302; H317; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H317; H410 |
| 4-chloroaniline | 4-chloroaniline | 106-47-8 | 203-401-0 | substance | Carc. 1B; Acute Tox. 3 *; Acute Tox. 3 *; Acute Tox. 3 *; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H350; H331; H311; H301; H317; H400; H410. Labelling pictogram and signal word: GHS06; GHS08; GHS09; Dgr. Labelling hazard statements: H350; H331; H311; H301; H317; H410 | |
| furalaxyl (ISO); methyl N-(2,6-dimethylphenyl)-N-(2-furylcarbonyl)-DL-alaninate | furalaxyl (ISO); methyl N-(2,6-dimethylphenyl)-N-(2-furylcarbonyl)-DL-alaninate | 57646-30-7 | 260-875-1 | substance | Acute Tox. 4 *; Aquatic Chronic 3 | Hazard statement codes: H302; H412. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302; H412 | |
| mefenacet (ISO); 2-(benzothiazol-2-yloxy)-N-methyl-N-phenylacetamide | mefenacet (ISO); 2-(benzothiazol-2-yloxy)-N-methyl-N-phenylacetamide | 73250-68-7 | 277-328-8 | substance | Aquatic Chronic 2 | Hazard statement codes: H411. Labelling pictogram and signal word: GHS09. Labelling hazard statements: H411 | |
| quaternary ammonium compounds, benzyl-C8-18-alkyldimethyl, chlorides | quaternary ammonium compounds, benzyl-C8-18-alkyldimethyl, chlorides | 63449-41-2 | 264-151-6 | substance | Acute Tox. 4 *; Acute Tox. 4 *; Skin Corr. 1B; Aquatic Acute 1 | Hazard statement codes: H312; H302; H314; H400. Labelling pictogram and signal word: GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H312; H302; H314; H400 | |
| 4,4'-methylenebis(2-ethylaniline); 4,4'-methylenebis(2-ethylbenzeneamine) | 4,4'-methylenebis(2-ethylaniline); 4,4'-methylenebis(2-ethylbenzeneamine) | 19900-65-3 | 243-420-1 | substance | Carc. 2; Acute Tox. 4 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H351; H302; H400; H410. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Wng. Labelling hazard statements: H351; H302; H410 | |
| biphenyl-2-ylamine | biphenyl-2-ylamine | 90-41-5 | 201-990-9 | substance | Carc. 2; Acute Tox. 4 *; Aquatic Chronic 3 | Hazard statement codes: H351; H302; H412. Labelling pictogram and signal word: GHS08; GHS07; Wng. Labelling hazard statements: H351; H302; H412 | |
| N5,N5-diethyltoluene-2,5-diamine monohydrochloride; 4-diethylamino-2-methylaniline monohydrochloride | N5,N5-diethyltoluene-2,5-diamine monohydrochloride; 4-diethylamino-2-methylaniline monohydrochloride | 2051-79-8 | 218-130-3 | substance | Acute Tox. 3 *; Eye Irrit. 2; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H301; H319; H317; H400; H410. Labelling pictogram and signal word: GHS06; GHS09; Dgr. Labelling hazard statements: H301; H319; H317; H410 | |
| flumetralin (ISO); N-(2-chloro-6-fluorobenzyl)-N-ethyl-α,α,α-trifluoro-2,6-dinitro-p-toluidine | flumetralin (ISO); N-(2-chloro-6-fluorobenzyl)-N-ethyl-α,α,α-trifluoro-2,6-dinitro-p-toluidine | 62924-70-3 | substance | Eye Irrit. 2; Skin Irrit. 2; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H319; H315; H317; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H319; H315; H317; H410 | ||
| o-phenylenediamine | o-phenylenediamine | 95-54-5 | 202-430-6 | substance | Carc. 2; Muta. 2; Acute Tox. 3 *; Acute Tox. 4 *; Acute Tox. 4 *; Eye Irrit. 2; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H351; H341; H301; H332; H312; H319; H317; H400; H410. Labelling pictogram and signal word: GHS06; GHS08; GHS09; Dgr. Labelling hazard statements: H351; H341; H301; H332; H312; H319; H317; H410 | |
| o-phenylenediamine dihydrochloride | o-phenylenediamine dihydrochloride | 615-28-1 | 210-418-7 | substance | Carc. 2; Muta. 2; Acute Tox. 3 *; Acute Tox. 4 *; Acute Tox. 4 *; Eye Irrit. 2; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H351; H341; H301; H332; H312; H319; H317; H400; H410. Labelling pictogram and signal word: GHS06; GHS08; GHS09; Dgr. Labelling hazard statements: H351; H341; H301; H332; H312; H319; H317; H410 | |
| m-phenylenediamine | m-phenylenediamine | 108-45-2 | 203-584-7 | substance | Muta. 2; Acute Tox. 3 *; Acute Tox. 3 *; Acute Tox. 3 *; Eye Irrit. 2; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H341; H331; H311; H301; H319; H317; H400; H410. Labelling pictogram and signal word: GHS06; GHS08; GHS09; Dgr. Labelling hazard statements: H341; H331; H311; H301; H319; H317; H410 | |
| m-phenylenediamine dihydrochloride | m-phenylenediamine dihydrochloride | 541-69-5 | 208-790-0 | substance | Muta. 2; Acute Tox. 3 *; Acute Tox. 3 *; Acute Tox. 3 *; Eye Irrit. 2; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H341; H331; H311; H301; H319; H317; H400; H410. Labelling pictogram and signal word: GHS06; GHS08; GHS09; Dgr. Labelling hazard statements: H341; H331; H311; H301; H319; H317; H410 | |
| 1,3-diphenylguanidine | 1,3-diphenylguanidine | 102-06-7 | 203-002-1 | substance | Repr. 2; Acute Tox. 4 *; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Aquatic Chronic 2 | Hazard statement codes: H361f ***; H302; H319; H335; H315; H411. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Wng. Labelling hazard statements: H361f ***; H302; H319; H335; H315; H411 | |
| spiroxamine (ISO); 8-tert-butyl-1,4-dioxaspiro[4.5]decan-2-ylmethyl (ethyl)(propyl)amine | spiroxamine (ISO); 8-tert-butyl-1,4-dioxaspiro[4.5]decan-2-ylmethyl (ethyl)(propyl)amine | 118134-30-8 | substance | Repr. 2; Acute Tox. 4; Acute Tox. 4; Acute Tox. 4; STOT RE 2; Skin Irrit. 2; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | M = 100 | M = 100 | Hazard statement codes: H361d; H332; H312; H302; H373 (eye); H315; H317; H400; H410. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Wng. Labelling hazard statements: H361d; H332; H312; H302; H373 (eye); H315; H317; H410 | |
| methyl-phenylene diamine; diaminotoluene; [technical product – reaction mass of 4-methyl-m-phenylene diamine (EC No 202-453-1) and 2-methyl-m-phenylene diamine (EC No 212-513-9)] | methyl-phenylene diamine; diaminotoluene; [technical product – reaction mass of 4-methyl-m-phenylene diamine (EC No 202-453-1) and 2-methyl-m-phenylene diamine (EC No 212-513-9)] | substance | Carc. 1B; Muta. 2; Repr. 2; Acute Tox. 3 *; Acute Tox. 4 *; STOT RE 2 *; Eye Irrit. 2; Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H350; H341; H361f***; H301; H312; H373**; H319; H317; H411. Labelling pictogram and signal word: GHS06; GHS08; GHS09; Dgr. Labelling hazard statements: H350; H341; H361f***; H301; H312; H373**; H319; H317; H411 | |||
| N,N-diethyl-N',N'-dimethylpropan-1,3-diyldiamine | N,N-diethyl-N',N'-dimethylpropan-1,3-diyldiamine | 62478-82-4 | 406-610-7 | substance | Flam. Liq. 3; Acute Tox. 4 *; Acute Tox. 4 *; STOT RE 2 *; Skin Corr. 1A; Aquatic Chronic 3 | Hazard statement codes: H226; H332; H302; H373 **; H314; H412. Labelling pictogram and signal word: GHS02; GHS08; GHS05; GHS07; Dgr. Labelling hazard statements: H226; H332; H302; H373 **; H314; H412 | |
| 4-[N-ethyl-N-(2-hydroxyethyl)amino]-1-(2-hydroxyethyl)amino-2-nitrobenzene, monohydrochloride | 4-[N-ethyl-N-(2-hydroxyethyl)amino]-1-(2-hydroxyethyl)amino-2-nitrobenzene, monohydrochloride | 132885-85-9 | 407-020-2 | substance | Acute Tox. 4 *; Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H302; H317; H412. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302; H317; H412 | |
| 6'-(isobutylethylamino)-3'-methyl-2'-phenylamino-spiro[isobenzo-2-oxofuran-7,9'- [9H]-xanthene] | 6'-(isobutylethylamino)-3'-methyl-2'-phenylamino-spiro[isobenzo-2-oxofuran-7,9'- [9H]-xanthene] | 95235-29-3 | 410-890-6 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | |
| 2'-anilino-6'-((3-ethoxypropyl)ethylamino)-3'-methylspiro(isobenzo-3-oxofuran)-1- (1H)-9'-xanthene | 2'-anilino-6'-((3-ethoxypropyl)ethylamino)-3'-methylspiro(isobenzo-3-oxofuran)-1- (1H)-9'-xanthene | 93071-94-4 | 411-730-8 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | |
| reaction mass of: trihexadecylmethylammonium chloride; dihexadecyldimethylammonium chloride | reaction mass of: trihexadecylmethylammonium chloride; dihexadecyldimethylammonium chloride | 405-620-9 | substance | Eye Dam. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H318; H400; H410. Labelling pictogram and signal word: GHS05; GHS09; Dgr. Labelling hazard statements: H318; H410 | ||
| (Z)-1-benzo[b]thien-2-ylethanone oxime hydrochloride | (Z)-1-benzo[b]thien-2-ylethanone oxime hydrochloride | 410-780-8 | substance | Acute Tox. 4 *; STOT RE 2 *; Eye Dam. 1; Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H302; H373 **; H318; H317; H411. Labelling pictogram and signal word: GHS08; GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H302; H373 **; H318; H317; H411 | ||
| reaction mass of: bis(5-dodecyl-2-hydroxybenzald-oximate) copper (II) C12-alkyl group is branched; 4-dodecylsalicylaldoxime | reaction mass of: bis(5-dodecyl-2-hydroxybenzald-oximate) copper (II) C12-alkyl group is branched; 4-dodecylsalicylaldoxime | 410-820-4 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | ||
| Reaction products of: trimethylhexamethylene diamine (a mixture of 2,2,4-trimethyl-1,6-hexanediamine and 2,4,4-trimethyl-1,6- hexanediamine, EINECS listed), Epoxide 8 (mono[(C10-C16-alkyloxy)methyl]oxirane derivatives) and p-toluene-sulfonic acid | Reaction products of: trimethylhexamethylene diamine (a mixture of 2,2,4-trimethyl-1,6-hexanediamine and 2,4,4-trimethyl-1,6- hexanediamine, EINECS listed), Epoxide 8 (mono[(C10-C16-alkyloxy)methyl]oxirane derivatives) and p-toluene-sulfonic acid | 410-880-1 | substance | Acute Tox. 4 *; Skin Corr. 1B; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H302; H314; H400; H410. Labelling pictogram and signal word: GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H302; H314; H410 | ||
| p-toluidine; 4-aminotoluene; [1] toluidinium chloride; [2] toluidine sulphate (1:1) [3] | p-toluidine; 4-aminotoluene; [1] toluidinium chloride; [2] toluidine sulphate (1:1) [3] | 106-49-0 [1] 540-23-8 [2] 540-25-0 [3] | 203-403-1 [1] 208-740-8 [2] 208-741-3 [3] | substance | Carc. 2; Acute Tox. 3 *; Acute Tox. 3 *; Acute Tox. 3 *; Eye Irrit. 2; Skin Sens. 1; Aquatic Acute 1 | Hazard statement codes: H351; H331; H311; H301; H319; H317; H400. Labelling pictogram and signal word: GHS06; GHS08; GHS09; Dgr. Labelling hazard statements: H351; H331; H311; H301; H319; H317; H400 | |
| 2,6-xylidine; 2,6-dimethylaniline | 2,6-xylidine; 2,6-dimethylaniline | 87-62-7 | 201-758-7 | substance | Carc. 2; Acute Tox. 4 *; Acute Tox. 4 *; Acute Tox. 4 *; STOT SE 3; Skin Irrit. 2; Aquatic Chronic 2 | Hazard statement codes: H351; H332; H312; H302; H335; H315; H411. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Wng. Labelling hazard statements: H351; H332; H312; H302; H335; H315; H411 | |
| dimethyldioctadecylammonium chloride; DODMAC | dimethyldioctadecylammonium chloride; DODMAC | 107-64-2 | 203-508-2 | substance | Eye Dam. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H318; H400; H410. Labelling pictogram and signal word: GHS05; GHS09; Dgr. Labelling hazard statements: H318; H410 | |
| metalaxyl-M (ISO); mefenoxam; (R)-2-[(2,6-dimethylphenyl)-methoxyacetylamino]propionic acid methyl ester | metalaxyl-M (ISO); mefenoxam; (R)-2-[(2,6-dimethylphenyl)-methoxyacetylamino]propionic acid methyl ester | 70630-17-0 | substance | Acute Tox. 4 *; Eye Dam. 1 | Hazard statement codes: H302; H318. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H302; H318 | ||
| 2-butyl-2-ethyl-1,5-diaminopentane | 2-butyl-2-ethyl-1,5-diaminopentane | 137605-95-9 | 412-700-7 | substance | Acute Tox. 4 *; Acute Tox. 4 *; STOT RE 2 *; Skin Corr. 1B; Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H312; H302; H373 **; H314; H317; H412. Labelling pictogram and signal word: GHS08; GHS05; GHS07; Dgr. Labelling hazard statements: H312; H302; H373 **; H314; H317; H412 | |
| N,N'-diphenyl-N,N'-bis(3-methylphenyl)-(1,1'-diphenyl)-4,4'-diamine | N,N'-diphenyl-N,N'-bis(3-methylphenyl)-(1,1'-diphenyl)-4,4'-diamine | 65181-78-4 | 413-810-8 | substance | Aquatic Chronic 2 | Hazard statement codes: H411. Labelling pictogram and signal word: GHS09. Labelling hazard statements: H411 | |
| reaction mass of: cis-(5-ammonium-1,3,3-trimethyl)-cyclohexanemethylammonium phosphate (1:1); trans-(5-ammonium-1,3,3-trimethyl)-cyclohexanemethylammonium phosphate (1:1) | reaction mass of: cis-(5-ammonium-1,3,3-trimethyl)-cyclohexanemethylammonium phosphate (1:1); trans-(5-ammonium-1,3,3-trimethyl)-cyclohexanemethylammonium phosphate (1:1) | 114765-88-7 | 411-830-1 | substance | Eye Dam. 1; Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H318; H317; H412. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H318; H317; H412 | |
| 5-acetyl-3-amino-10,11-dihydro-5H-dibenz [b,f]azepine-hydrochloride | 5-acetyl-3-amino-10,11-dihydro-5H-dibenz [b,f]azepine-hydrochloride | 410-490-1 | substance | Acute Tox. 4 *; STOT RE 2 *; Eye Dam. 1; Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H302; H373 **; H318; H317; H411. Labelling pictogram and signal word: GHS08; GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H302; H373 **; H318; H317; H411 | ||
| 3,5-dichloro-2,6-difluoropyrdine-4-amine | 3,5-dichloro-2,6-difluoropyrdine-4-amine | 2840-00-8 | 220-630-1 | substance | Acute Tox. 4 *; Acute Tox. 4 *; Aquatic Chronic 2 | Hazard statement codes: H312; H302; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H312; H302; H411 | |
| bis(N-methyl-N-phenylhydrazine) sulfate | bis(N-methyl-N-phenylhydrazine) sulfate | 618-26-8 | 423-170-1 | substance | Flam. Liq. 2; STOT RE 1; Acute Tox. 4 *; Eye Dam. 1; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H225; H372**; H302; H318; H317; H400; H410. Labelling pictogram and signal word: GHS02; GHS05; GHS08; GHS07; GHS09; Dgr. Labelling hazard statements: H225; H372**; H302; H318; H317; H410 | |
| 4-chlorophenyl cyclopropyl ketone O-(4-aminobenzyl)oxime | 4-chlorophenyl cyclopropyl ketone O-(4-aminobenzyl)oxime | 405-260-2 | substance | Acute Tox. 4 *; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H302; H317; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H317; H410 | ||
| N,N,N',N'-tetraglycidyl-4,4'-diamino-3,3'-diethyldiphenylmethane | N,N,N',N'-tetraglycidyl-4,4'-diamino-3,3'-diethyldiphenylmethane | 130728-76-6 | 410-060-3 | substance | Muta. 2; Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H341; H317; H411. Labelling pictogram and signal word: GHS08; GHS09; Wng. Labelling hazard statements: H341; H317; H411 | |
| 4,4'-methylenebis(N,N'-dimethylcyclohexanamine | 4,4'-methylenebis(N,N'-dimethylcyclohexanamine | 13474-64-1 | 412-840-9 | substance | Acute Tox. 4 *; STOT RE 2 *; Skin Corr. 1A; Aquatic Chronic 3 | Hazard statement codes: H302; H373 **; H314; H412. Labelling pictogram and signal word: GHS08; GHS05; GHS07; Dgr. Labelling hazard statements: H302; H373 **; H314; H412 | |
| lithium 1-amino-4-(4-tert-butylanilino) anthraquinone-2-sulfonate | lithium 1-amino-4-(4-tert-butylanilino) anthraquinone-2-sulfonate | 125328-86-1 | 411-140-0 | substance | Eye Dam. 1; Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H318; H317; H411. Labelling pictogram and signal word: GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H318; H317; H411 | |
| 4,4-dimethoxybutylamine | 4,4-dimethoxybutylamine | 19060-15-2 | 407-690-6 | substance | Acute Tox. 4 *; Skin Corr. 1B; Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H302; H314; H317; H412. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H302; H314; H317; H412 | |
| 2-(O-aminooxy)ethylamine dihydrochloride | 2-(O-aminooxy)ethylamine dihydrochloride | 37866-45-8 | 412-310-7 | substance | Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H317; H412. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317; H412 | |
| polymer of 1,3-dibromopropane and N,Ndiethyl-N',N'-dimethyl-1,3-propanediamine | polymer of 1,3-dibromopropane and N,Ndiethyl-N',N'-dimethyl-1,3-propanediamine | 143747-73-3 | 410-570-6 | substance | Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H400; H410. Labelling pictogram and signal word: GHS09; Wng. Labelling hazard statements: H410 | |
| 2-naphthylamino-6-sulfomethylamide | 2-naphthylamino-6-sulfomethylamide | 104295-55-8 | 412-120-4 | substance | STOT RE 2 *; Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H373 **; H317; H411. Labelling pictogram and signal word: GHS08; GHS09; Wng. Labelling hazard statements: H373 **; H317; H411 | |
| 1,4,7,10-tetraazacyclododecane disulfate | 1,4,7,10-tetraazacyclododecane disulfate | 112193-77-8 | 412-080-8 | substance | Acute Tox. 4 *; STOT SE 3; Eye Dam. 1; Aquatic Chronic 3 | Hazard statement codes: H302; H335; H318; H412. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H302; H335; H318; H412 | |
| 1-(2-propenyl)pyridinium chloride | 1-(2-propenyl)pyridinium chloride | 25965-81-5 | 412-740-5 | substance | Acute Tox. 4 *; Skin Sens. 1 | Hazard statement codes: H302; H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302; H317 | |
| 3-aminobenzylamine | 3-aminobenzylamine | 4403-70-7 | 412-230-2 | substance | Acute Tox. 4 *; Skin Corr. 1B; Aquatic Chronic 2 | Hazard statement codes: H302; H314; H411. Labelling pictogram and signal word: GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H302; H314; H411 | |
| 2-phenylthioaniline | 2-phenylthioaniline | 1134-94-7 | 413-030-8 | substance | Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H317; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H317; H411 | |
| 1-ethyl-1-methylmorpholinium bromide | 1-ethyl-1-methylmorpholinium bromide | 65756-41-4 | 418-210-1 | substance | Muta. 2 | Hazard statement codes: H341. Labelling pictogram and signal word: GHS08; Wng. Labelling hazard statements: H341 | |
| 1-ethyl-1-methylpyrrolidinium bromide | 1-ethyl-1-methylpyrrolidinium bromide | 69227-51-6 | 418-200-5 | substance | Muta. 2 | Hazard statement codes: H341. Labelling pictogram and signal word: GHS08; Wng. Labelling hazard statements: H341 | |
| 6'-(dibutylamino)-3'-methyl-2'-(phenylamino)spiro[isobenzofuran-1(3H),9-(9H)-xanthen]-3-one | 6'-(dibutylamino)-3'-methyl-2'-(phenylamino)spiro[isobenzofuran-1(3H),9-(9H)-xanthen]-3-one | 89331-94-2 | 403-830-5 | substance | Aquatic Chronic 3 | Hazard statement codes: H412. Labelling pictogram and signal word: —. Labelling hazard statements: H412 | |
| 1-[3-[4-((heptadecafluorononyl)oxy)-benzamido]propyl]-N,N,N-trimethylammonium iodide | 1-[3-[4-((heptadecafluorononyl)oxy)-benzamido]propyl]-N,N,N-trimethylammonium iodide | 59493-72-0 | 407-400-8 | substance | Eye Dam. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H318; H400; H410. Labelling pictogram and signal word: GHS05; GHS09; Dgr. Labelling hazard statements: H318; H410 | |
| bis(N-(7-hydroxy-8-methyl-5-phenylphenazin-3-ylidene)dimethylammonium) sulfate | bis(N-(7-hydroxy-8-methyl-5-phenylphenazin-3-ylidene)dimethylammonium) sulfate | 149057-64-7 | 406-770-8 | substance | STOT RE 2 *; Eye Dam. 1; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H373 **; H318; H317; H400; H410. Labelling pictogram and signal word: GHS08; GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H373 **; H318; H317; H410 | |
| 2,3,4-trifluoroaniline | 2,3,4-trifluoroaniline | 3862-73-5 | 407-170-9 | substance | Acute Tox. 4 *; Acute Tox. 4 *; STOT RE 2 *; Skin Irrit. 2; Eye Dam. 1; Aquatic Chronic 2 | Hazard statement codes: H312; H302; H373 **; H315; H318; H411. Labelling pictogram and signal word: GHS08; GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H312; H302; H373 **; H315; H318; H411 | |
| 4,4'-(9H-fluoren-9-ylidene)bis(2-chloroaniline) | 4,4'-(9H-fluoren-9-ylidene)bis(2-chloroaniline) | 107934-68-9 | 407-560-9 | substance | Aquatic Chronic 2 | Hazard statement codes: H411. Labelling pictogram and signal word: GHS09. Labelling hazard statements: H411 | |
| 4-amino-2-(aminomethyl)phenol dihydrochloride | 4-amino-2-(aminomethyl)phenol dihydrochloride | 135043-64-0 | 412-510-4 | substance | Acute Tox. 4 *; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H302; H317; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H317; H410 | |
| 4,4'-methylenebis(2-isopropyl-6-methylaniline) | 4,4'-methylenebis(2-isopropyl-6-methylaniline) | 16298-38-7 | 415-150-6 | substance | STOT RE 2 *; Aquatic Chronic 2 | Hazard statement codes: H373 **; H411. Labelling pictogram and signal word: GHS08; GHS09; Wng. Labelling hazard statements: H373 **; H411 | |
| polymer of allylamine hydrochloride | polymer of allylamine hydrochloride | 71550-12-4 | 415-050-2 | substance | Acute Tox. 4 *; Skin Sens. 1 | Hazard statement codes: H302; H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302; H317 | |
| 2-isopropyl-4-(N-methyl)aminomethylthiazole | 2-isopropyl-4-(N-methyl)aminomethylthiazole | 154212-60-9 | 414-800-6 | substance | Acute Tox. 4 *; Acute Tox. 4 *; Skin Irrit. 2; Eye Dam. 1; Aquatic Chronic 2 | Hazard statement codes: H312; H302; H315; H318; H411. Labelling pictogram and signal word: GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H312; H302; H315; H318; H411 | |
| 3-methylaminomethylphenylamine | 3-methylaminomethylphenylamine | 18759-96-1 | 414-570-7 | substance | Acute Tox. 4 *; Acute Tox. 4 *; Skin Corr. 1B; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H312; H302; H314; H317; H400; H410. Labelling pictogram and signal word: GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H312; H302; H314; H317; H410 | |
| 2-hydroxy-3-[(2-hydroxyethyl)-[2-(1-oxotetradecyl)amino]ethyl]amino]-N,N,N-trimethyl-1-propanammonium chloride | 2-hydroxy-3-[(2-hydroxyethyl)-[2-(1-oxotetradecyl)amino]ethyl]amino]-N,N,N-trimethyl-1-propanammonium chloride | 141890-30-4 | 414-670-0 | substance | Acute Tox. 4 *; Eye Dam. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H302; H318; H400; H410. Labelling pictogram and signal word: GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H302; H318; H410 | |
| bis[tributyl 4-(methylbenzyl)ammonium] 1,5-naphthalenedisulfonate | bis[tributyl 4-(methylbenzyl)ammonium] 1,5-naphthalenedisulfonate | 160236-81-7 | 415-210-1 | substance | Acute Tox. 4 *; Acute Tox. 4 *; Eye Dam. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H332; H302; H318; H400; H410. Labelling pictogram and signal word: GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H332; H302; H318; H410 | |
| 4-chloro-o-toluidine; [1] 4-chloro-o-toluidine hydrochloride [2] | 4-chloro-o-toluidine; [1] 4-chloro-o-toluidine hydrochloride [2] | 95-69-2 [1] 3165-93-3 [2] | 202-441-6 [1] 221-627-8 [2] | substance | Carc. 1B; Muta. 2; Acute Tox. 3 *; Acute Tox. 3 *; Acute Tox. 3 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H350; H341; H331; H311; H301; H400; H410. Labelling pictogram and signal word: GHS06; GHS08; GHS09; Dgr. Labelling hazard statements: H350; H341; H331; H311; H301; H410 | |
| 2,4,5-trimethylaniline; [1] 2,4,5-trimethylaniline hydrochloride [2] | 2,4,5-trimethylaniline; [1] 2,4,5-trimethylaniline hydrochloride [2] | 137-17-7 [1] 21436-97-5 [2] | 205-282-0 [1] [2] | substance | Carc. 1B; Acute Tox. 3 *; Acute Tox. 3 *; Acute Tox. 3 *; Aquatic Chronic 2 | Hazard statement codes: H350; H331; H311; H301; H411. Labelling pictogram and signal word: GHS06; GHS08; GHS09; Dgr. Labelling hazard statements: H350; H331; H311; H301; H411 | |
| 4,4'-thiodianiline and its salts | 4,4'-thiodianiline and its salts | 139-65-1 | 205-370-9 | substance | Carc. 1B; Acute Tox. 4 *; Aquatic Chronic 2 | Hazard statement codes: H350; H302; H411. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Dgr. Labelling hazard statements: H350; H302; H411 | |
| 4,4'-oxydianiline and its salts; p-aminophenyl ether | 4,4'-oxydianiline and its salts; p-aminophenyl ether | 101-80-4 | 202-977-0 | substance | Carc. 1B; Muta. 1B; Repr. 2; Acute Tox. 3 *; Acute Tox. 3 *; Acute Tox. 3 *; Aquatic Chronic 2 | Hazard statement codes: H350; H340; H361f ***; H331; H311; H301; H411. Labelling pictogram and signal word: GHS06; GHS08; GHS09; Dgr. Labelling hazard statements: H350; H340; H361f ***; H331; H311; H301; H411 | |
| 2,4-diaminoanisole; 4-methoxy-m-phenylenediamine; [1] 2,4-diaminoanisole sulphate [2] | 2,4-diaminoanisole; 4-methoxy-m-phenylenediamine; [1] 2,4-diaminoanisole sulphate [2] | 615-05-4 [1] 39156-41-7 [2] | 210-406-1 [1] 254-323-9 [2] | substance | Carc. 1B; Muta. 2; Acute Tox. 4 *; Aquatic Chronic 2 | Hazard statement codes: H350; H341; H302; H411. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Dgr. Labelling hazard statements: H350; H341; H302; H411 | |
| N,N,N',N'-tetramethyl-4,4'-methylendianiline | N,N,N',N'-tetramethyl-4,4'-methylendianiline | 101-61-1 | 202-959-2 | substance | Carc. 1B; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H350; H400; H410. Labelling pictogram and signal word: GHS08; GHS09; Dgr. Labelling hazard statements: H350; H410 | |
| 3,4-dichloroaniline | 3,4-dichloroaniline | 95-76-1 | 202-448-4 | substance | Acute Tox. 3 *; Acute Tox. 3 *; Acute Tox. 3 *; Eye Dam. 1; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H331; H311; H301; H318; H317; H400; H410. Labelling pictogram and signal word: GHS06; GHS05; GHS09; Dgr. Labelling hazard statements: H331; H311; H301; H318; H317; H410 | |
| C8-10 alkyl dimethyl hydroxyethyl ammoniumchloride (chain < C8: <3 %, chain= C8: 15 %-70 %, chain= C10: 30 %-85 %, chain > C10: <3 %) | C8-10 alkyl dimethyl hydroxyethyl ammoniumchloride (chain < C8: <3 %, chain= C8: 15 %-70 %, chain= C10: 30 %-85 %, chain > C10: <3 %) | 417-360-3 | substance | Acute Tox. 4 *; Acute Tox. 4 *; Skin Irrit. 2 | Hazard statement codes: H312; H302; H315. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H312; H302; H315 | ||
| C.I. Basic Violet 3; 4-[4,4'-bis(dimethylamino) benzhydrylidene] cyclohexa-2,5-dien-1-ylidene]dimethylammonium chloride | C.I. Basic Violet 3; 4-[4,4'-bis(dimethylamino) benzhydrylidene] cyclohexa-2,5-dien-1-ylidene]dimethylammonium chloride | 548-62-9 | 208-953-6 | substance | Carc. 2; Acute Tox. 4 *; Eye Dam. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H351; H302; H318; H400; H410. Labelling pictogram and signal word: GHS08; GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H351; H302; H318; H410 | |
| C.I. Basic Violet 3 with ≥ 0,1 % of Michler's ketone (EC no. 202-027-5) | C.I. Basic Violet 3 with ≥ 0,1 % of Michler's ketone (EC no. 202-027-5) | 548-62-9 | 208-953-6 | substance | Carc. 1B; Acute Tox. 4 *; Eye Dam. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H350; H302; H318; H400; H410. Labelling pictogram and signal word: GHS08; GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H350; H302; H318; H410 | |
| famoxadone (ISO); 3-anilino-5-methyl-5-(4-phenoxyphenyl)-1,3-oxazolidine-2,4-dione | famoxadone (ISO); 3-anilino-5-methyl-5-(4-phenoxyphenyl)-1,3-oxazolidine-2,4-dione | 131807-57-3 | substance | STOT RE 2 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H373 **; H400; H410. Labelling pictogram and signal word: GHS08; GHS09; Wng. Labelling hazard statements: H373 **; H410 | ||
| 4-ethoxyaniline; p-phenetidine | 4-ethoxyaniline; p-phenetidine | 156-43-4 | 205-855-5 | substance | Muta. 2; Acute Tox. 4 *; Acute Tox. 4 *; Acute Tox. 4 *; Eye Irrit. 2; Skin Sens. 1 | Hazard statement codes: H341; H332; H312; H302; H319; H317. Labelling pictogram and signal word: GHS08; GHS07; Wng. Labelling hazard statements: H341; H332; H312; H302; H319; H317 | |
| N-methylbenzene-1,2-diammonium hydrogen phosphate | N-methylbenzene-1,2-diammonium hydrogen phosphate | 424-460-0 | substance | Acute Tox. 4 *; Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H302; H317; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H317; H411 | ||
| 6-methoxy-m-toluidine; p-cresidine | 6-methoxy-m-toluidine; p-cresidine | 120-71-8 | 204-419-1 | substance | Carc. 1B; Acute Tox. 4 * | Hazard statement codes: H350; H302. Labelling pictogram and signal word: GHS08; GHS07; Dgr. Labelling hazard statements: H350; H302 | |
| 5-nitro-o-toluidine; [1] 5-nitro-o-toluidine hydrochloride [2] | 5-nitro-o-toluidine; [1] 5-nitro-o-toluidine hydrochloride [2] | 99-55-8 [1] 51085-52-0 [2] | 202-765-8 [1] 256-960-8 [2] | substance | Carc. 2; Acute Tox. 3 *; Acute Tox. 3 *; Acute Tox. 3 *; Aquatic Chronic 3 | Hazard statement codes: H351; H331; H311; H301; H412. Labelling pictogram and signal word: GHS06; GHS08; Dgr. Labelling hazard statements: H351; H331; H311; H301; H412 | |
| N-[(benzotriazole-1-yl)methyl)]-4-carboxybenzenesulfonamide | N-[(benzotriazole-1-yl)methyl)]-4-carboxybenzenesulfonamide | 170292-97-4 | 416-470-9 | substance | Eye Irrit. 2; Aquatic Chronic 2 | Hazard statement codes: H319; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H319; H411 | |
| 2,6-dichloro-4-trifluoromethylaniline | 2,6-dichloro-4-trifluoromethylaniline | 24279-39-8 | 416-430-0 | substance | Acute Tox. 4 *; Acute Tox. 4 *; Skin Irrit. 2; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H332; H302; H315; H317; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H332; H302; H315; H317; H410 | |
| isobutylidene-(2-(2-isopropyl-4,4-dimethyloxazolidine- 3-yl)-1,1-dimethylethyl)amine | isobutylidene-(2-(2-isopropyl-4,4-dimethyloxazolidine- 3-yl)-1,1-dimethylethyl)amine | 148348-13-4 | 419-850-2 | substance | Skin Corr. 1B; Aquatic Chronic 3 | Hazard statement codes: H314; H412. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H314; H412 | |
| 4-(2,2-diphenylethenyl)-N,N-di-phenylbenzenamine | 4-(2,2-diphenylethenyl)-N,N-di-phenylbenzenamine | 89114-90-9 | 421-390-2 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | |
| 3-chloro-2-(isopropylthio)aniline | 3-chloro-2-(isopropylthio)aniline | 179104-32-6 | 421-700-6 | substance | Skin Irrit. 2; Aquatic Chronic 2 | Hazard statement codes: H315; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H315; H411 | |
| 1-amino-1-cyanamino-2,2-dicyanoethylene, sodium salt | 1-amino-1-cyanamino-2,2-dicyanoethylene, sodium salt | 19450-38-5 | 425-870-2 | substance | Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H317; H412. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317; H412 | |
| 1-methoxy-2-propylamine | 1-methoxy-2-propylamine | 37143-54-7 | 422-550-4 | substance | Flam. Liq. 2; Skin Corr. 1B; Acute Tox. 4 *; Aquatic Chronic 3 | Hazard statement codes: H225; H314; H302; H412. Labelling pictogram and signal word: GHS02; GHS05; GHS07; Dgr. Labelling hazard statements: H225; H314; H302; H412 | |
| (2-hydroxy-3-(3,4-dimethyl-9-oxo-10-thiaanthracen-2-yloxy)propyl)trimethylammonium chloride | (2-hydroxy-3-(3,4-dimethyl-9-oxo-10-thiaanthracen-2-yloxy)propyl)trimethylammonium chloride | 402-200-7 | substance | Aquatic Chronic 3 | Hazard statement codes: H412. Labelling pictogram and signal word: —. Labelling hazard statements: H412 | ||
| N-nitro-N-(3-methyl-3,6-dihydro-2H-1,3,5-oxadiazin-4-yl)amine | N-nitro-N-(3-methyl-3,6-dihydro-2H-1,3,5-oxadiazin-4-yl)amine | 153719-38-1 | 431-060-1 | substance | Acute Tox. 4 *; Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H302; H317; H412. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302; H317; H412 | |
| 2-amino-4-(trifluoromethyl)benzenethiol hydrochloride | 2-amino-4-(trifluoromethyl)benzenethiol hydrochloride | 4274-38-8 | 429-560-8 | substance | Skin Corr. 1B; Acute Tox. 4 *; Acute Tox. 4 *; Acute Tox. 4 *; STOT RE 2 *; Skin Sens. 1; Aquatic Acute 1 | Hazard statement codes: H314; H332; H312; H302; H373**; H317; H400. Labelling pictogram and signal word: GHS05; GHS08; GHS07; GHS09; Dgr. Labelling hazard statements: H314; H332; H312; H302; H373**; H317; H400 | |
| cis-1-(3-(4-fluorophenoxy)propyl)-3-methoxy-4-piperidinamine | cis-1-(3-(4-fluorophenoxy)propyl)-3-methoxy-4-piperidinamine | 104860-26-6 | 425-080-8 | substance | Acute Tox. 4 *; Acute Tox. 4 *; STOT RE 2 *; Eye Dam. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H312; H302; H373**; H318; H400; H410. Labelling pictogram and signal word: GHS05; GHS08; GHS07; GHS09; Dgr. Labelling hazard statements: H312; H302; H373**; H318; H410 | |
| N-benzyl-N-ethyl-(4-(5-nitro-benzo[c]isothiazol-3-ylazo)phenyl)amine | N-benzyl-N-ethyl-(4-(5-nitro-benzo[c]isothiazol-3-ylazo)phenyl)amine | 186450-73-7 | 425-300-2 | substance | Skin Sens. 1; Aquatic Chronic 4 | Hazard statement codes: H317; H413. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317; H413 | |
| N2,N4,N6-tris{]4-[}(1,4-dimethylpentyl)amino{]phenyl[}-1,3,5-triazine-2,4,6-triamine | N2,N4,N6-tris{]4-[}(1,4-dimethylpentyl)amino{]phenyl[}-1,3,5-triazine-2,4,6-triamine | 121246-28-4 | 426-150-0 | substance | Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H317; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H317; H410 | |
| 1,4,7,10-tetraazacyclododecane | 1,4,7,10-tetraazacyclododecane | 294-90-6 | 425-450-9 | substance | Skin Corr. 1B; Acute Tox. 4 *; Acute Tox. 4 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H314; H312; H302; H400; H410. Labelling pictogram and signal word: GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H314; H312; H302; H410 | |
| 3-(2’-phenoxyethoxy)propylamine | 3-(2’-phenoxyethoxy)propylamine | 6903-18-0 | 427-870-8 | substance | Acute Tox. 4 *; Skin Irrit. 2; Eye Dam. 1; Aquatic Chronic 3 | Hazard statement codes: H302; H315; H318; H412. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H302; H315; H318; H412 | |
| benzyl-N-(2-(2-methoxyphenoxy)ethyl)amine hydrochloride | benzyl-N-(2-(2-methoxyphenoxy)ethyl)amine hydrochloride | 120606-08-8 | 428-290-8 | substance | Acute Tox. 4 *; Eye Dam. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H302; H318; H400; H410. Labelling pictogram and signal word: GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H302; H318; H410 | |
| reaction mass of: N-(3-(trimethoxysilyl)propyl)ethylenediamine; N-benzyl-N-(3-(trimethoxysilyl)propyl)ethylenediamine; N-benzyl-N’-[3-(trimethoxysilyl)propyl]ethylenediamine; N,N’-bis-benzyl-N’-[3-(trimethoxysilyl)propyl]ethylenediamine; N,N,N’-tris-benzyl-N’-[3-(trimethoxysilyl)propyl]ethylenediamine; N,N-bis-benzyl-N’-[3-(trimethoxysilyl)propyl]ethylenediamine | reaction mass of: N-(3-(trimethoxysilyl)propyl)ethylenediamine; N-benzyl-N-(3-(trimethoxysilyl)propyl)ethylenediamine; N-benzyl-N’-[3-(trimethoxysilyl)propyl]ethylenediamine; N,N’-bis-benzyl-N’-[3-(trimethoxysilyl)propyl]ethylenediamine; N,N,N’-tris-benzyl-N’-[3-(trimethoxysilyl)propyl]ethylenediamine; N,N-bis-benzyl-N’-[3-(trimethoxysilyl)propyl]ethylenediamine | 414-340-6 | substance | Flam. Liq. 3; Acute Tox. 4 *; Acute Tox. 4 *; Acute Tox. 4 *; STOT SE 2; Eye Dam. 1; Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H226; H332; H312; H302; H371; H318; H317; H412. Labelling pictogram and signal word: GHS02; GHS05; GHS08; GHS07; Dg. Labelling hazard statements: H226; H332; H312; H302; H371; H318; H317; H412 | ||
| mepanipyrim; 4-methyl-N-phenyl-6-(1-propynyl)-2-pyrimidinamine | mepanipyrim; 4-methyl-N-phenyl-6-(1-propynyl)-2-pyrimidinamine | 110235-47-7 | substance | Carc. 2; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H351; H400; H410. Labelling pictogram and signal word: GHS08; GHS09; Wng. Labelling hazard statements: H351; H410 | ||
| N,N-bis(cocoyl-2-oxypropyl)-N,N-dibutylammonium bromide | N,N-bis(cocoyl-2-oxypropyl)-N,N-dibutylammonium bromide | 431-530-4 | substance | Skin Corr. 1A; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H314; H317; H400; H410. Labelling pictogram and signal word: GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H314; H317; H410 | ||
| 3-((C12-18)-acylamino)-N-(2-((2-hydroxyethyl)amino)-2-oxoethyl)-N,N-dimethyl-1-propanaminium chloride | 3-((C12-18)-acylamino)-N-(2-((2-hydroxyethyl)amino)-2-oxoethyl)-N,N-dimethyl-1-propanaminium chloride | 164288-56-6 | 427-370-1 | substance | Eye Dam. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H318; H400; H410. Labelling pictogram and signal word: GHS05; GHS09; Dgr. Labelling hazard statements: H318; H410 | |
| reaction mass of: triisopropanolamine salt of 1-amino-4-(3-propionamidoanilino)anthraquinone-2-sulfonic acid; triisopropanolamine salt of 1-amino-4-[3,4-dimethyl-5-(2-hydroxyethylaminosulfonyl) anilino]anthraquinone-2-sulfonic acid | reaction mass of: triisopropanolamine salt of 1-amino-4-(3-propionamidoanilino)anthraquinone-2-sulfonic acid; triisopropanolamine salt of 1-amino-4-[3,4-dimethyl-5-(2-hydroxyethylaminosulfonyl) anilino]anthraquinone-2-sulfonic acid | 186148-38-9 | 430-410-9 | substance | Aquatic Chronic 3 | Hazard statement codes: H412. Labelling pictogram and signal word: —. Labelling hazard statements: H412 | |
| hydroxylammonium hydrogensulfate; hydroxylamine sulfate(1:1); [1] hydroxylamine phosphate; [2] hydroxylamine dihydrogenphosphate; [3] hydroxylamine 4-methylbenzenesulfonate [4] | hydroxylammonium hydrogensulfate; hydroxylamine sulfate(1:1); [1] hydroxylamine phosphate; [2] hydroxylamine dihydrogenphosphate; [3] hydroxylamine 4-methylbenzenesulfonate [4] | 10046-00-1 [1] 20845-01-6 [2] 19098-16-9 [3] 53933-48-5 [4] | 233-154-4 [1] 244-077-0 [2] 242-818-2 [3] 258-872-5 [4] | substance | Expl. 1.1; Carc. 2; Acute Tox. 4 *; Acute Tox. 4 *; STOT RE 2 *; Eye Irrit. 2; Skin Irrit. 2; Skin Sens. 1; Aquatic Acute 1 | Hazard statement codes: H201; H351; H312; H302; H373**; H319; H315; H317; H400. Labelling pictogram and signal word: GHS01; GHS08; GHS07; GHS09; Dgr. Labelling hazard statements: H201; H351; H312; H302; H373**; H319; H315; H317; H400. Notes: T | |
| (3-chloro-2-hydroxypropyl) trimethylammonium chloride …% | (3-chloro-2-hydroxypropyl) trimethylammonium chloride …% | 3327-22-8 | 222-048-3 | substance | Carc. 2; Aquatic Chronic 3 | Hazard statement codes: H351; H412. Labelling pictogram and signal word: GHS08; Wng. Labelling hazard statements: H351; H412. Notes: B | |
| biphenyl-3,3’, 4,4’-tetrayltetraamine; diaminobenzidine | biphenyl-3,3’, 4,4’-tetrayltetraamine; diaminobenzidine | 91-95-2 | 202-110-6 | substance | Carc. 1B; Muta. 2 | Hazard statement codes: H350; H341. Labelling pictogram and signal word: GHS08; Dgr. Labelling hazard statements: H350; H341 | |
| pyrimethanil (ISO); N-(4,6-dimethylpyrimidin-2-yl) aniline | pyrimethanil (ISO); N-(4,6-dimethylpyrimidin-2-yl) aniline | 53112-28-0 | substance | Aquatic Chronic 2 | Hazard statement codes: H411. Labelling pictogram and signal word: GHS09. Labelling hazard statements: H411 | ||
| piperazine hydrochloride; [1] piperazine dihydrochloride; [2] piperazine phosphate [3] | piperazine hydrochloride; [1] piperazine dihydrochloride; [2] piperazine phosphate [3] | 6094-40-2 [1] 142-64-3 [2] 1951-97-9 [3] | 228-042-7 [1] 205-551-2 [2] 217-775-8 [3] | substance | Repr. 2; Eye Irrit. 2; Skin Irrit. 2; Resp. Sens. 1; Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H361fd; H319; H315; H334; H317; H412. Labelling pictogram and signal word: GHS08; Dgr. Labelling hazard statements: H361fd; H319; H315; H334; H317; H412 | |
| cyprodinil (ISO); 4-cyclopropyl-6-methyl-N-phenylpyrimidin-2-amine | cyprodinil (ISO); 4-cyclopropyl-6-methyl-N-phenylpyrimidin-2-amine | 121552-61-2 | substance | Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | M=10 | Hazard statement codes: H317; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H317; H410 | |
| (1S-cis)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine 2-hydroxy-2-phenylacetate | (1S-cis)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine 2-hydroxy-2-phenylacetate | 79617-97-3 | 420-560-3 | substance | Eye Dam. 1; Aquatic Acute 1; Aquatic Chronic 1 | M=10 | Hazard statement codes: H318; H400; H410. Labelling pictogram and signal word: GHS05; GHS09; Dgr. Labelling hazard statements: H318; H410 |
| 3-(piperazin-1-yl)-benzo[d]isothiazole hydrochloride | 3-(piperazin-1-yl)-benzo[d]isothiazole hydrochloride | 87691-88-1 | 421-310-6 | substance | Repr. 2; Acute Tox. 4 *; Eye Irrit. 2; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H361f***; H302; H319; H317; H400; H410. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Wng. Labelling hazard statements: H361f***; H302; H319; H317; H410 | |
| 2-ethylphenylhydrazine hydrochloride | 2-ethylphenylhydrazine hydrochloride | 19398-06-2 | 421-460-2 | substance | Carc. 2; STOT RE 1; Acute Tox. 4 *; Eye Dam. 1; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | M=10 | Hazard statement codes: H351; H372**; H302; H318; H317; H400; H410. Labelling pictogram and signal word: GHS05; GHS08; GHS07; GHS09; Dgr. Labelling hazard statements: H351; H372**; H302; H318; H317; H410 |
| (2-chloroethyl)(3-hydroxypropyl)ammonium chloride | (2-chloroethyl)(3-hydroxypropyl)ammonium chloride | 40722-80-3 | 429-740-6 | substance | Carc. 1B; Muta. 1B; STOT RE 2 *; Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H350; H340; H373**; H317; H412. Labelling pictogram and signal word: GHS08; GHS07; Dgr. Labelling hazard statements: H350; H340; H373**; H317; H412 | |
| N-[3-(1,1-dimethylethyl)-1H-pyrazol-5-yl]-N’-hydroxy-4-nitrobenzenecarboximidamide | N-[3-(1,1-dimethylethyl)-1H-pyrazol-5-yl]-N’-hydroxy-4-nitrobenzenecarboximidamide | 152828-23-4 | 423-530-8 | substance | STOT RE 1; Acute Tox. 4 *; Aquatic Chronic 3 | Hazard statement codes: H372**; H302; H412. Labelling pictogram and signal word: GHS08; GHS07; Dgr. Labelling hazard statements: H372**; H302; H412 | |
| reaction product of diphenylamine, phenothiazine, and alkenes, branched (C8-10, C9-rich) | reaction product of diphenylamine, phenothiazine, and alkenes, branched (C8-10, C9-rich) | 439-540-0 | substance | Skin Irrit. 2; Skin Sens. 1; Aquatic Chronic 4 | Hazard statement codes: H315; H317; H413. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H315; H317; H413 | ||
| 4-[(3-chlorophenyl)(1H-imidazol-1-yl)methyl]-1,2-benzenediamine dihydrochloride | 4-[(3-chlorophenyl)(1H-imidazol-1-yl)methyl]-1,2-benzenediamine dihydrochloride | 159939-85-2 | 425-030-5 | substance | Repr. 2; Acute Tox. 4 *; Skin Corr. 1B; Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H361f***; H302; H314; H317; H411. Labelling pictogram and signal word: GHS05; GHS08; GHS07; GHS09; Dgr. Labelling hazard statements: H361f***; H302; H314; H317; H411 | |
| chloro-N,N-dimethylformiminium chloride | chloro-N,N-dimethylformiminium chloride | 3724-43-4 | 425-970-6 | substance | Repr. 1B; Acute Tox. 4 *; Skin Corr. 1A | Hazard statement codes: H360D***; H302; H314. Labelling pictogram and signal word: GHS05; GHS08; GHS07; Dgr. Labelling hazard statements: H360D***; H302; H314. Supplementary hazard statements: EUH014 | |
| cis-1-(3-chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride | cis-1-(3-chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride | 51229-78-8 | 426-020-3 | substance | Flam. Sol. 2; Repr. 2; Acute Tox. 4 *; Skin Irrit. 2; Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H228; H361d***; H302; H315; H317; H411. Labelling pictogram and signal word: GHS02; GHS08; GHS07; GHS09; Wng. Labelling hazard statements: H228; H361d***; H302; H315; H317; H411 | |
| imidacloprid (ISO); (E)-1-(6-chloro- 3-pyridylmethyl)-N-nitroimidazolidin-2-ylideneamine;(2E)-1-[(6-chloropyridin- 3-yl) methyl]-N-nitroimidazolidin-2-imine | imidacloprid (ISO); (E)-1-(6-chloro- 3-pyridylmethyl)-N-nitroimidazolidin-2-ylideneamine;(2E)-1-[(6-chloropyridin- 3-yl) methyl]-N-nitroimidazolidin-2-imine | 138261-41-3 | 428-040-8 | substance | Acute Tox. 3; Aquatic Acute 1; Aquatic Chronic 1 | Oral: ATE = 131 mg/kg bw | M = 100 | M = 1000 | Hazard statement codes: H301; H400; H410. Labelling pictogram and signal word: GHS06; GHS09; Dgr. Labelling hazard statements: H301; H410. Date of Secretary of State decision: 2023-09-23. Date of entry into legal effect: 2023-10-20. Final compliance date: 2025-04-20 |
| 7-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one; [containing < 0,5 % formamide (EC No 200-842-0)] | 7-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one; [containing < 0,5 % formamide (EC No 200-842-0)] | 199327-61-2 | 429-400-7 | substance | Aquatic Chronic 3 | Hazard statement codes: H412. Labelling pictogram and signal word: —. Labelling hazard statements: H412 | |
| 7-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one; [containing ≥ 0,5 % formamide (EC No 200-842-0)] | 7-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one; [containing ≥ 0,5 % formamide (EC No 200-842-0)] | 199327-61-2 | 429-400-7 | substance | Repr. 1B; Aquatic Chronic 3 | Hazard statement codes: H360D***; H412. Labelling pictogram and signal word: GHS08; Dgr. Labelling hazard statements: H360D***; H412 | |
| reaction products of diisopropanolamine with formaldehyde (1:4) | reaction products of diisopropanolamine with formaldehyde (1:4) | 220444-73-5 | 432-440-8 | substance | Carc. 2; Acute Tox. 4 *; Skin Corr. 1B; Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H351; H302; H314; H317; H411. Labelling pictogram and signal word: GHS05; GHS08; GHS07; GHS09; Dgr. Labelling hazard statements: H351; H302; H314; H317; H411 | |
| 1-(3-methoxypropyl)-4-piperidinamine | 1-(3-methoxypropyl)-4-piperidinamine | 179474-79-4 | 431-950-8 | substance | Acute Tox. 4 *; Acute Tox. 4 *; Skin Corr. 1B; Aquatic Chronic 3 | Hazard statement codes: H312; H302; H314; H412. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H312; H302; H314; H412 | |
| benzyl(S)-2-[(2’-cyanobiphenyl-4-ylmethyl)pentanoylamino]-3-methylbutyrate | benzyl(S)-2-[(2’-cyanobiphenyl-4-ylmethyl)pentanoylamino]-3-methylbutyrate | 137864-22-3 | 427-470-3 | substance | Acute Tox. 4 *; Skin Sens. 1 | Hazard statement codes: H302; H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302; H317 | |
| tripropylammonium dihydrogenphosphate | tripropylammonium dihydrogenphosphate | 35687-90-2 | 433-700-3 | substance | Acute Tox. 4 * | Hazard statement codes: H302. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302 | |
| N-ethyl-3-trimethoxysilyl-2-methyl-propanamine | N-ethyl-3-trimethoxysilyl-2-methyl-propanamine | 227085-51-0 | 437-720-3 | substance | Eye Dam. 1 | Hazard statement codes: H318. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318 | |
| 3,5-dichloro-2-fluoro-4-(1,1,2,3,3,3-hexafluoropropoxy)aniline | 3,5-dichloro-2-fluoro-4-(1,1,2,3,3,3-hexafluoropropoxy)aniline | 121451-05-6 | 441-190-9 | substance | Acute Tox. 4 *; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | M=10 | Hazard statement codes: H302; H317; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H317; H410 |
| bis(2-hydroxyethyl)-(2-hydroxypropyl)ammonium acetate | bis(2-hydroxyethyl)-(2-hydroxypropyl)ammonium acetate | 191617-13-7 | 444-360-0 | substance | Aquatic Chronic 3 | Hazard statement codes: H412. Labelling pictogram and signal word: —. Labelling hazard statements: H412 | |
| 3-chloro-4-(3-fluorobenzyloxy)aniline | 3-chloro-4-(3-fluorobenzyloxy)aniline | 202197-26-0 | 445-590-4 | substance | Muta. 2; Acute Tox. 4 *; STOT RE 2 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H341; H302; H373**; H400; H410. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Wng. Labelling hazard statements: H341; H302; H373**; H410 | |
| bis(hydrogenated tallow C16-18-alkyl)hydroxylamine | bis(hydrogenated tallow C16-18-alkyl)hydroxylamine | 418-370-0 | substance | Skin Sens. 1; Aquatic Chronic 4 | Hazard statement codes: H317; H413. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317; H413 | ||
| reaction mass of: 1-[di(4-octylphenyl)aminomethyl]-5-methyl-1H-benzotriazole; 1-[di(4-octylphenyl)aminomethyl]-4-methyl-1H-benzotriazole; reaction mass of: N-[(5-methyl-1H-benzotriazol-1-yl)methyl]-4-octyl-N-(4-octylphenyl)aniline; N-[(4-methyl-1H-benzotriazol-1-yl)methyl]-4-octyl-N-(4-octylphenyl)aniline | reaction mass of: 1-[di(4-octylphenyl)aminomethyl]-5-methyl-1H-benzotriazole; 1-[di(4-octylphenyl)aminomethyl]-4-methyl-1H-benzotriazole; reaction mass of: N-[(5-methyl-1H-benzotriazol-1-yl)methyl]-4-octyl-N-(4-octylphenyl)aniline; N-[(4-methyl-1H-benzotriazol-1-yl)methyl]-4-octyl-N-(4-octylphenyl)aniline | 420-720-2 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | ||
| (S)-azetidine-2-carboxylic acid 4-cyanobenzylamide hydrochloride | (S)-azetidine-2-carboxylic acid 4-cyanobenzylamide hydrochloride | 433-010-2 | substance | Acute Tox. 4 *; Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H302; H317; H412. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302; H317; H412 | ||
| reaction mass of: ethyl 2-((4-(5,6-dichlorobenzothiazol-2-ylazo)phenyl)ethylamino)benzoate; ethyl 2-((4-(6,7-dichlorobenzothiazol-2-ylazo)phenyl)ethylamino)benzoate | reaction mass of: ethyl 2-((4-(5,6-dichlorobenzothiazol-2-ylazo)phenyl)ethylamino)benzoate; ethyl 2-((4-(6,7-dichlorobenzothiazol-2-ylazo)phenyl)ethylamino)benzoate | 160987-57-5 | 434-970-5 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | |
| ammonium (η-6-2-(2-(1,2-dicarboxylatoethylamino) ethylamino)butane-1,4-dioato(4-)) iron(3+) monohydrate | ammonium (η-6-2-(2-(1,2-dicarboxylatoethylamino) ethylamino)butane-1,4-dioato(4-)) iron(3+) monohydrate | 435-210-5 | substance | Aquatic Chronic 2 | Hazard statement codes: H411. Labelling pictogram and signal word: GHS09. Labelling hazard statements: H411 | ||
| alkyl(rapeseed oil), bis(2-hydroxyethyl)ammonium fluoride | alkyl(rapeseed oil), bis(2-hydroxyethyl)ammonium fluoride | 435-650-8 | substance | Acute Tox. 4 *; Skin Corr. 1A; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H302; H314; H400; H410. Labelling pictogram and signal word: GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H302; H314; H410 | ||
| (R, S)-1-[2-amino-1 (4-methoxyphenyl)ethyl]cyclohexanol acetate | (R, S)-1-[2-amino-1 (4-methoxyphenyl)ethyl]cyclohexanol acetate | 445-750-3 | substance | Acute Tox. 4 *; Eye Dam. 1; Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H302; H318; H317; H412. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H302; H318; H317; H412 | ||
| fatty acids, C18-unsatd., dimers, reaction products with 1-piperazineethanamine and tall oil | fatty acids, C18-unsatd., dimers, reaction products with 1-piperazineethanamine and tall oil | 206565-89-1 | 447-880-6 | substance | Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | M=10 | Hazard statement codes: H315; H318; H317; H400; H410. Labelling pictogram and signal word: GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H315; H318; H317; H410 |
| 1-amino-4-[(4-amino-2-sulfofenyl)amino]-9,10-dihydro-9,10-dioxo-2-anthracenesulfonic acid, disodium salt, reaction products with 2-[[3-[(4,6-dichloro-1,3,5-triazin-2-yl)ethylamino]phenyl]sulfonyl]ethyl hydrogen sulfate, sodium salts | 1-amino-4-[(4-amino-2-sulfofenyl)amino]-9,10-dihydro-9,10-dioxo-2-anthracenesulfonic acid, disodium salt, reaction products with 2-[[3-[(4,6-dichloro-1,3,5-triazin-2-yl)ethylamino]phenyl]sulfonyl]ethyl hydrogen sulfate, sodium salts | 500717-36-2 | 451-430-4 | substance | Eye Dam. 1; Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H318; H317; H412. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H318; H317; H412 | |
| reaction mass of: 4-amino-3-(4-ethenesulfonyl-2-sulfonatophenylazo)-5-hydroxy-6-(5-{]4-chloro-6-[}4-(2-sulfonatooxyethanesulfonyl) phenylamino{]-1,3,5-triazin-2-ylamino[}-2-sulfonatophenylazo)naphthalene-2,7-disulfonate potassium/sodium; 4-amino-5-hydroxy-6-(5-{]4-chloro-6-[}4-(2-sulfonatooxyethanesulfonyl) phenylamino{]-1,3,5-triazin-2-ylamino[}-2-sulfonatophenylazo)-3-(2-sulfonato-4-(2-sulfonatooxyethanesulfonyl) phenylazo)naphthalene-2,7-disulfonate potassium/sodium | reaction mass of: 4-amino-3-(4-ethenesulfonyl-2-sulfonatophenylazo)-5-hydroxy-6-(5-{]4-chloro-6-[}4-(2-sulfonatooxyethanesulfonyl) phenylamino{]-1,3,5-triazin-2-ylamino[}-2-sulfonatophenylazo)naphthalene-2,7-disulfonate potassium/sodium; 4-amino-5-hydroxy-6-(5-{]4-chloro-6-[}4-(2-sulfonatooxyethanesulfonyl) phenylamino{]-1,3,5-triazin-2-ylamino[}-2-sulfonatophenylazo)-3-(2-sulfonato-4-(2-sulfonatooxyethanesulfonyl) phenylazo)naphthalene-2,7-disulfonate potassium/sodium | 586372-44-3 | 451-440-9 | substance | Eye Dam. 1 | Hazard statement codes: H318. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318 | |
| ethidium bromide; 3,8-diamino-1-ethyl-6-phenylphenantridinium bromide | ethidium bromide; 3,8-diamino-1-ethyl-6-phenylphenantridinium bromide | 1239-45-8 | 214-984-6 | substance | Muta. 2; Acute Tox. 2 *; Acute Tox. 4 * | Hazard statement codes: H341; H330; H302. Labelling pictogram and signal word: GHS06; GHS08; Dgr. Labelling hazard statements: H341; H330; H302 | |
| (R, S)-2-amino-3,3-dimethylbutane amide | (R, S)-2-amino-3,3-dimethylbutane amide | 144177-62-8 | 447-860-7 | substance | Repr. 2; STOT RE 2 *; Eye Irrit. 2; Skin Irrit. 2; Skin Sens. 1 | Hazard statement codes: H361f***; H373**; H319; H315; H317. Labelling pictogram and signal word: GHS08; GHS07; Wng. Labelling hazard statements: H361f***; H373**; H319; H315; H317 | |
| bupirimate (ISO); 5-butyl-2-ethylamino-6- methylpyrimidin-4-yl dimethylsulphamate | bupirimate (ISO); 5-butyl-2-ethylamino-6- methylpyrimidin-4-yl dimethylsulphamate | 41483-43-6 | 255-391-2 | substance | Carc. 2; Skin Sens. 1B; Aquatic Chronic 1 | M = 1 | Hazard statement codes: H351; H317; H410. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Wng. Labelling hazard statements: H351; H317; H410 |
| 3-amino-9-ethyl carbazole; 9-ethylcarbazol-3-ylamine | 3-amino-9-ethyl carbazole; 9-ethylcarbazol-3-ylamine | 132-32-1 | 205-057-7 | substance | Carc. 1B | Hazard statement codes: H350. Labelling pictogram and signal word: GHS08; Dgr. Labelling hazard statements: H350 | |
| leucomalachite green; N,N,N',N'-tetramethyl-4,4'- benzylidenedianiline | leucomalachite green; N,N,N',N'-tetramethyl-4,4'- benzylidenedianiline | 129-73-7 | 204-961-9 | substance | Carc. 2; Muta. 2 | Hazard statement codes: H351; H341. Labelling pictogram and signal word: GHS08 Wng. Labelling hazard statements: H351; H341 | |
| octadecylamine | octadecylamine | 124-30-1 | 204-695-3 | substance | Asp. Tox. 1; STOT RE 2; Skin Irrit. 2; Eye Dam. 1; Aquatic Acute 1; Aquatic Chronic 1 | M = 10 | M = 10 | Hazard statement codes: H304; H373; (gastro-intestinal tract, liver, immune system); H315; H318; H400; H410. Labelling pictogram and signal word: GHS05; GHS08; GHS09; Dgr. Labelling hazard statements: H304; H373; (gastro-intestinal tract, liver, immune system); H315; H318; H410 |
| (Z)-octadec-9-enylamine | (Z)-octadec-9-enylamine | 112-90-3 | 204-015-5 | substance | Acute Tox. 4; Asp. Tox. 1; STOT SE 3; STOT RE 2; Skin Corr. 1B; Aquatic Acute 1; Aquatic Chronic 1 | M = 10 | M = 10 | Hazard statement codes: H302; H304; H335; H373 (gastro-intestinal tract, liver, immune system); H314; H400; H410. Labelling pictogram and signal word: GHS05; GHS07; GHS08; GHS09; Dgr. Labelling hazard statements: H302; H304; H335; H373 (gastro-intestinal tract, liver, immune system); H314; H410 |
| amines, hydrogenated tallow alkyl | amines, hydrogenated tallow alkyl | 61788-45-2 | 262-976-6 | substance | Asp. Tox. 1; STOT RE 2; Skin Irrit. 2; Eye Dam. 1; Aquatic Acute 1; Aquatic Chronic 1 | M = 10 | M = 10 | Hazard statement codes: H304; H373 (gastro-intestinal tract, liver, immune system); H315; H318; H400; H410. Labelling pictogram and signal word: GHS08; GHS05; GHS09; Dgr. Labelling hazard statements: H304; H373 (gastro-intestinal tract, liver, immune system); H315; H318; H410 |
| amines, coco alkyl | amines, coco alkyl | 61788-46-3 | 262-977-1 | substance | Acute Tox. 4; Asp. Tox. 1; STOT SE 3; STOT RE 2; Skin Corr. 1B; Aquatic Acute 1; Aquatic Chronic 1 | M = 10 | M = 10 | Hazard statement codes: H302; H304; H335; H373 (gastro-intestinal tract, liver, immune system); H314; H400; H410. Labelling pictogram and signal word: GHS05; GHS07; GHS08; GHS09; Dgr. Labelling hazard statements: H302; H304; H335; H373 (gastro-intestinal tract, liver, immune system); H314; H410 |
| amines, tallow alkyl | amines, tallow alkyl | 61790-33-8 | 263-125-1 | substance | Acute Tox. 4; Asp. Tox. 1; STOT RE 2; Skin Corr. 1B; Aquatic Acute 1; Aquatic Chronic 1 | M = 10 | M = 10 | Hazard statement codes: H302; H304; H373 (gastro-intestinal tract, liver, immune system); H314; H400; H410. Labelling pictogram and signal word: GHS05; GHS07; GHS08; GHS09; Dgr. Labelling hazard statements: H302; H304; H373(gastro-intestinal tract, liver, immune system); H314; H410 |
| fluazinam (ISO); 3- chloro-N-[3-chloro-2,6- dinitro-4-(trifluoromethyl)phenyl]-5- (trifluoromethyl) pyridin-2-amine | fluazinam (ISO); 3- chloro-N-[3-chloro-2,6- dinitro-4-(trifluoromethyl)phenyl]-5- (trifluoromethyl) pyridin-2-amine | 79622-59-6 | substance | Repr. 2; Acute Tox. 4; Eye Dam. 1; Skin Sens. 1A; Aquatic Acute 1; Aquatic Chronic 1 | M = 10 | M = 10 | Hazard statement codes: H361d; H332; H318; H317; H400; H410. Labelling pictogram and signal word: GHS08; GHS07; GHS05; GHS09; Dgr. Labelling hazard statements: H361d; H332; H318; H317; H410 | |
| triflumizole (ISO); (1E)-N-[4-chloro-2-(trifluoromethyl)phenyl]-1- (1H-imidazol-1-yl)-2- propoxyethanimine | triflumizole (ISO); (1E)-N-[4-chloro-2-(trifluoromethyl)phenyl]-1- (1H-imidazol-1-yl)-2- propoxyethanimine | 68694-11-1 | substance | Repr. 1B; Acute Tox. 4; STOT RE 2; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | M = 1 | M = 1 | Hazard statement codes: H360D; H302; H373 (liver); H317; H400; H410. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Dgr. Labelling hazard statements: H360D; H302; H373 (liver); H317; H410 | |
| reaction products of paraformaldehyde and 2-hydroxypropylamine (ratio 3:2); [formaldehyde released from 3,3′-methylenebis [5-methyloxazolidine]; formaldehyde released from oxazolidin]; [MBO] | reaction products of paraformaldehyde and 2-hydroxypropylamine (ratio 3:2); [formaldehyde released from 3,3′-methylenebis [5-methyloxazolidine]; formaldehyde released from oxazolidin]; [MBO] | substance | Carc. 1B; Muta. 2; Acute Tox. 4; Acute Tox. 3; Acute Tox. 4; STOT RE 2; Skin Corr. 1B; Eye Dam. 1; Skin Sens. 1A; Aquatic Chronic 2 | Hazard statement codes: H350; H341; H332; H311; H302; H373 (gastrointestinal tract, respiratory tract); H314; H318; H317; H411. Labelling pictogram and signal word: GHS08; GHS06; GHS05; GHS09; Dgr. Labelling hazard statements: H350; H341; H332; H311; H302; H373 (gastrointestinal tract, respiratory tract); H314; H317; H411. Supplementary hazard statements: EUH071. Notes: 8; 9 | |||
| reaction products of paraformaldehyde with 2-hydroxypropylamine (ratio 1:1); [formaldehyde released from α,α,α-trimethyl- 1,3,5-triazine-1,3,5 (2H,4H,6H)-triethanol]; [HPT] | reaction products of paraformaldehyde with 2-hydroxypropylamine (ratio 1:1); [formaldehyde released from α,α,α-trimethyl- 1,3,5-triazine-1,3,5 (2H,4H,6H)-triethanol]; [HPT] | substance | Carc. 1B; Muta. 2; Acute Tox. 4; Acute Tox. 4; STOT RE 2; Skin Corr. 1C; Eye Dam. 1; Skin Sens. 1A; Aquatic Chronic 2 | Hazard statement codes: H350; H341; H332; H302; H373 (gastrointestinal tract, respiratory tract); H314; H318; H317; H411. Labelling pictogram and signal word: GHS08; GHS07; GHS05; GHS09; Dgr. Labelling hazard statements: H350; H341; H332; H302; H373 (gastrointestinal tract, respiratory tract); H314; H317; H411. Supplementary hazard statements: EUH071. Notes: 8; 9 | |||
| methylhydrazine | methylhydrazine | 60-34-4 | 200-471-4 | substance | Carc. 1B | Hazard statement codes: H350. Labelling pictogram and signal word: GHS08; Dgr. Labelling hazard statements: H350’ | |
| reaction mass of 1-[2-(2-aminobutoxy)ethoxy]but-2-ylamine and 1-({[2-(2-aminobutoxy)ethoxy]methyl}propoxy) but-2-ylamine | reaction mass of 1-[2-(2-aminobutoxy)ethoxy]but-2-ylamine and 1-({[2-(2-aminobutoxy)ethoxy]methyl}propoxy) but-2-ylamine | 447-920-2 | substance | Repr. 2; Acute Tox. 4; Skin Corr. 1B; Eye Dam. 1 | Hazard statement codes: H361f; H302; H314; H318. Labelling pictogram and signal word: GHS08; GHS07; GHS05; Dgr. Labelling hazard statements: H361f; H302; H314. Supplementary hazard statements: EUH071 | ||
| mecetronium etilsulfate; N-ethyl-N,N-dimethylhexadecan-1-aminium ethyl sulfate; mecetronium ethyl sulphate; [MES] | mecetronium etilsulfate; N-ethyl-N,N-dimethylhexadecan-1-aminium ethyl sulfate; mecetronium ethyl sulphate; [MES] | 3006-10-8 | 221-106-5 | substance | Skin Corr. 1; Eye Dam. 1; Aquatic Acute 1; Aquatic Chronic 1 | M = 100 | M = 1000 | Hazard statement codes: H314; H318; H400; H410. Labelling pictogram and signal word: GHS05; GHS09; Dgr. Labelling hazard statements: H314; H410. Supplementary hazard statements: EUH071 |
| benfluralin (ISO); N-butyl-N-ethyl-α,α,α-trifluoro-2,6-dinitro-p-toluidine | benfluralin (ISO); N-butyl-N-ethyl-α,α,α-trifluoro-2,6-dinitro-p-toluidine | 1861-40-1 | 217-465-2 | substance | Carc. 2; Repr. 2; Skin Irrit. 2; Eye Irrit. 2; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | M=10 | M=10 | Hazard statement codes: H351; H361d; H315; H319; H317; H400; H410. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Wng. Labelling hazard statements: H351; H361d; H315; H319; H317; H410. Date of Secretary of State decision: 2024-02-02. Date of entry into legal effect: 2024-03-02. Final compliance date: 2025-09-02 |
| N,N-dimethyl-p-toluidine | N,N-dimethyl-p-toluidine | 99-97-8 | 202-805-4 | substance | Acute Tox. 3; Acute Tox. 4; STOT RE 2; Carc. 1B; Aquatic Chronic 3 | oral: ATE = 140 mg/kg bw | inhalation: ATE = 1.4 mg/L (dusts or mists) | Hazard statement codes: H301; H332; H373 (blood system; respiratory tract); H350; H412. Labelling pictogram and signal word: GHS08; GHS06; Dgr. Labelling hazard statements: H301; H332; H373; (blood system; respiratory tract); H350; H412. Date of Secretary of State decision: 2024-02-02. Date of entry into legal effect: 2024-03-02. Final compliance date: 2025-09-02 |
| 1-phenylethan-1-one (1-phenylethylidene)hydrazone | 1-phenylethan-1-one (1-phenylethylidene)hydrazone | 729-43-1 | 211-979-0 | substance | Skin Sens. 1 | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317. Date of Secretary of State decision: 2025-01-15. Date of entry into legal effect: 2025-02-15. Final compliance date: 2026-08-15 | |
| 1,4-Benzenediamine, N,N'-mixed Ph and tolyl derivs. | 1,4-Benzenediamine, N,N'-mixed Ph and tolyl derivs. | 68953-84-4 | 273-227-8 | substance | Skin Sens. 1; Repr. 1B | Hazard statement codes: H317; H360FD. Labelling pictogram and signal word: GHS07; GHS08; Dgr. Labelling hazard statements: H317; H360FD. Date of Secretary of State decision: 2025-01-15. Date of entry into legal effect: 2025-02-15. Final compliance date: 2026-08-15 | |
| fenpropidin (ISO); (R,S)-1-[3-(4-tert-butylphenyl)-2-methylpropyl]piperidine | fenpropidin (ISO); (R,S)-1-[3-(4-tert-butylphenyl)-2-methylpropyl]piperidine | 67306-00-7 | substance | Repr. 2; Acute Tox. 4; Acute Tox. 4; STOT SE 3; STOT SE 3; STOT RE 2; Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Inhalation: ATE = 1.2 mg/L | (dusts or mists) | Oral: ATE = 1 330 mg/kg bw | M = 1 000 | M = 10 000 | Hazard statement codes: H361d; H332; H302; H335; H336; H373 (nervous system, eyes, lungs); H315; H318; H317; H400; H410. Labelling pictogram and signal word: GHS08; GHS07; GHS05; GHS09; Dgr. Labelling hazard statements: H361d; H332; H302; H335; H336; H373 (nervous system, eyes, lungs); H315; H318; H317; H410. Date of Secretary of State decision: 2025-09-12. Date of entry into legal effect: 2025-09-23. Final compliance date: 2027-03-23 | |
| N-1-naphthylaniline; N-phenylnaphthalen-1-amine | N-1-naphthylaniline; N-phenylnaphthalen-1-amine | 90-30-2 | 201-983-0 | substance | Acute Tox. 4; STOT RE 2; Skin Sens. 1 | oral: ATE = 1 200 mg/kg bw | Hazard statement codes: H302; H373 (blood system); H317. Labelling pictogram and signal word: GHS07; GHS08; Wng. Labelling hazard statements: H302; H373 (blood system); H317. Date of Secretary of State decision: 2025-09-12. Date of entry into legal effect: 2025-09-23. Final compliance date: 2027-03-23 |
| ethyleneimine; aziridine | ethyleneimine; aziridine | 151-56-4 | 205-793-9 | substance | Flam. Liq. 2; Carc. 1B; Muta. 1B; Acute Tox. 2 *; Acute Tox. 1; Acute Tox. 2 *; Skin Corr. 1B; Aquatic Chronic 2 | Hazard statement codes: H225; H350; H340; H330; H310; H300; H314; H411. Labelling pictogram and signal word: GHS02; GHS06; GHS08; GHS05; GHS09; Dgr. Labelling hazard statements: H225; H350; H340; H330; H310; H300; H314; H411. Notes: D |
Official source
Entries are copied exactly as published. Not legal advice; always check the official text.